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Chapter 1
The SERK protein family
Structure and function of multi-tasking co-receptors in plants
M. aan den Toorn
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The cell is the smallest biological unit that still exhibits all the hallmark proper-
ties of life. No cell can exist in isolation, for its survival it needs to interact with 
and respond correctly to environmental changes or developmental cues. This is 
true whether it is a unicellular organism, or part of a specialised tissue or organ 
in a multicellular organism. All cells possess a distinct physical barrier, the plas-
ma membrane, between their internal components and the external environment. 
For extracellular signals, or ligands, to elicit intracellular responses, the plasma 
membrane contains many membrane spanning receptor molecules. These proteins 
contain an extracellular domain capable of perceiving signals and an intracellular 
domain capable of transducing that signal into the cell. The signal transduction 
cascade can be seen as a canonical reaction, where ligand binding to a recep-
tor protein causes a conformational change leading to activation of intracellular 
signalling proteins (e.g. second messengers) and ending with the generation of 
transcriptional and non-transcriptional effects. During the cascade the signal is 
often amplified; more downstream proteins are activated than the number of li-
gand-bound-receptors initially present (Berg et al. 2002). Signalling cascades do 
not function as separate pathways but are part of intricate signalling networks, 
which are essential to be able to integrate the multitude of signals that a single 
cell perceives at any given moment. The precise composition and connections in 
these signalling networks differ for cells of different tissues, organs or developmen-
tal stages, providing plasticity in responses to a signal (Hynes et al. 2013). Cells 
achieve their specific signalling networks by altering the organisation of signalling 
proteins in location, time and concentration (Bhattacharyya et al. 2006, Kholoden-
ko 2006, Scott et al. 2009; Good et al. 2011). 
Formation of receptor complexes is essential in most signalling pathways. 
Many of the well-known eukaryotic receptor proteins, such as the receptor tyrosine 
kinases (RTKs) (van der Geer et al. 1994) and class I cytokine receptors (Bazan 
1990) in animals and the receptor like kinases (RLKs) in plants (Shiu et al. 2001), 
are single pass transmembrane receptors that either have an intracellular kinase 
domain or associate with intracellular kinases. Since the intracellular kinase and 
extracellular ligand-binding domain are only linked via a single pass transmem-
brane helix, activation of these receptors occurs via dimeric or oligomeric complex-
es (Heldin 1995; Zhang et al. 2006; Ehrlich et al. 2011). Initial models stated that 
the inactive receptors are monomers and ligand-induced recruitment of interaction 
partners caused activation (Schlessinger 2000). In contrast, recent studies show 
that at least some receptors are already present in preformed oligomeric complex-
es in absence of activating ligand, such as epidermal growth factor receptor EGFR 
(Gadella et al. 1995; Clayton et al. 2005), cytokine receptor gp130 (Tenhumberg 
et al. 2006) and brassinosteroid receptor BRI1 (Bücherl et al. 2013). Whether the 
inactive receptor is monomeric or present in preformed complexes, activation still 
requires a structural change to an “active” dimeric or oligomeric conformation, 
induced by ligand binding. This brings the kinase domains of the receptors in close 
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enough proximity to activate each other via transphosphorylation events (Pang et 
al. 2012) With the growing amount of structural data available on receptor pro-
teins (with and without ligand, in complex with interaction partners or inhibitors) 
we are now moving towards an atomic-level understanding of the mechanisms of 
signal transduction (as of July 2013, 3336 entries with the GO ID cell-surface recep-
tor signalling pathway can be found in the RCSB Protein Data Bank; Berman et al. 
2000). It is becoming increasingly clear that conformational changes in receptor 
complex structure are essential for ligand binding, complex formation and subse-
quent enzymatic catalysis (Grant et al. 2010).
When more than one type of receptor is part of the signalling complex required 
to mediate a cellular response, we can distinguish main receptors and co-receptors. 
The main receptor is defined here as the protein that both perceives a specific sig-
nal and induces intracellular changes in response to that signal. A co-receptor, or 
accessory/auxiliary receptor, is defined as a receptor that, on its own, cannot per-
ceive the signal or transduce the signal across the membrane but still has a function 
in the signal transduction pathway. Many co-receptors are found to be promiscu-
ous, being able to form complexes with several different main receptors, which 
allows them to function in multiple signalling pathways (Kirkbride et al. 2005). 
The Somatic Embryogenesis Receptor-like Kinase (SERK) protein family in plants 
is a good example of such multi-tasking co-receptors (Chinchilla et al. 2009). This 
family of receptor-like kinases functions in several diverse signalling pathways, and 
its members have partially overlapping functions (explained in more detail below). 
They are essential for proper signal transduction in several signalling cascades. 
This raises the questions why such additional receptors are needed, what kind of 
additional layer of modulation and regulation they provide, and how they confer 
their specific functions in the different signalling complexes.
In this chapter I will discuss current knowledge on signalling functions of the 
SERK co- receptor family and how this relates to other co-receptors. Next I will 
discuss the recent structural data on SERK proteins and their signalling complexes 
and the implications this new data provides for plant signalling complexes. 
The multi-tasking functions of the SERK co-receptor 
family 
The SERKs are a family of leucine-rich-repeat receptor like kinases (LRR-RLKs). Af-
ter initially being implicated in the pluripotent potential of somatic cells (Schmidt 
et al. 1997), the SERK proteins were later identified to function in several differ-
ent, seemingly unrelated, signalling pathways and show partial redundancy (Al-
brecht et al. 2005; Albrecht et al. 2008; Roux et al. 2011). The family consists of 
five highly homologous members in A. thaliana, arisen through gene duplication 
events (Hecht et al. 2001). Since the high homology between the SERK proteins 
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and their overlapping expression pattern would suggest redundancy, the precise 
biochemical mechanism for specificity in this protein family remains unclear. As of 
yet, autonomous ligand binding has not been established for the SERKs, and the 
emerging picture is that they form higher order complexes with main receptors to 
modulate signal transduction as co-receptors, which are essential for proper signal 
transduction (Gou et al. 2012) (see Figure 1). The SERK co-receptors are promis-
cuous, implicated in more than one signalling pathway including somatic embryo-
genesis (SERK1; Schmidt et al. 1997), abscission (SERK1;Lewis et al. 2010), male 
SERK 1
SERK 5
SERK 4/
BKK1
SERK 3/
BAK1
SERK 2
Somatic 
embryogenesis
EXS1/EMS?
BRI1
FLS2/EFR/PEPR1
Abscission
Brassinosteroid responses
Sporogenesis
Plant development
Plant defence responses
Cell death
?
?
?
?
Co-receptor Main receptor Pathway
Figure 1 The different signalling pathways that make use of SERK co-receptors
The SERK co-receptors function in divers pathways, and only show partial functional redundancy. 
Their precise mode of action and necessity in the different pathways is not completely clear, and 
might differ for the different signalling pathways. 
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sporogenesis (SERK1 and SERK2; Albrecht et al. 2005), brassinosteroid signalling 
(SERK1, SERK3/BRI1 Associated Kinase 1 (BAK1) and SERK4/BAK1-like Kinase 
1 (BKK1); Li et al. 2002; Nam et al. 2002; Karlova et al. 2006; He et al. 2007; Al-
brecht et al. 2008), plant development (SERK1, SERK3/BAK1 and SERK4/BKK1; 
Du et al. 2012), plant defence (SERK3/BAK1 and SERK4/BKK1; Chinchilla et al. 
2007; Heese et al. 2007; Postel et al. 2010) and cell death responses (SERK3/BAK1 
and SERK4/BKK1; He et al. 2007; Kemmerling et al. 2007). They form complexes 
with main receptors such as Brassinosteroid Insensitive 1 (BRI11; Russinova et al. 
2004; Wang et al. 2008), Flagellin Sensitive 2 (FLS2; the main receptor for bacteri-
al flagellin; Chinchilla et al. 2007; Heese et al. 2007) , Elongation Factor Receptor 
(EFR; the main receptor for the bacterial effector elongation factor Tu; Zipfel et al. 
2006; Roux et al. 2011) and interaction has been proposed for Excess Microsporo-
cytes 1 (EMS1)/Extra Sporogenous Cells (EXS) (involved in sporogenesis; Albrecht 
et al. 2005)) (see Figure 1). How the highly homologous SERK proteins are able 
to convey their specificity both in function and complex formation is not clear (see 
Chapter 2). Differences have been reported in the manner in which different sig-
nalling pathways use the SERK co-receptors. For example, BRI1 kinase activity is 
essential for the formation of SERK3/ BAK1 - BRI1 complexes (Wang et al. 2008), 
while neither FLS2 nor SERK3/ BAK1 kinase activity is necessary for the FLS2-
SERK3/BAK1 complex formation (Schulze et al. 2010; Schwessinger et al. 2011). 
Also, a C-terminal tagged SERK3/BAK1 was found to be impaired in its function in 
flagellin signalling, while such a fusion protein was still completely functional in 
the brassinosteroid pathway (Ntoukakis et al. 2011).
The SERK proteins have been implicated in the regulation of main receptors 
via several modes of action. Many of these have also been described for other co-re-
ceptors in the animal and plant field, and will be discussed below in more detail. 
Co-receptor function in receptor activation and signal amplification
Co-receptors can regulate receptor complex activity in different manners, one of 
which is by activating the main receptor via transphosphorylation events. An exam-
ple of this can be found for SERK3/BAK1 co-receptor and main receptor BRI1 (Li 
et al. 2002). The main receptor BRI1 first activates its co-receptor by specific trans-
phosphorylation of activation loop residues of SERK3/ BAK1. Activated SERK3/ 
BAK1 then phosphorylates the main receptor on residues in the juxtamembrane 
and C-terminal domain, events essential to achieve full downstream signalling ac-
tivity (Wang et al. 2008). 
A similar mechanism can be seen in the EGFR pathway, where transphosphor-
ylation between main and co–receptors is also important for activation of the re-
ceptor kinase. Here the kinase domains form so-called asymmetrical dimers where 
one receptor kinase domain acts as a donor, ‘donating’ a phosphor group to the 
‘receiver’ kinase that activates downstream signalling (Zhang et al. 2006). Of the 
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four EGFR family members (EGFR, ERBB2, 3 and 4) only EGFR and ERBB4 are 
main receptors. The ERBB2 receptor has an active kinase domain, but is not known 
to bind any ligand. ERBB2 can form heterodimers with the other three EGF re-
ceptors (EGFR, ERBB3 and ERBB4) when they are bound to ligands and act as a 
‘donor’ kinase (Liu et al. 2012). ERBB2 is the preferred heterodimerization partner 
for the other EGFRs and increases their binding affinity for ligand (Karunagaran 
et al. 1996) resulting in prolonged signalling. In addition, heterodimers including 
ERBB2 are more stable and less prone to endocytosis and degradation indicating 
that presence of ERBB2 strengthens the cellular response to EGF (Haslekas et al. 
2005; Offterdinger et al. 2008). In contrast to ERBB2, ERBB3 can bind ligand, but 
possesses an inactive kinase domain. ERBB3 can also form heterodimers with the 
other EGFRs (including ERBB2) and acts as an ‘receiver’ kinase to initiate down-
stream signalling (Campbell et al. 2010 and Figure 2).
Figure 2 Mode of action of the EGFR signalling complexes with main and co-receptors
The EGFR protein family consists of four members, two of which can be seen as proper main recep-
tors, while the other two either miss the ligand binding capacity (ERBB2) or intracellular enzymatic 
activity (ERBB3). The active complex is an asymmetric homo- or heterodimer, where one kinase 
acts as a donor (B) and one as a receiver (A) moiety. The co-receptors are either always donor 
(ERBB2) or receiver (ERBB3), while the main receptors (EGFR and ERBB4) can fulfil both roles. 
Picture from Gerbin 2010. 
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Co-receptor function in signal modulation via ligand interactions
In contrast to the SERK and ERBB co-receptors, many co-receptors do not possess 
an intracellular kinase domain. This type of co-receptors can either be transmem-
brane proteins with short intracellular domains without any enzymatic activity, or 
extracellular proteins anchored to the membrane by glycosylphosphatidylinositol 
(GPI). They function in ligand binding and mediating cellular adhesion (Kirkbride 
et al. 2005). In some signalling complexes, the co-receptors contribute so much to 
the affinity for the signalling molecule that ligand binding in absence of the co-re-
ceptor is negligible. Such is for instance the case in the neurophilin (NRP) co-recep-
tors and semaphorin binding. NRPs have a high binding affinity for two structurally 
unrelated classes of ligands, the class 3 semaphorins (secreted polypeptides with 
key roles in axonal guidance) and certain members of the vascular endothelial 
growth factors (VEGF). Most of the class 3 semaphorins (but not VEGF) require 
NRP1 or 2 as obligate co-receptors to the plexin main receptors (Pellet-Many et 
al. 2008), which do not bind semaphorins on their own. The semaphorins seem to 
share a binding interface with both the plexin receptor and the NRP1, but only the 
plexins mediate the signal into the cell (Antipenko et al. 2003). In VEGF signalling, 
NRP1 was found to enhance (i) VEGF binding to VEGF receptor2 (VEGFR2), (ii) 
VEGFR2 phosphorylation and (iii) VEGF-induced signalling (Whitaker et al. 2001; 
Soker et al. 2002; Mac Gabhann et al. 2005). NRP1 is not an obligate co-receptor 
in VEGF-signalling, and VEGFR2 activation can occur in absence of NRP1 (Pan et 
al. 2007), however NRP1 is required for optimal signalling in certain biological 
processes (Pellet-Many et al. 2008). The precise manner in which NRP1 modulates 
VEGR2 signalling is not known, presence of NRP1 does not appear to change the 
affinity of VEGR2 for ligand (Whitaker et al. 2001), but it is hypothesised that 
NRP1 stabilises the signalling complex thereby lengthening the signal propagation 
(Jia et al. 2006). 
In Fibroblast Growth Factor (FGF) signalling, the FGF-receptor depends on the 
Klotho co-receptors for endocrine signalling, but not for paracrine signalling. The 
main FGF receptor (FGFR) has a much lower binding affinity for endocrine FGF 
compared to paracrine FGFs. The Klotho co-receptors increase the affinity of the 
FGFR for the endocrine FGFs and lower it for paracrine FGFs in specific tissues 
(Goetz et al. 2012). In this manner, the FGF receptor complex can be converted in a 
specific endocrine or paracrine receptor complex based on the presence or absence 
of the co-receptor. In plants, the co-receptor Too Many Mouths (TMM) interacts 
with main receptors of the ERECTA-family functioning stomatal patterning (Shpak 
et al. 2005). TMM modulates the signal by differing in affinity for the two EREC-
TA-ligands (EPF1 and EPF2) and forming heterodimers with the different ERECTA 
main receptors (Lee et al. 2012). The incredibly complex WNT signalling path-
way is involved in a multitude of developmental processes, such as embryonic axis 
formation and segmentation, and involves more than 15 different receptors and 
co-receptors (Niehrs 2012). The main receptor, Frizzled, uses different co-receptors 
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(such as LRP5, LRP6, ROR1 and ROR2) as a means to direct signal transduction 
through distinct signalling pathways. 
In the brassinosteroid pathway, the main receptor BRI1 has roughly the same 
binding affinity for its ligand with or without the presence of its co-receptor SERK3/ 
BAK1, which led to the hypothesis that SERK3/ BAK1 did not contribute to brassi-
nosteroid binding (Kinoshita et al. 2005). However, recent crystallographic studies 
of the extracellular domain of BRI1 showed that binding of ligand created a small 
hydrophobic patch, which might serve as an interaction platform for co-receptors. 
In this scenario, co-receptors would interact with the ligand and could have a func-
tion in binding affinity of the main receptor BRI1 to its ligand (Hothorn et al. 2011; 
She et al. 2011). This notion was shown to be correct in a recent study where the 
extracellular domains of BRI1 and SERK1 were co-crystallised in the presence of 
the BL ligand (Santiago et al. 2013), designating the SERKs as true co-receptors. 
The structure of the FLS2 extracellular domain with the SERK3/ BAK1 extracel-
lular domain in presence of the ligand flg22 (a 22 amino acid peptide which was 
shown to bind to FLS2 and elicit immune responses (Gómez-Gómez et al. 2000) 
has shown that also in this signalling pathway the SERK co-receptor has inter-
actions with both the ligand and the main receptor (Sun et al. 2013). It is thus 
unlikely that the SERK co-receptors do not contribute to the binding affinity of 
the signalling complex. Most likely the unchanged binding affinity in absence of 
SERK3/ BAK1 reported by Kinoshita et al. is due to redundancy between the SERK 
family members. 
Co-receptor function in receptor localisation
After receptor activation, signal propagation is often controlled by means of re-
ceptor downregulation. This downregulation of receptors involves endocytosis of 
signalling complexes and subsequent intracellular degradation of both receptor 
and ligand, or the recycling of receptor back to the plasma membrane. Endosomal 
trafficking affects receptor concentration at the plasma membrane and can thus 
profoundly affect signalling (Chen et al. 2005). In addition, some receptors con-
tinue to signal from endosomal compartments, as was seen for the platelet-derived 
growth factor receptor (Wang et al. 2004) and the receptor tyrosine kinase c-Met 
(the receptor of hepatocyte growth factor; Kermorgant et al. 2008). The Ephrin 
receptors even require internalisation for their signalling functions (Sadowski et 
al. 2009). Co-receptors can affect signalling by regulating the endocytosis of (parts 
of) the receptor complex. An example is the TβRIII co-receptor, which is phosphor-
ylated by the TβRII main receptor in response to TGF-β (Chen et al. 2003). The 
phosphorylation of TβRIII causes recruitment of β-arrestin 2, followed by internal-
isation of the complex and downregulation of signalling. For VEGFR2, interaction 
with its co-receptor NRP1 causes the main receptor to follow a different endocytic 
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route, leading to reduced degradation and more recycling of the receptor, increas-
ing signal attenuation (Ballmer-Hofer et al. 2011). 
In protoplasts, SERK3/ BAK1 accelerates endocytosis of BRI1, changing the ra-
tio of endocytic to PM localised BRI1 receptor (Russinova et al. 2004). The precise 
function of endocytosis in BRI1-mediate signalling (downregulation or attenua-
tion) is not yet completely clear (Geldner et al. 2007; Irani et al. 2012). Geldner et 
al. 2007 reported an increase in brassinosteroid signalling activity upon addition 
of the drug BFA (Brefeldin A), which they attributed to the increased endosomal 
localisation of BRI1. This led to the conclusion that a substantial amount of brass-
inosteroid signalling takes place in endosomal compartments. However, recent 
studies indicate that the PM is the major site for brassinosteroid signalling (Irani et 
al. 2012) and the increased signalling upon BFA treatment is caused by an increase 
of PM localised BRI1- SERK3/BAK1 hetero-oligomers (Bücherl et al. 2013). These 
new studies suggest that endocytosis of the BRI1-SERK3/BAK1 complex most likely 
is involved in downregulation of signalling. The same co-receptor SERK3/ BAK1 
was found to impair endocytosis of a different main receptor in flagellin signalling 
(FLS2) (Chinchilla et al. 2007), indicating that co-receptors can have opposing 
functions in different signalling pathways. 
Another means by which co-receptors can influence signal transduction is by 
sequestering the signalling complex to specific locations on the plasma membrane, 
such as microdomains or membrane rafts enriched in sphingolipids and cholester-
ol. An example of this is the glycosyl phosphatidylinositol (GPI)-anchored co-recep-
tor GFR α1, which recruits the main receptor c-RET (binding a specific class of neu-
rotrophic factors) to membrane rafts, which is necessary for efficient downstream 
signalling (Tansey et al. 2000). Whether the SERKs also function in recruiting main 
receptors to specific membrane locations is a question that remains to be answered 
(see Chapter 5).
Co-receptors as mediators of cross-talk
At any given moment, a cell is bombarded by a multitude of signals. All cells have 
to integrate these signals into a comprehensive response or developmental change. 
For this reason, cross-talk between different signal transduction cascades is essen-
tial. Cross-talk can exist on multiple levels within a signalling cascade, one of which 
can be co-receptors shared between different signalling routes. This cross-talk can 
manifest itself as competition, two signalling cascades competing for a limited pool 
of shared co-receptors, or synergistic, where the co-receptor activates a common 
downstream signalling partner. In animal systems, the insulin and WNT pathway 
show cross talk at several levels in the signalling cascade, one of which is at the 
level of co-receptors. The co-receptor LRP5 is used both by the insulin receptor and 
the WNT pathway, and here the cross-talk seems to be synergistic, LRP5 providing 
a bridge between the two different signalling pathways (Palsgaard et al. 2012). 
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The SERK3/BAK1 co-receptor is an essential player in both the brassinosteroid 
and flagellin (immunity) pathway in A. thaliana. Cross-talk between these two 
pathways is evident, and is proposed to be at the level of the co-receptor (Belkhadir 
et al. 2012). However, investigations proved that SERK3/BAK1 could not be the 
limiting factor (Albrecht et al. 2012) and recent studies have identified at least one 
position of cross talk between the innate immunity and brassinosteroid signalling 
pathway further downstream (Shi et al. 2013). Whether this downstream cross-
talk is mediated via SERK3/BAK1 is not clear. 
The structure of the SERK co-receptors
As has been explained above, one of the hallmarks of co-receptors is that they 
modulate the signal transduction across the membrane, either by extracellular 
interactions, intracellular interactions, or both. Here, we will review the current 
knowledge on the structure of the SERK proteins and their interaction with main 
receptors, and discuss functional domains of the co-receptors. 
Domain structure of the SERK proteins
SERK-protein homologues were identified in a number of plant species, including 
monocots, dicots and nonvascular plants (Baudino et al. 2001; Hecht et al. 2001; 
Sasaki et al. 2007; Mantelin et al. 2011; Nolan et al. 2011; Park et al. 2011; Ma 
et al. 2012), where they all follow the same basic domain structure (see Figure 
3). The extracellular domain of SERKs consists of a leucine zipper, sometimes also 
revered to as the N-capping residues, followed by ~5 leucine-rich-repeats (LRRs) 
and a serine-proline-proline (SPP) motif containing domain, a combination that is 
unique for the SERK proteins (Hecht et al. 2001). A single transmembrane helix 
connects the extracellular domain to the intracellular domain, which consists of a 
juxtamembrane domain, a kinase domain and a C-terminal tail. 
Figure 3 Overview of the typical domain structure of SERK proteins
Numbers below the graphic depict approximate amino acid numbers (based on SERK1 domain 
structure and sequence). EC= extracellular domain, IC= intracellular domain. SP= signal pep-
tide. LZ= leucine zipper, LRR= leucine rich repeats, SPP= serine-proline-proline motif containing 
domain, TM= transmembrane domain, JxM= juxtamembrane domain, KD= kinase domain, C = 
C-terminal tail domain. 
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Three dimensional structure of SERK intracellular domain
In 2011 and 2012 two crystal structures of the SERK3/ BAK1 intracellular domain 
have been elucidated (Cheng et al. 2011; Yan et al. 2012). Besides the complete 
kinase, both structures contain part of the JxM domain and the C-terminal tail, but 
neither of these domains is well-resolved. The structure of the SERK3/ BAK1 kinase 
domain follows the basic structure found for Ser/Thr kinases, with a two-lobed 
structure consisting of a small N-terminal lobe (mostly consisting of anti-parallel 
β-sheets) and the larger C-terminal lobe (consisting mostly of α-helices) as well as 
a catalytic cleft between the two lobes (Cheng et al. 2011; Yan et al. 2012). Both 
crystal structures of SERK3/ BAK1 are of the active state of the protein, as similarity 
to other active kinases indicates. Phosphorylation of residues in the catalytic loop, 
and especially T450 and T455, stabilises the active state (see Figure 4). T450 phos-
phorylation was found to be essential for transphosphorylation activity of SERK3/ 
BAK1 on FLS2 (Wang et al. 2008; Yan et al. 2012), however, not for BRI1 trans-
phosphorylation in yeast (Yun et al. 2009) indicating that differential phosphoryla-
tion of the activation loop probably changes the conformation and specificity of the 
SERK kinase domains. In vivo experiments do indicate that T450 is an important 
residue in the brassinosteroid pathway (Wang et al. 2008). In brassinosteroid sig-
nalling, SERK3/ BAK1 is first phosphorylated by BRI1, followed by the reciprocal 
reaction which leads to a fully activation signalling complex (Wang et al. 2008). So 
although mutating T450 does not influence basal transphorhorylation activity of 
SERK3/ BAK1 onto BRI1, it does influence the sequential activation of receptors. 
Further investigations into the function of different phosphorylation sites on the 
activity and more importantly the specificity of the SERK proteins in different path-
ways is necessary to increase our knowledge on these plant-signalling pathways. 
The SERK kinase domains, as well as several other kinase domains of receptor 
kinases show intrinsic activity in vitro (Shah et al. 2001; Wang et al. 2005; Karlova 
et al. 2009; Aan den Toorn et al. 2012), without the need of complex formation 
or other cellular components to activate its phosphorylation activity. For receptor 
kinases, this means that their cytoplasmic kinase domain needs to be inhibited by 
some means in vivo to avoid aberrant, premature phosphorylation. The biochem-
ical mechanisms with which receptor kinase domains are kept inactive are poorly 
understood, mechanisms that have been proposed are inhibitor binding (Jaillais et 
al. 2011b), auto-inhibitory sequences (Wang et al. 2005) or dephosphorylation of 
essential phosphorylation sites (Ostman et al. 2001). In addition, protein intrinsic 
disorder has been implicated in regulation of signalling events, especially for recep-
tors that use multiple protein chains to confer signal (Sigalov et al. 2011). How the 
kinase domains of the SERK co-receptors are kept inactive remains to be elucidated 
(see Chapter 4).
In the structure reported by Cheng et al. the SERK3/ BAK1 kinase domain is in 
complex with the BAK1 Interacting Domain (BID) of the bacterial effector AvrPtoB 
(Cheng et al. 2011). This bacterial effector was shown to interact with the kinase 
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Figure 4 Phosphorylation of the BAK1 activation loop stabilises the kinase active state. 
A) Ribbon model of the BAK kinase domain structure in complex with the ATP analogue AMP-PNP 
(coloured stick). B&C) phosphorylated residue T450 (B) and T455 (C) contribute to the stabilisation of 
the activation loop conformation. Dashed lines indicate hydrogen-bonding interactions. Picture adapt-
ed from Yan et al. 2012. 
Figure 5
Crystal structure of BRI1 extra-
cellular domain in complex with 
SERK1 extracellular domain
A) Surface representation of the 
BRI1 extracellular domain (light 
blue) in complex with SERK1 co-re-
ceptor extracellular domain (red). 
B) Ribbon representation of the 
BRI1- SERK1 extracellular domain 
complex, with the brassinosteroid 
ligand depicted in yellow, BRI1 
LRRs in blue, BRI1 island domain in 
green, SERK1 N-capping residues 
in red and SERK1 LRRs in brown. 
No structural rearrangements were 
apparent upon complex formation; 
the binding of extracellular domains 
seems to function mainly in bringing 
the intracellular kinase domains in 
close proximity. The SERK1 N-cap-
ping residues fold onto the steroid 
ligand, and seem to have a function 
in brassinosteroid binding. Picture 
from Santiago et al. 2013. 
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domains of SERK3/ BAK1 and FLS2, interfering with PAMP-triggered immunity 
(PTI) (Xing et al. 2007). The crystal structure shows that the method by which 
AvrPtoB inhibits SERK3/ BAK1 function is by interaction with the catalytic cleft of 
SERK3/ BAK1, via contacts with the P+1-loop (in the substrate-binding region) of 
the SERK3/ BAK1 kinase domain. The presence of AvrPto in the catalytic cleft of 
SERK3/ BAK1 would make complex formation with interaction partners impossible 
and thus inhibit formation of the active signalling complex FLS2-SERK3/ BAK1. 
Since SERK3/ BAK1 also makes other complexes where kinase interactions are 
essential (Wang et al. 2008), it could be that the presence of AvrPtoB influences 
more than just PTI.
Structural implications of complex formation of SERK with main 
receptors
Currently, two crystal structures have been reported of SERK extracellular domains 
in complex with main receptor extracellular domains. These are the SERK1 -BRI1 
extracellular domain complex (Santiago et al. 2013) and the SERK3/ BAK1- FLS2 
extracellular domain complex (Sun et al. 2013). These structures provide the first 
observations on the SERK co-receptors in the signalling complexes
The BRI1 extracellular domain was first elucidated (with and without ligand 
binding) in absence of SERK co-receptors (Hothorn et al. 2011; She et al. 2011). 
The 25 LRRs of BRI1 curve to form a ‘super-helix’, where the island domain, in-
volved in ligand binding, folds back into the interior of the curved structure. The 
super-helical curvature was also observed for the FLS2 extracellular domain (Sun 
et al. 2013) and is clearly distinct from animal LRR-domains which fold to a horse-
shoe like shape without the extra curvature of the super-helix (Kobe et al. 2001). 
Both the FLS2 and BRI1 extracellular domains were found as a monomer irrespec-
tive of ligand presence, both in crystals as well as in solution (Hothorn et al. 2011; 
She et al. 2011; Sun et al. 2013). This, and the fact that homodimerization seemed 
to create some impossible steric clashes for BRI1, indicates that ligand induced ho-
modimerization of the main receptor extracellular domain is unlikely (Hothorn et 
al. 2011). Ligand binding also does not induce large conformational changes to the 
main receptor extracellular domain; besides some structuring of the island domain 
and connecting loops no significant changes are observed in the BRI1 structure 
(Hothorn et al. 2011) and also the FLS2 extracellular domain does not change sub-
stantially after ligand binding (Sun et al. 2013). This is in contrast to the previous 
hypothesis that ligand binding would induce large conformational changes in the 
signalling complex, resulting in activation (Wang et al. 2008; Jaillais et al. 2011a). 
These observations led to the hypothesis that the main receptor and ligand alone 
are not sufficient for initial activation of the main receptor; an additional player 
(a co-receptor) is essential to induce conformational changes in the complex upon 
ligand binding. The crystal structures of the BRI1-SERK1 and FLS2-SERK3/ BAK1 
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extracellular domain complexes corroborate this hypothesis. For both complexes, 
ligand binding is essential for interaction between the co-receptor and main re-
ceptor extracellular domains. The SERK1- BRI1 complex showed that the SERK1 
N-capping residues (sometimes also referred to as a leucine zipper domain, see 
Figure 3, although this crystal structure seems to indicate that this is not the cor-
rect term) fold onto the island domain of BRI1, making contacts with both the 
ligand binding domain of the main receptor and the steroid hormone, establishing 
the SERKs as true co-receptors (see Figure 5). The structure of the FLS2- SERK3/ 
BAK1 complex shows similar observations. The SERK3/ BAK1 extracellular domain 
makes interactions with both the ligand (flg22) and the main receptor, indicating 
that this seems the common mode in which SERK co-receptor function in signalling 
complexes. 
The observation that ligand binding is essential for interaction between main 
and co-receptor, and that homodimerization of the main receptor seems unlikely, is 
in contrast to some other reports that show the presence of preformed complexes 
of BRI1 and SERK3/ BAK1 in planta (Bücherl et al. 2013) and homodimerization 
of BRI1 (Wang et al. 2005; Hink et al. 2008) and FLS2 (Sun et al. 2012). It is im-
portant to realise that the current structures only include the extracellular domains 
and not the complete receptors. Interactions between transmembrane domains or 
kinase domains might very well contribute to interactions in the absence of ligand. 
Ligand binding could then induce extracellular domain interactions that cause a 
change in overall receptor complex formation, which might lead to signalling ac-
tivation. 
Concluding remarks
Co-receptors are important players in signalling, due to their promiscuous nature 
they create more flexibility and provide a place of confluence between different 
signalling pathways. Often, co-receptors have either extracellular interactions with 
the main ligand functioning in ligand binding and specificity, or an intracellular 
interaction functioning in signalling complex activation or downstream signalling. 
The SERK protein family in plants seems to have a dual co-receptor function, hav-
ing both interactions with the ligand as well as transphosphorylation activity on the 
main receptor. Most likely, different interaction sites and different substrate speci-
ficity of the kinases are important for their functions as multi-tasking co-receptors. 
The current crystal structures of plant LRR-RLKs provide us with a first atomic 
scale map of interactions between the SERK co-receptors and their partners. These 
structures and others will be essential for our understanding of the different func-
tions and complexes of the SERK co-receptor family. 
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Outline of this thesis
In this thesis I will report the work done on the SERK co-receptor family to further 
our knowledge on their specific functions in the different signalling cascades. I try 
to take a more structural look at the proteins to identify domains and regulatory 
elements that could provide these proteins with their multi-tasking yet specific 
functions in plant development and immunity. 
SERK co-receptors are found in all monocots and dicots, but also in non-flow-
ering plants such as the moss Physcomitrella patens. In Chapter 2 I provide a 
thorough sequence analysis of SERKs in different plant species, to try and identify 
which motifs or domains in the sequence are important for the observed functional 
differences between the SERK family members in the A. thaliana . Using chimeric 
SERK constructs, we attempt to couple specific signalling functions to either the 
intracellular or extracellular SERK domains. 
Additional high resolution crystal structures of the SERK proteins can greatly 
increase our knowledge on the function and complex formation of these proteins. 
In Chapter 3 I discuss our attempts to elucidate the crystal structure of different 
domains of the SERK proteins. 
Receptor activation needs to be tightly controlled to avoid aberrant signalling. 
Although many investigations have been focused on how receptors can be acti-
vated, a perhaps even more important question is how receptors are kept in their 
“non-responsive” states. For EGF, BRI1, SERK1, 2, 3 and 4 as well as many more, 
their in-vitro produced kinase domains have intrinsic phosphorylation activities. 
Thus additional regulatory elements have to be present in the cell to keep the re-
ceptors from signalling in the absence of ligand. In Chapter 4 I investigate one 
possible manner to regulate protein activity, namely intrinsic disorder.
Proper localisation is essential for proper function of proteins. As was previous-
ly discussed, some co-receptors influence signalling complex activity by changing 
the subcellular location. In Chapter 5, I discuss the use of a microscopic technique 
called Variable Angle Epifluorescence Microscopy (VAEM), a variant of Total Inter-
nal Reflection Fluorescence (TIRF) microscopy to investigate the subcellular and 
membrane location of proteins in planta, and use this technique to visualise the 
membrane localisation of co-receptor SERK3/BAK1 and main receptor BRI1. 
The final chapter of this thesis is the general discussion, where I will review all 
the new observations discribed in this thesis and discuss them in light of current 
literature.
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On the Origin of SERKs
Bioinformatics analysis of the Somatic Embryogenesis Receptor 
Kinase
M. aan den Toorn, C. Albrecht, S.C. de Vries
Abstract
SERKs (somatic embryogenesis receptor like kinases) are leucine -rich- repeat re-
ceptor-like-kinases involved in several, seemingly unrelated, plant-signalling path-
ways. In A. thaliana, functional and genetic analysis on four SERK proteins have 
indicated that they are only partly redundant; their functions overlap but each 
member performs a specific subset of signalling roles. The molecular basis for the 
functional specificity within this highly homologous protein family is currently not 
known. 
Sequence analysis of SERK proteins from different plant species indicates that 
the SERKs are a highly conserved protein family present in monocots, dicots and 
non-vascular plants. Residues in the extracellular domain that are important for 
interaction with other receptor kinases are highly conserved, even amongst SERK 
members without function in the corresponding pathways. SERK2, for instance, 
is conserved in its interaction domain for BRI1, while SERK2 does not function in 
the brassinosteroid pathway. Further sequence analysis indicates that SERK3/BAK1 
and SERK4/BKK1 have diverged from the original SERK protein sequence in both 
their extracellular domain and cytoplasmic domain, which could account for the 
functional divergence. Functional analysis of chimeric SERK proteins shows that 
different domains provide the SERK proteins with different functional specificity. 
The SERK1 or SERK2 extracellular domains are essential for SERK function in male 
sporogenesis, while both the SERK3 extracellular domain and cytoplasmic domain 
are essential for SERK3 specific brassinosteroid signalling and flagellin signalling 
functions. 
The emerging picture is that SERKs are ancient genes, which have been recruit-
ed to newly evolved signalling pathways. The interaction domains in the extracel-
lular SERK domain are conserved, allowing all SERKs to form complexes. However, 
specific functional residues must have been altered, both in the extracellular and 
intracellular domain, which allow for differences in functionality. 
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Introduction
In plants, the majority of cell-surface receptors belong to the very large protein 
family of RLKs (Shiu and Bleecker 2001b), which in turn is part of the monophyl-
etic RLK/Pelle gene family that shares a common ancestor with the animal recep-
tor tyrosine and receptor serine/threonine kinases (RTKs and RSKs) (Shiu and 
Bleecker 2001b). After the divergence of plant and animal lineages, a significant 
expansion of the plant RLK family has occurred, resulting in a gene family of more 
than 600 members in Arabidopsis, representing 2.5% of the protein-coding genes 
(Shiu and Bleecker 2001a). Such an extensive number of different receptors pro-
vide plants with impressive possibilities to respond rapidly and precisely to a large 
number of external signals. The RLK family expansion seems to be lineage-specific, 
and caused both by whole genome duplications and tandem duplications (Shiu and 
Bleecker 2001a). Gene duplicates were most likely retained because they either 
developed new functions (as can be seen for instance for the symbiosis receptors), 
or because a partitioning of ancestral functions or expression patterns has occurred 
between duplicates (Nadeau and Sankoff 1997). The many duplicates of plant 
RLKs have made functional studies on specific receptors difficult, as single mutants 
often do not show clear phenotypes due to (partial) redundancy.
A typical RLK follows the same basic domain structure as animal RTKs (van 
der Geer et al. 1994, Walker 1994) with an N-terminal signal sequence, an extra-
cellular, ligand binding domain (extracellular domain) followed by a single pass 
transmembrane domain (TM) and an intracellular kinase domain (cytoplasmic do-
main). The motifs making up the extracellular part of RLKs vary greatly among 
members, the most common being leucine rich repeats (LRR) (235 of the ~610 
RLKs contain 1 to 32 LRRs in their extracellular domain; Shiu and Bleecker 2001a). 
LRR-RLKs are involved in many different signalling processes such as hormone 
signalling (Li and Chory 1997), immunity (Gómez-Gómez and Boller 2000) and 
growth and development (Clark et al. 1997). The family of LRR-RLKs can be di-
vided into 13 subfamilies (LRR-RLK I to LRR-RLK XIII) (Shiu and Bleecker 2001b). 
This subdivision was based on kinase phylogeny, but for the most part follows a 
division based on the extracellular domain structure. This division does not appear 
to be coupled to functionality, as a great diversity of transcriptional responses and 
expression patterns was found within the different subfamilies (Chae et al. 2009).
The SERKs, or Somatic Embryogenesis Receptor Kinases, belong to the LRR-RLK 
II group of receptor-like kinases. Besides the SERK genes, the LRR-RLK II group 
consists of two other distinct branches in A. thaliana; a group of functionally unas-
signed proteins and the NIKs (NSP-interacting kinases), which are virulence targets 
of the bipartite geminivirus nuclear shuttle protein (NSP) (Fontes et al. 2004). 
The SERK proteins have a small extracellular domain consisting of 4.5-5 LRRs. 
They distinguish themselves from other LRR-RLK II members by the presence of 
a proline-rich domain (SPP-domain) in the extracellular domain, just preceding 
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the transmembrane domain (Hecht et al. 2001). This unique domain of unknown 
function was hypothesised to provide a flexible hinge to the SERK extracellular 
domain (Schmidt et al. 1997, Hecht et al. 2001). Genes encoding SERKs have been 
identified in all higher plants genomes, both monocots and dicots, and Sasaki et al. 
reportedly identified the presence of SERK homologues in the lower plant liverwort 
Marchantia polymorpha and even in the unicellular green algae Closterium ehren-
bergii (Sasaki et al. 2007). SERK was first identified in Daucus carota cell cultures, 
where it marked single somatic cells competent to form embryos (Schmidt et al. 
1997). In A. thaliana, the SERK protein family consists of five close homologues 
(SERK1-5) (Hecht et al. 2001) that have arisen through gene duplications. An ini-
tial duplication event that gave rise to ancestral precursors of SERK1, 2 and SERK3, 
4, 5 was followed by further duplications to form the current protein family (Hecht 
et al. 2001, He et al. 2007). The five AtSERK proteins were found to function in 
multiple and diverse signalling pathways, which are seemingly unrelated (Albrecht 
et al. 2005, Albrecht et al. 2008, Roux et al. 2011). These signalling pathways in-
clude e.g. male sporogenesis, separation of floral organs and Mi-1-mediated resist-
ance to potato aphids (SERK1 and SERK2) (Albrecht et al. 2005, Lewis et al. 2010, 
Mantelin et al. 2011), brassinosteroid (BR) signalling (SERK1, SERK3/BRI-associ-
ated kinase 1,BAK1, and SERK4/BAK1-like kinase 1, BKK1) (Li et al. 2002, Nam 
and Li 2002, Karlova et al. 2006, He et al. 2007, Albrecht et al. 2008), flagellin 
signalling (SERK3/BAK1 and SERK4/BKK1) (Chinchilla et al. 2007, Heese et al. 
2007) and cell death responses (SERK3/BAK1 and SERK4/BKK1) (He et al. 2007, 
Kemmerling et al. 2007). SERK5 has no recorded function and might be a pseu-
dogene (He et al. 2007). Interaction has been established between SERK3/BAK1 
and the main ligand-binding receptors Brassinosteroid Insensitive 1 (BRI1) (Li and 
Chory 1997, Li et al. 2002, Nam and Li 2002, Russinova et al. 2004, Wang et al. 
2008), BRI-like 3 (BRL3) (Fabregas et al. 2013) Flagellin Sensing 2 (FLS2) (Chin-
chilla et al. 2007, Heese et al. 2007), and EF-tu Receptor (EFR) (Roux et al. 2011), 
while Excess Microsporocytes 1 (EMS1)/Extra Sporogenous Cells (EXS) has been 
proposed as interaction partner of SERK1 and SERK2 (Albrecht et al. 2005). These 
main ligand binding receptors are also LRR-RLKs, BRI1 and BRL3 (both 24 LRRs, 
involved in brassinosteroid signalling; Li and Chory 1997, Fabregas et al. 2013) 
and EMS1/EXS (30 LRRs, involved in sporogenesis; Canales et al. 2002, Zhao et 
al. 2002) are both part of the LRR-RLK X subfamily, while FLS2 (28 LRRs, involved 
in flagellin sensing; Gómez-Gómez and Boller 2000) and EFR (21 LRRs, binding 
bacterial elicitor EF-tu; Zipfel et al. 2006) belong to the LRR-RLK XII subfamily. 
SERK1 and SERK3 act as a true co-receptor involved in binding the ligand together 
with the main receptor BRI1 (Santiago et al. 2013) and FLS2 (Sun et al. 2013) 
respectively. The current model for the interaction between BRI1 and SERK3 /
BAK1 assumes reciprocal transphosphorylation events to arrive at a fully functional 
signalling unit (Wang et al. 2005a, Wang et al. 2008) and in the absence of several 
of the SERK members BR signalling is fully impaired (Gou et al. 2012). For clarity, 
we will refer hereafter to SERK3 without mentioning its BAK1 nomenclature.
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Current genetic data indicate that the SERKs are critical regulators of the plant 
developmental pathways served by the corresponding main receptors (Gou et al. 
2012). However, it is not clear which precise cellular functions are under control of 
the SERKs. The genetic data also shows that the diverse SERK genes have partially 
non-overlapping functions, and isoform-specific signalling contributes to the diver-
sity of SERK activities. Potential divergence of cis-regulatory sequences (Mazet and 
Shimeld 2002, Prince and Pickett 2002) is not the mechanism used to obtain the 
functional divergence, because the serk1 serk2 male sterile phenotype cannot be 
restored by the SERK3 protein while expression of SERK2 or SERK1 under control 
of the SERK3 promoter is sufficient (Albrecht et al. 2005). This observation is also 
supported by the fact that SERK3 functions in different signalling pathways at the 
same time, in the same cell (Robatzek et al. 2006, Savaldi-Goldstein et al. 2007). 
At the moment, the protein domains that contribute to SERK specificity and redun-
dancy are not very well defined.
This chapter describes attempts to map SERK specificity to certain structural 
domains, motifs or residues. Sequence analysis shows that both extracellular do-
mains and cytoplasmic domains contain divergent sequences that could account 
for the different functionality. Domain-swap experiments corroborate the con-
clusion that evolutionary changes to both extracellular domain and cytoplasmic 
domain are important for SERK specificity. Remarkably, some SERK domains are 
interchangeable between family members in one pathway but not in another. In 
particular, whereas the SERK3 protein cannot replace SERK1 or SERK2 in male 
fertility, its kinase domain can replace the ones of both SERK1 and SERK2. In con-
trast, neither the SERK2 extracellular nor the kinase domain can replace SERK3 
domains in BR signalling. Interestingly this last observation can also be predicted 
from the bioinformatics analysis while the finding that the SERK3 kinase domain 
restores fertility is rather unexpected. These data suggest that the SERK proteins 
have a phosphorylation dependent role as well as a more structural function in the 
different pathways.
Materials and Methods
Plant materials and growth 
Arabidopsis thaliana ecotype Columbia (Col-0) was used as wild-type control. For 
Arabidopsis sterile seedlings, seeds were surface sterilised and germinated on ½ 
strength Murashige and Skoog (MS) medium including vitamins (DUCHEFA) sup-
plemented with 1% sucrose and 0.8% agar. Plants were grown at 22oC under fluo-
rescent light with 16h light/8h dark photoperiods, unless otherwise specified. The 
mutant lines used in this study are serk1-1, serk1-3, serk2-2, serk3-2, bri1-119, fls2.
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Constructs and plant transformation
Most manipulations involved Gateway-mediated cloning following the manufac-
turer instructions. Primers used for each step are described in Supplemental Tables 
1 and 2.
Coding regions and promoter sequences were amplified from genomic DNA us-
ing Phusion high fidelity DNA polymerase (New England Biolabs). The 2 kb promot-
er regions were directionally cloned with XhoI-SacII in a modified pDONRP4-P1r. 
The amplified coding regions were directionally cloned into pENTR-D-TOPO (Invit-
rogen). These promoter and TOPO constructs together with pDONRstop or pDON-
RP2r-P3-GFP and pK7m34GW were recombined using LR clonase II PLUS (Invitro-
gen), creating untagged or C-terminal GFP gene fusions respectively (Karimi et al. 
2007). The constructs were verified by sequencing. These binary vectors contain-
ing the different constructs tagged with GFP or untagged were used to transform 
Arabidopsis Col-0 plants.
Hypocotyl and root growth assays
Freshly harvested seeds were surface sterilised and placed on either ½ MS plates 
without hormones or ½ MS plates containing different concentrations of brassino-
lide (Sigma). The plates were kept at 4oC for 2 days and then placed at 22oC either 
in dark or grown under 16h light/8h dark photoperiods. The hypocotyl length was 
measured after 4 days incubation in dark and the root length with and without BRs 
was determined after 7 days growth in light. Every experiment was performed in 
duplicate and repeated twice.
Seedling growth inhibition
Seedlings were germinated on MS agar for 5 days and then transferred to 96-well 
plates containing liquid MS with flg22 at 25 or 50 nM concentrations (one seedling 
per well and 12 wells per concentration). Seedlings were incubated with peptides 
for 10 days before determination of fresh weight. 
Protein extraction and immunoprecipitation in Arabidopsis
Seedlings were ground in liquid nitrogen and extraction buffer (50 mM Tris-HCl 
pH 7.5; 150 mM NaCl; 1% NP-40; 0.5% sodium deoxycholate; 1% (v/v) protease 
inhibitor cocktail (Sigma)) added at 2ml/g tissue powder. Samples were clarified 
by two steps of centrifugation, 20 minutes centrifugation at 4oC 5,000g followed 
by a second centrifugation of the supernatant at 18,000g at 4oC. Supernatants were 
adjusted to 4 mg/ml protein and incubated 4 hours at 4oC with 30 µl GFP Trap-A 
beads (Chromotek, Germany). Following incubation, beads were then collected 
36
Chapter 2
by centrifugation at 2000g at 4oC and washed 4 times with PBS containing 0.5 % 
(v/v) Nonidet P-40, before adding 2x loading buffer and heating at 70oC for 15 
min. 
SDS-PAGE and immunoblotting
Proteins were separated by SDS/PAGE 8.5% before electroblotting onto PVDF 
membrane (BioRad) at 30V overnight. Membranes were rinsed in PBS and blocked 
for 4 hour in 5 % nonfat milk in PBS-Tween (0.1% (v/v)). Antibodies were dilut-
ed in blocking to the following dilutions: anti-GFP-HRP (Miltenyi Biotec) 1:5000; 
rabbit polyclonal anti-BRI1 1:2000 (Cyril Zipfel, The Sainsbury Laboratories, Nor-
wich, UK); rabbit polyclonal anti-phosphothreonine 1:1000 (Zymed-Invitrogen) 1: 
5000. Membranes were incubated with primary antibodies overnight. Membranes 
were washed 3 x 10 minutes in PBS-Tween (0.1%) and then incubated 1 hour with 
the secondary antibodies, anti-rabbit-HRP (Sigma). Chemiluminescent substrate 
(Lumigen ECL, GE Healthcare) was applied before reading on Chemidoc system 
(BioRad).
Fluorescence Microscopy
Anthers and root apices from transgenic plants harbouring the 35S::bes-1D-GFP 
construct were used for confocal analyses. Transgenic roots were analysed using 
a ZEISS confocal microscope (ZEISS AXIOVERT 100M equipped with a LSM510, 
Argon LASER with 488nm laserline). The settings for the GFP were as follow, 488-
nm LASER à HFT488/543 à Sample à HFT488/543 à mirror à NFT545 à 
BP505-550 à detector. Autofluorescence spectral bleed-through was assessed by 
imaging at the same time with the YFP/GFP channel a channel that detects red 
fluorescence: 514 nm LASER à HFT458/514 à Sample à NFT635vis à LP650 à 
detector. Pinhole was adjusted for each channel in such a way that Z-resolution is 
equal (typically 2 micrometers). Amplifier gain for YFP/GFP and autofluorescence/
spectral bleed-through channels is always the same between experiments. 
Data set
Amino acid sequence and CDS (coding DNA sequence) of genes annotated as 
SERKs either in literature or in database entries were collected from the NCBI da-
tabase (www.ncbi.nlm.nih.gov). Additional sequences were found with a protein 
Blast (Altschul et al. 1990) against the non-redundant protein sequences from fully 
sequenced plant genomes, using NCBI website tools. The A. thaliana SERK1 pro-
tein sequence was used as query sequence. Homologous sequences with the spe-
cific SERK domain structure (similar amount of LRRs, an SPP domain and a kinase 
domain) were taken along in the analysis. A total of 67 putative SERK sequences 
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were used for further analysis (see Table 1). As an outgroup the AtNIK1 and AtNIK2 
CDS and protein sequences (protein id Q9LFS4 and Q8RY65 respectively) and the 
CDS and protein sequences of LRR-II genes AT5G63710 and AT5G65240 (protein 
id Q8W4S5 and C0LGX1 respectively) were taken along in the analysis. 
Sequence analysis
Multiple sequence alignment (MSA) was performed in MEGA5.1 (Tamura et al. 
2011) using ClustalW and Protein Weight Matrix Gonnet. Parameters for the MSA 
were; gap opening penalty: 30 (pairwise alignment) and 5 (multiple alignment), 
gap extension penalty: 0.2 (pairwise alignment) and 0.1 (multiple alignment). 
The different SERK protein domains were defined from the MSA compared to 
the A. thaliana SERK1 sequence (Aan den Toorn et al. 2012). These domains are: 
The signal sequence (aa 1- 29) the leucine zipper (or N-capping residues) (aa 30 - 
73), the LRRs (aa 74 - 198 ), the SPP domain (aa 199 - 235), the transmembrane 
domain (aa 236 - 258), the juxta-membrane domain (aa 259 – 295) the kinase 
domain (aa 296 - 577) and the C-terminal tail (aa 578 - 625). 
Divergence between the different protein sequences was calculated by the 
number of amino acid substitutions per site from averaging over all sequence pairs. 
Analyses were conducted using the JTT matrix-based model (Jones et al. 1992). All 
ambiguous positions were removed for each sequence pair. Analyses were conduct-
ed in MEGA5.1 (Tamura et al. 2011). 
Selection pressure on the sequences was evaluated by calculating non synon-
ymous (Ka) and synonymous (Ks) substitution rates for SERK coding sequences 
as reported in the NCBI database (Table 1). Ka/Ks ratio was calculated using the 
KaKs_Calculator with model averaging (Zhang et al. 2006b). 
Phylogenetic analysis
Phylogenetic analysis of SERK MSA was performed using the Neighbour-Joining 
(NJ) method (Saitou and Nei 1987) with a bootstrap test of 1000 replicates. Dis-
tances are computed using the Dayhoff method (Schwartz and Dayhoff 1978) and 
are in the units of the number of amino acid substitutions per site. Analysis was 
performed in MEGA 5.1 (Tamura et al. 2011). The tree was either rooted with the 
non-SERK LRRII outgroup or using the more distantly related LRR-RLK BRI1 pro-
tein sequence (protein ID O22476). 
Protein Structure analysis
Conservation score as determined by the CONSURF webserver (Glaser et al. 2005, 
Landau et al. 2005, Ashkenazy et al. 2010) was plotted onto the reported struc-
ture of the SERK1 extracellular domain (pdb 4LSC) (Santiago et al. 2013) and 
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the SERK3/ BAK1 kinase domain (pdb 3TL8) (Cheng et al. 2011). Input was a 
MSA of SERK protein sequences (Table 1), produced similarly as described above, 
only the sequences of non-SERKs (protein ids Q67X31, Q6K4T4, G4XGX3, Q659J0, 
Q659J1, A7VM46) and sequences with large gaps in the alignment (protein id 
C6FF61) were removed. The remaining 57 sequences were used in the analysis. 
Molecular graphics and analyses were performed with the UCSF Chimera 1.8.1 
(Pettersen et al. 2004), which was also used to plot hydrophobicity. 
Results
Phylogenetic analyses of the SERK protein family in plants
To identify the residues or domains that could account for the functional diver-
gence in the SERK family, SERK protein sequences from different plants species 
were analysed (Table 1). SERK genes are characterised by the presence of 11 exons 
with conserved splicing boundaries (Baudino et al. 2001, Hecht et al. 2001). To 
study the phylogenetic relationship between SERK proteins from different plant 
species, a multiple sequence analysis was performed on 67 protein sequences that 
were either annotated as SERK in literature, or were identified in database search-
es using the characteristic domain structure (4.5-5 LRRs and the SPP motifs) as 
criterion. All known plant genomes contain multiple SERK homologues, including 
the moss Physcomitrella patens (3 SERK homologues) and club moss Selaginella 
moellendorffii (4 SERK homologues). For phylogenetic analysis, two A. thaliana 
protein sequences from each of the two other LRR-RLK II clades (NIK proteins and 
functionally unassigned proteins) were taken along as outliers (see Table 1).
The phylogenetic relationship between the SERK proteins was investigated 
by constructing a neighbour-joining tree (see Figure 1). The results revealed an 
evolutionary partitioning of the SERKs in four major clusters; non-vascular SERK 
proteins, monocot SERK proteins, and two distinct clusters of dicot SERK proteins. 
Only one rice protein (Uniprot id: Q67X31) does not follow this division as it is 
placed outside the monocot SERK proteins. This protein does not contain a true 
SPP domain and differs from the other SERKs at several positions across the pro-
tein sequence, indicating that it is not a true SERK protein. Taking a more distantly 
related protein sequence as outlier (the LRR-RLK BRI1), does not change the shape 
of the tree (data not shown). Our finding that the SERK protein family branches 
are based on plant lineages, in contrast to clusters of SERK orthologues from dif-
ferent plant lineages, seems to suggest that parallel lineage specific expansion is 
common in this protein family. As a result, true orthologues of specific SERK pro-
teins are difficult to distinguish between e.g. monocot and dicot plants based on 
sequence comparison only. This problem has already surfaced in literature in the 
search for SERK3 proteins in other plant species (Park et al. 2011).
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Figure 1 Neighbour-joining tree SERK protein family
NJ joining tree based on a multiple sequence alignment of the 71 proteins sequence from Table 1. 
These include 67 putative SERK proteins sequences and four A. thaliana LRR-II non-SERK proteins 
(taken along as out-group). Bootstrap values (in percentages) from 1000 replicates are shown next 
to the branches. Branches with a replicate percentage below 50% were collapsed. The evolutionary 
distances were computed using the Dayhoff matrix based method. Four distinct groups can be 
inferred from this NJ tree; LRRII non-SERKs are proteins which group together with the A. thaliana 
non-SERK proteins and are thus not true SERKs. SERK Dicot S3/4 proteins are sequences solely 
from dicotyledons that group together with A. thaliana SERK3, 4 and 5, while the SERK Dicots 
S1./2 proteins are dicot SERKs which group with A. thaliana S1/2. All SERK sequences from 
non-vascular plants group together as do the sequences from monocotyledons (Monocot).
In addition, our analysis identified two proteins in Poa pratensis (Uniprot id: 
Q659J0 and Uniprot id: Q659J1) that are annotated as SERKs (Albertini et al. 
2005), but are actually more closely related to the A. thaliana NIK-proteins. Also, 
we identified one rice protein (Uniprot id: Q6K4T4) and one wheat protein (Uni-
prot id: G4XGX3) that place within the third (unassigned) group of the LRR-RLK II 
subfamily (Singla et al. 2008). The receptor-like kinase from Closterium ehrenbergii 
(Uniprot id: A7VM46), a unicellular alga, was reported as a SERK homologue (Sa-
saki et al. 2007), however, our analysis indicates that this C. ehrenbergii protein is 
not a SERK, but is placed in another clade within the LRR-RLK II-subfamily.
Divergence in the dicot SERK proteins
The neighbour-joining (NJ) tree in Figure 1 indicates a bifurcation in the dicot 
SERK proteins, one group containing AtSERK1 and 2 (hereafter dicot SERK1/2) 
and one containing AtSERK3, 4 and 5 (hereafter called dicot SERK3/4). Of all 
dicot genomes analysed, only poplar contained no SERK3/4 protein. The monocot 
SERK proteins do not show a similar bifurcation. Based on sequence analysis and 
on their place within the NJ tree, the monocot SERKs are more similar to dicot 
SERK1/2 proteins than dicot SERK3/4 proteins (see Figure 1 and 2). Thus, it ap-
pears that monocot genomes do not contain a gene closely related to A. thaliana 
SERK3 or SERK4/BKK1. Similarly, the non-vascular SERKs analysed in this study 
form one cluster and do not split into two groups. Based on sequence alignments, 
the non-vascular SERKs resemble the dicot SERK1/2 proteins more closely than 
the dicot SERK3/4 protein (see Figure 2). This indicates that the duplication event 
giving rise to AtSERK1, 2 and AtSERK3, 4 is dicot specific and occurred after the 
split between monocot and dicot plants. 
To investigate how tightly these groups can be defined, the evolutionary di-
vergence within the four groups (dicot SERK1/2, dicot SERK3/4, monocot and 
nonvascular SERKs) was estimated by calculating the number of amino acid sub-
stitutions per site in the extracellular domain and cytoplasmic domain within each 
group (see Table 2, ‘intra’). In addition, the number of amino acid substitutions 
between each group and the other three groups was calculated to see which group 
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had diverged most from the others (see Table 2 ‘inter’). The dicot SERK1/2 shows 
the least variation within the group, while the dicot SERK3/4 group is most heter-
ogeneous. For all groups, the cytoplasmic domain shows much less variation than 
the extracellular domain. This is most likely due to the kinase domain, which has 
to retain its biochemical properties and is therefore more restricted in its variation. 
This analysis was repeated for each of the SERK domains separately (see Table 
3). The TM domain and the kinase domain are the most conserved regions of 
the SERKs while the C-terminal tail and the SPP-domain vary the most. All SERK 
proteins contain the RD motif (an arginine residue immediately preceding the con-
served catalytic aspartate) in the catalytic loop (except for AtSERK5, which might 
be a pseudogene) indicating that all are activated by phosphorylation of the acti-
vation loop (Nolen et al. 2004). The dicot SERK3/4 group shows most amino acid 
substitutions in every domain, but is especially different from other SERKs in the 
SPP domain and the C-terminal tail (see Table 3). The multiple sequence alignment 
Table 2 Estimates of Average Evolutionary Divergence of SERK complete protein se-
quence, extracellular domain and intracellular domain
The number of amino acid substitutions per site from averaging over all sequence pairs is shown, 
either within a clade (intra) or for sequences in a clade compared to all other sequences (inter). The 
complete amino acid sequence minus the signal sequence (complete), the extracellular part of the 
protein (ectodomain) or the intracellular part (cytoplasmic) was used for analysis.
 Complete Ectodomain Cytoplasmic 
 intra inter intra inter intra inter 
Dicot S1/2 0.082 0.197 0.142 0.317 0.053 0.144
Monocot 0.118 0.195 0.165 0.302 0.091 0.145
Non-Vasc 0.179 0.235 0.304 0.371 0.121 0.176
Dicot S3/4 0.226 0.253 0.356 0.388 0.173 0.197
All 0.195 0.305 0.145  
Table 3 Estimates of Average Evolutionary Divergence of different Domains of SERK
The number of amino acid substitutions per site from averaging over all sequence pairs is shown, 
either within a clade (intra) or for sequences in a clade compared to all other sequences (inter). The 
different domains analysed are leucine zipper/ N-capping residues (LZ-Ncap), leucine rich repeats 
(LRR), serine-proline rich domain (SPP), transmembrane domain (TM), juxtamembrane domain 
(JxM), kinase domain (KD) and C-terminal tail (C-tail).
 LZ-Ncap LRR SPP TM JxM KD C-tail
 intra inter intra inter intra inter intra inter intra inter intra inter intra inter 
Dicot S1/2 0.21 0.30 0.13 0.25 0.32 0.92 0.05 0.11 0.07 0.15 0.04 0.10 0.15 0.49
Monocot 0.11 0.25 0.14 0.24 0.32 0.86 0.14 0.14 0.09 0.15 0.07 0.11 0.29 0.48
Non-Vasc 0.35 0.36 0.20 0.28 0.69 0.10 0.10 0.11 0.12 0.20 0.11 0.14 0.19 0.41
Dicot S3/4 0.34 0.39 0.27 0.30 1.30 1.33 0.11 0.11 0.18 0.22 0.14 0.14 0.40 0.67
All 0.29  0.24 0.90  0.11 0.16  0.11 0.45  
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Figure 2A Multiple sequence alignment of SPP domain 
Detail of the SERK MSA, focused on the SPP domain. The dicot SERK3/4 protein sequences 
are clearly distinct from the other SERK proteins sequences by missing a, otherwise conserved, 
cysteine pair preceding the SPP domain, and having a shorter more heterogeneous SPP domain. 
shows that the dicot SERK3/4 proteins have lost an otherwise conserved cysteine 
pair placed just before the SPP domain while this domain is more variable and 
often shorter (see Figure 2A). In the C-terminal tail, tyrosine residues are more 
abundant in the SERK3/4 proteins (see Figure 2B). The juxtamembrane domain, a 
domain that was found to be important in the regulation of other LRR-RLKs (Wang 
et al. 2005b), is well conserved in the entire protein family.
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Figure 2B Multiple sequence alignment of C-terminal tail 
Detail of the SERK MSA, focused on the C-terminal tail domain. Although highly homologous 
amongst the monocot, nonvascular and dicot SERK1/2 protein sequences, the dicot SERK3/4 
show more divergence in this domain, and especially a higher occurrence of tyrosine residues across 
the domain.
The SERK genes are under purifying selection
Genes that obtain a new function are often found to be under positive selection (se-
lection to maximise change), meaning that most retained mutations cause changes 
in the amino-acid sequence. On the other hand, genes that perform vital func-
tions in a cell are usually under purifying selection (selection to minimise change), 
where most mutations are silent on protein level. To infer the direction of natural 
selection for the SERK genes, the Ka/Ks ratio (nonsynonymous/ synonymous sub-
stitution rates) for each of the SERK protein coding sequences was calculated. A 
Ka/Ks ratio of 1 is indicative of neutral selection (no specific direction), lower than 
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1 indicates purifying selection (selection to minimise change) and higher than 1 
indicates positive selection (selection to maximise change). Ka/Ks was estimated 
using the KaKs calculator software (Zhang et al. 2006b), with the method of model 
averaging. The SERK genes that had a significant deviation from the 0-hypothesis 
(Ka/Ks = 1, or neutral selection) all showed purifying evolution (see Table 4). 
Because this might be due to pressure on the kinase domain to maintain its phos-
phorylation activity, the same analysis was performed on the extracellular domain, 
cytoplasmic domain and TM domain separately. This analysis shows that indeed 
the extracellular domain is more often under positive selection compared to the 
cytoplasmic domain, and the average Ka/Ks ratio for the extracellular domain of 
the dicot SERK3/4 group is slightly higher compared to the other groups. This 
might indicate that some proteins, and more so in the dicot SERK3/4 group, have 
diverged from the original SERK function by changes in their extracellular domain. 
However, the majority of SERKs are under selective pressure to minimise variation 
on protein sequence. An interesting observation is the high occurrence of positive 
selection found on the transmembrane domain (see Table 4). There is evidence 
that TMs in animal receptors are crucial for dimerization and play an important 
role in ‘strengthening’ receptor complexes (Li and Hristova 2010). Thus, the pos-
itive selection pressure on the TM could be involved in accommodating different 
oligomerization partners. However, since no changes in TM are observed between, 
for instance, SERK1 and SERK3, this cannot be the reason for the observed func-
tional differences between SERK family members. 
SERKs show lower conservation in specific structural domains
The conservation score of each amino acid calculated for 57 SERK protein se-
quences (see Table1, all identified SERK proteins but excluding C6FF61 due to a 
large gap in the LRR domain), was plotted onto the published crystal structure of 
SERK1-extracellular domain (PDB 4LSC) (Santiago et al. 2013) with use of the 
ConSurf algorithm (see Figure 3A and B, where cyan corresponds to low conser-
vation scores and red to higher conservation scores). The solvent exposed convex 
side (see Figure 3A) is more variable compared to the concave side of the LRR 
domain (see Figure 3B). Figure 3C and 3D display the hydrophobicity plots of the 
convex and the concave side respectively. On the solvent exposed side (convex), 
there is a conserved hydrophobic groove (coloured red) between variable, more 
hydrophilic, regions (coloured blue) (see Figure 3A and 3C). The concave side, 
which was found to interact with the extracellular domain of BRI1, displays two 
patches of high conservation. One of these is implicated in the BRI1-SERK1 inter-
action (Santiago et al. 2013) which for the most part overlaps with the reported 
interaction side of SERK3-FLS2 (Sun et al. 2013; and Table 5). All the residues that 
were reported as having interaction with the BRI1 and FLS2 extracellular domains 
and the corresponding BR and flg22 ligand (flg22 constitutes the 22 amino acids 
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Table 4 Ka/Ks ratio for SERK coding sequence, extracellular domain, cytoplasmic do-
main and TM
Evolutionary pressure on SERK coding sequences as evaluated by Ka/Ks ratio. Ratios with a  p- value 
< 0.05 (0-hypothesize is Ka/Ks=1) are coloured, red depicting a ratio below 1 (purifying selection), 
blue above 1 (positive selection). Analysis is done on the complete coding sequence (Tot), the extra-
cellular domain (Ecto), the cytoplasmic domain (Cyto) or the transmembrane domain (TM).
Dicot S1/2  Ka/Ks Dicot S3/4  Ka/Ks
Tot. Ecto Cyto TM Tot. Ecto Cyto TM
PtSERK1 0.90 0.89 0.91 1.71 MtSERK2 0.86 1.25 0.79 1.26
PtSERK2 0.89 0.73 0.73 1.62 MtSERK3 0.82 1.21 0.90 1.27
PtSERK3 0.89 1.15 0.95 1.9 MtSERK4 0.98 0.94 0.73 1.64
PtSERK4 0.84 1.29 0.96 2.94 MtSERK5 0.96 0.95 0.8 2.21
DlSERK 0.92 0.82 0.99 1.43 MtSERK6 1.07 1.75 0.71 1.22
MtSERK1 0.96 0.92 0.88 2.31 GmSERK2 0.93 1.79 0.8 2.21
GmSERK1 0.90 0.85 1.05 1.67 GhSERK2 1.03 0.97 1.23 0.92
CuSERK 0.94 0.95 0.75 1.97 GhSERK3 1.05 0.94 1.3 0.98
CsSERK 0.98 0.89 0.76 1.97 VvSERK3 0.88 1.34 0.91 1.4
VvSERK1 0.81 1.01 0.98 1.03 SlSERK3A 0.84 1.04 0.79 1.16
VvSERK2 0.88 1.17 0.91 1.38 SlSERK3B 1.01 1.1 0.97 1.35
GhSERK1 0.76 0.95 0.9 1.67 AtSERK3 0.91 0.82 0.97 1.06
CpSERK1 0.98 1.24 0.85 0.97 AtSERK4 1.07 1.09 1 0.91
CpSERK2 1.05 1.24 0.84 1.1 AtSERK5 0.96 0.88 0.93 nd
StSERK 0.82 1.21 0.98 1.1 NbSERK3A 0.90 1.01 0.92 1.14
SpSERK 0.83 1.29 0.96 1.2 NbSERK3B 0.91 0.92 0.91 1.14
SlSERK1 0.84 1.26 0.87 1.1
DcSERK 1.07 1.13 1.02 1.39
AtSERK1 1.02 0.87 1.54 1.43
AtSERK2 0.90 0.79 0.95 1.12
average 0.91 1.03 0.94 1.55 average 0.95 1.13 0.92 1.33
Non-vascular  Ka/Ks Monocots  Ka/Ks
Total Ecto Cyto TM Total Ecto Cyto TM
SmSERK1 0.96 1.18 0.94 0.44 OsSERK1 0.96 0.97 0.89 1.53
SmSERK2 0.96 1.15 0.94 0.61 OsbiSERK 1 0.92 0.96 0.99
SmSERK3 1.01 0.95 1.12 3.81 SbSERK1 1.02 0.91 0.84 1.12
SmSERK4 0.98 1 1.14 3.81 SbSERK2 1.03 1.23 0.83 1.28
MpSERK 1.08 1.29 1.09 1.71 SbSERK3 0.92 0.99 1.07 1.8
PpSERK1 0.9 0.91 1.03 2.27 AcSERK1 0.85 1.04 0.89 1.13
PpSERK2 1.07 0.95 1.05 1.4 AcSERK2 0.94 0.86 1.21 1.38
PpSERK3 0.97 0.91 1.23 1.76 AcSERK3 0.91 1.05 0.91 1.55
ClSERK 1.01 1.02 1.04 1.13
CnSERK 0.89 0.9 1.27 0.99
ZmSERK1 0.87 1.16 0.63 1.43
ZmSERK2 0.98 0.93 1.07 1.62
ZmSERK3 1.03 0.92 1.11 1.36
TaSERK1 1.01 1.49 0.82 0.99
average 0.99 1.04 1.07 1.97 average 0.94 1.01 0.96 1.3
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Figure 3 Conservation in the SERK LRR domain 
Conservation score for each amino acid as determined using the ConSurf algorithm (Ashkenazy et 
al. 2010) was plotted onto the reported structure of the SERK1 extracellular domain (pdb 4LSC; 
Santiago et al. 2013). Higher scores, plotted as red onto the structure, represent residues of higher 
conservation, whereas lower scores, indicated by cyan, depict more variable residues. Input was the 
MSA of 57 SERK protein sequences. In (A) the convex or solvent exposed side of the SERK LRR is 
depicted, in (B) the concave side is shown, which has interactions with the main ligand receptors. In 
(C) and (D) the hydrophobicity plots (hydrophobic regions are depicted by red, hydrophilic regions 
by blue) of the convex and concave sides are depicted respectively. 
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of flagellin competent to elicit a biological response) are well conserved among 
the SERK family members, but are much less so in the non-SERK LRR-RLK II sub-
family proteins that were included in the NJ tree (see Table 5). Therefore, these 
interaction domains appear to be SERK-specific. The conserved groove on the sol-
vent exposed site and the additional conserved region on the concave site seem to 
indicate that other important interaction domains are present on the extracellular 
domain of SERKs. 
The kinase domain in the SERK protein family contains many completely con-
served amino acids. Again, the ConSurf algorithm was used to plot the conserva-
tion score of this domain for the 57 sequences onto the crystal structure of SERK3 
kinase domain (PDB 8TL) (see Figure 4). The activation loop, the catalytic loop and 
catalytic cleft between the N-lobe and C-lobe, are almost completely conserved. All 
Figure 4 Conservation in the SERK kinase domain
The ConSurf algorithm (Ashkenazy et al. 2010) was used to plot the conservation score per amino 
acid onto the crystal structure of AtSERK3 kinase domain (PDB 3TL8; Cheng et al 2011), using the 
MSA of 57 SERK kinase sequences as input. Most of the kinase domain is conserved between the 
family members, all non-conserved residues (depicted in cyan space-fill) are found on one side of 
the kinase domain, away from the catalytic cleft of the kinase.
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variability in the kinase domain of the SERKs can be found on one site of the kinase 
domain, away from the catalytic side. Within this variable region is the KID, kinase 
insert domain, which is a known variable region in kinases, thought to function in 
protein-protein interactions (Hubbard et al. 1994, Shewchuk et al. 2000).
Table 5 Conservation of SERK interacting residues
Interacting residues of SERK1 and SERK3 (numbering according to SERK1 sequence) with main 
receptors BRI1 and FLS2 respectively were assessed for their conservation amongst SERKs (Cons. 
SERKs), amongst the non-SERK LRR-II proteins depicted in Figure 1 (Cons. Non-SERKs) and 
specifically in the non-vascular plant Physcomitrella patens (P. patens). If this final column is empty, 
residues in P. patens are similar to those of SERK1. Non-conserved residues were only found in one 
of the three P. patens SERK proteins (protein id A9STU8). Conservation score assessed via Jalview 
2.8, score of 11 indicates 100% conservation
Residue Main receptor 
interaction
Ligand inter-
action
Cons. SERK Cons. 
non-SERK
P. Patens 
Thr 53 flg22 10 4 Pro
Leu 54 flg22 10 4
Val 55 flg22 10 6
Cys 58 BRI1 10 11
Phe 61 FLS2 BL 10 5
His 62 BL 10 3 Tyr
Thr 64 BRI1 10 6
Cys 65 BRI1 10 11
Asn 66 BRI1 7 3
Arg 73 BRI &FLS2 5 4
Asp 75 BRI1 10 4
Gly 77 BRI1 4 6
Tyr97 BRI &FLS2 10 0
Glu 99 BRI1 10 0 Val
Tyr 101 BRI &FLS2 5 0
Ser 121 BRI1 11 7
Asp 123 BRI1 11 8
Tyr 125 BRI1 10 4
Arg 144 FLS2 9 5
Phe 145 BRI &FLS2 11 3
Arg 147 BRI &FLS2 11 3
SERKs show different affinities for the main receptors BRI1 and 
FLS2
The residues implicated in interaction with the ligand and main receptor are well 
conserved amongst the SERK family, suggesting all SERKs should be able to form 
these complexes. However, genetic studies neither provide evidence for a role of 
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Figure 5 Co-immunoprecipitation of SERKs-GFP and BRI1 proteins. 
A: Transgenic Arabidopsis seedlings expressing SERK1, SERK2 and SERK3 driven by their own 
promoter and tagged with GFP were treated with brassinazole (Brz, 2.5 µM for 3 days), propicona-
zole (PPC, 1µM for 3 days) or epibrassinosteroid (BL, 1µM for 10 minutes). Total proteins (input) 
were subjected to immunoprecipitation with anti-GFP beads followed by immunoblot analysis with 
anti-GFP antibodies to detect SERK-GFP and anti-BRI1 antibodies to detect BRI1. BRI1 is only 
co-immunoprecipitated in SERK1 (left columns) and SERK3 (right columns) but not SERK2 (mid-
dle).  Molecular weight of detected proteins indicated in kDa.
B: SERK2 under the SERK3 promotor (middle columns) behaves as SERK2 under its own promotor 
(right), and not like SERK3 (left).
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SERK2 in brassinosteroid signalling nor for SERK1 and SERK2 in PTI (PAMP trig-
gered immunity)/flagellin signalling (supplemental Figure 1). SERK2 is expressed 
in the right cells to potentially interact with BRI1 (supplemental data 2) while 
SERK1 and SERK2 have been shown to form a ligand-induced complex with FLS2 
in vivo but with much lower affinity compared to SERK3 (Roux et al. 2011). To 
determine whether SERK1 and SERK2 interact with BRI1, extracts of seedlings 
expressing SERK1, SERK2 or, as a control, SERK3 tagged with GFP were subjected 
to co-immunoprecipitation experiments using native anti-BRI1 antibodies. SERK1 
expressed under its own promoter shows a much lower expression than SERK2 
and SERK3 driven by their respective promoters. Heterooligomer formation in the 
absence of the BR ligand was observed between SERK1, SERK3 and BRI1, while 
a clear ligand-dependent increase was noted only for SERK3. No interaction was 
found between SERK2 and BRI1 (see Figure 5). The amount of BRI1 being im-
munoprecipitated by SERK1 is more or less similar to that of SERK3, while the 
SERK1 input is much lower. Apparently there are marked differences in terms of 
stoichiometry or affinity in the main/co-receptor complexes (see Figure 5). Thus, 
the SERK proteins, although used redundantly in some pathways, are functionally 
distinct; they show different phenotypes and affinities for the main receptors BRI1 
and FLS2 (Roux et al., 2011).
Both extracellular and intracellular SERK domains convey specificity 
in different pathways
To determine whether the observed differences in protein-protein interactions and 
functionality can be attributed to either the extracellular or the cytoplasmic domain 
of the SERK proteins a number of chimeric proteins were tested in three different 
Figure 6 Overview of chimeric SERK proteins
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receptor mutant backgrounds, i.e. serk1-1 serk2 serk3-2, serk1-3 serk3-2, serk3-2 
serk4. All the constructs employed the SERK3 promoter because the phenotypes of 
interest can be rescued with a SERK member expressed under control of the SERK3 
promoter fragment. A schematic representation of all chimeric constructs using a 
SxESyK terminology in which x is the SERK member donating the E(extracellular 
Figure 7 SERK1 or SERK2 extracellular domain is required to restore male sporogenesis.
A. Inflorescence of a serk1 serk2 double mutant, expressing the SERK3 gene driven by the SERK2 
promoter (PSERK2:SERK3-YFP), the S2ES3K and S3ES2K chimers under the SERK3 promoter. 
Plants expressing PSERK2:SERK3-YFP and PSERK3:S2ES3K show normal seedpods, plants expressing 
PSERK3:S3ES2K are sterile. B. The chimeric proteins are visualised in the anther tissue by con-
focal microscopy, in double mutant background for PSERK2:SERK3-YFP and PSERK3:S2ES3K and in 
heterozygote serk1serk1 serk2SERK2 background for PSERK3:S3ES2K. T is tapetum. C. Western 
blot shows the expression of the chimeric proteins and the corresponding Coomassie blue staining 
(CBB).
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domain) and y the member from which the cytoplasmic K(inase) domain is derived 
is presented in Figure 6.
The sterility phenotype of the serk1 serk2 double mutant can be fully com-
plemented by S1ES3K and S2ES3K chimeric proteins using 4 and 6 independent 
transgenic lines respectively. All show full complementation as shown by the pres-
ence of pollen and the restoration of the silique size. In contrast, no rescue of 
the sterility phenotype can be observed with any other chimeric protein, such as 
S3ES1K or S3ES2K, 4 and 9 independent transgenic lines respectively have been 
tested, all showing full sterility phenotype (see Figure 7A). There is no difference 
in the level of expression of the transgenes that could account for the failure of the 
rescue (see Figure 7C) and the transgenes are expressed in the proper cell layer (i.e 
the tapetum layer) to allow full complementation (see Figure 7B). Apparently, the 
SERK1 and SERK2 extracellular domains, but not the kinase moieties, are critical 
for sporogenesis and mediate the specificity of the SERK1 and SERK2 genes within 
that pathway.
In the brassinosteroid pathway, serk3 mutant plants show a weak BR-deficient 
phenotype. Neither serk1 nor serk2 single mutants show any defects in BR-signal-
ling. The double mutant serk1 serk3 (but not serk2 serk3) shows a more severe 
BR-deficiency than the single serk3 (although still not as severe as the “cabbage” 
phenotype of a bri1 strong allele) (Li et al. 2002, Nam and Li 2002, Albrecht et al. 
2008). SERK1 thus has an overlapping but not completely redundant function to 
SERK3 in the BR-signalling pathway. In order to study the relevance of the differ-
ent receptor domains to mediate specificity in brassinosteroid signalling, a series 
of chimeric proteins were introduced in the double mutant serk1-3 serk3-2 and in 
the triple mutant serk1-1 serk2-2 serk3-2. Due to fertility problems of the homozy-
gous double and triple mutants, the constructs were transformed in heterozygote 
backgrounds and further characterised by genotyping to identify double or triple 
Figure 8 BR-phenotype complementation by chimeric SERK proteins
 A. Hypocotyl assay and BR-induced root growth inhibition of complemented serk1 serk3 mu-
tant with chimeric SERK proteins. Absolute growth of hypocotyl was measured after 4 day in the 
dark. Root growth of 8 days old seedlings grown on medium containing increasing amount of brassi-
nolide. Bars represent SE (n=20). These experiments were repeated tree times with similar results.
B. Complex formation between SERK2 and BRI1 is restored when exchanging the cytoplasmic 
domain of SERK2 with the cytoplasmic domain of SERK1. Transgenic Arabidopsis seedlings ex-
pressing SERK1, SERK2, S1ES2K and S2ES1K driven by their own promoter (SERK1 and SERK2) 
or by SERK3 promoter (S1ES2K and S2ES1K) and tagged with GFP were treated with brassinazole 
(BZR, 2.5µM for 3 days), propiconazole (PPC, 1µM for 3 days) or epibrassinosteroid (BL, 1µM for 
10 minutes). Total proteins (input) were subjected to immunoprecipitation with anti-GFP immu-
noaffinity beads followed by immunoblot analysis with anti-GFP antibodies to detect SERK-GFP, 
anti-BRI1 antibodies to detect BRI1. Molecular weight of detected proteins indicated in kDa.
C. Hypocotyl assay of complemented serk1 serk3 mutant with chimeric SERK proteins. Ab-
solute growth of hypocotyl was measured after 4 day in the dark. Bars represent SE (n=20). These 
experiments were repeated tree times with similar results.
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homozygotes carrying the transgene. Rescue was confirmed through quantification 
of hypocotyl length and root inhibition growth assay (see Figure 8).
The results show that both the SERK1 extracellular (S1ES3K) and cytoplasmic 
(S3ES1K) domains can revert the serk1 serk3 phenotype to nearly wild type. The 
S2ES3K or S3ES2K chimers can revert the serk1 serk3 phenotype close to the serk3 
phenotype but not to wild type (see Figure 8A). The differences in complementa-
tion observed between SERK1-SERK3 and SERK2-SERK3 chimers can be partly at-
tributed to the kinase domain; the SERK2 extracellular domain coupled to a SERK1 
kinase regains the ability to interact with BRI1 and can partially rescue the serk1 
serk3 double mutant (see Figure 8B and C).
Null serk3 mutants are impaired in flagellin signalling indicating that other 
members of the SERK family cannot fully substitute for SERK3 in this pathway. This 
is further supported by the fact that serk1 and serk2 mutants in combination with 
serk3 do not enhance the serk3 PTI phenotype. Since GFP-tagged versions of SERK3 
were found to impair flagellin signalling (Ntoukakis et al. 2011), only untagged 
chimeric constructs were used for the rescue of the PTI-related phenotypes. The 
previously described chimeric constructs introduced in serk1 serk3 mutant back-
ground were therefore used to assess which domain is conferring SERK3 specificity 
in the flagellin pathway. A late response triggered by flg22 is the inhibition of 
seedling growth. In that assay, serk3 mutants are impaired in flagellin-induced in-
hibition of seedling growth and are insensitive up to 50 nM of flg22 (Chinchilla et 
al. 2007). None of the chimeric proteins in the serk3 mutants restored responsive-
ness to flagellin back to wild type. serk3 seedlings carrying the S3ES1K or S3ES2K 
chimers are less sensitive to flg22 than untransformed serk3 (see Figure 9A). In-
stead, the S3ES1K and S3ES2K chimers even showed a dominant-negative effect 
on FLS2-mediated signalling, suggesting that both the SERK3 extracellular and 
cytoplasmic domains are indispensable for the response to flagellin. The failure of 
the chimeric proteins to replace the SERK3 protein in PTI was not due to a reduced 
ability to associate with FLS2 (see Figure 9B).
Figure 9 None of the chimeric proteins restores PAMP signalling.
A. PAMP-induced seedling growth inhibition of complemented serk1 serk3 mutant with chimer-
ic SERK proteins. Seedling growth inhibition in response to increasing concentrations of flg22 in 
Col[0], serk3, serk1 serk3 and complemented serk1 serk3 mutants with different swap domains 
SERK proteins. Seedlings are weighed 10 days after treatment. Results are given as absolute or 
relative growth measured as fresh weight in Figure A and B, respectively. Results are average +- 
SE (n=10). All experiments were repeated at least three times with similar results.
B. The chimeric proteins are not impaired in their ability to interact with FLS2. Transgenic Arabidop-
sis seedlings expressing SERK3, S1ES3K and S3ES1K driven by SERK3 promoter and tagged with 
GFP were treated with flagellin (flg22, 1µM for 10 minutes). Total proteins (input) were subjected 
to immunoprecipitation with anti-GFP immunoaffinity beads followed by immunoblot analysis with 
anti-GFP antibodies to detect SERK-GFP, anti-FLS2 antibodies to detect FLS2. Molecular weight 
of detected proteins indicated in kDa.
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Discussion
The SERK family in A. thaliana has arisen through gene duplications followed by 
functional divergence. The end result is a protein family of five highly homologous 
members that show only partial functional redundancy (Hecht et al. 2001, Albrecht 
et al. 2008). The functional divergence between these highly similar proteins, and 
the multiple and distinct pathways in which they are implicated, raises questions 
on how the SERKs operate. The functional plasticity of the SERK protein family as 
found in A. thaliana was identified as well in rice (Singla et al. 2009, Park et al. 
2011), barrel clover (Nolan et al. 2009, 2011) and tobacco (Chaparro-Garcia et 
al. 2011, Mantelin et al. 2011), indicating that the ability to function in multiple 
signalling pathways, via interaction with different main receptors, is probably a 
common mode of action for SERK proteins of different plant species. Previous anal-
yses on SERK genes and proteins have clearly demonstrated that the differences in 
SERK functions are mostly caused by differences in protein sequence, rather than 
different gene expression patterns or levels. Sequence analysis coupled to domain 
swap experiments show that changes in both SERK extracellular and cytoplasmic 
domains contribute to the functional divergence of the proteins. 
SERKs are ancient, essential genes that have been conserved 
during speciation
Multiple SERK genes are found in each of the analysed plant genomes, including 
dicots, monocots and non-vascular plants. This indicates that SERK genes are at 
least 160 M years old, and were present before the split of non-vascular and vas-
cular plants. The brassinosteroid and flagellin pathways, in which AtSERK1, 3 and 
4 have been implicated, are thought to have arisen after this split (Rensing et al. 
2008, Boller and Felix 2009). This hypothesis is supported by our genome analyses 
of P. patens and S. moelendorffii using BLAST algorithms with the BRI1 sequence of 
A. thaliana. The analyses did not result in the identification of confident BRI1 or-
thologues in these species (data not shown). Thus, the SERK co-receptors predate 
the main ligand binding receptor BRI1 and FLS2. The SERKs present in genomes 
that diverged earlier during speciation (such as the P. patens genome) closely re-
semble the SERKs from monocot and dicots. The SERKs have thus been conserved 
throughout evolution. Indeed we found that the SERKs are under purifying evolu-
tionary pressure, i.e. under evolutionary pressure to minimise sequence diversity. 
All plant genomes analysed have multiple homologous SERK gene copies, 
presumably arisen through duplications. These duplicates have been preserved as 
close homologues in the genome, while classic evolutionary theory predicts that 
duplicated genes either diverge or are lost after time (Wagner 1998). The presence, 
and maintenance, of multiple SERK copies in the plant genome, indicates the func-
tional relevance of the simultaneous presence of these receptors. This might be due 
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to unequal or partial redundancy restricted to a particular signalling process; une-
qual redundancy is defined as the situation where “the duplicated gene, although 
dispensable, contributes significantly to the overall activity of the gene pair, as 
revealed by double mutant analysis” (Briggs et al. 2006). This unequal redundan-
cy has led to sub-functionalisation in non-overlapping processes; SERK1, 2 and 4 
are not essential for BR signalling, but are under selective pressure because they 
are essential for sporogenesis and cell death signalling respectively. It is currently 
unclear whether the observed unequal redundancy is caused by different heteroo-
ligomer configurations with different subcellular localisation and/or differences 
in the use of phosphorylation sites. Differences in the affinity between SERKs and 
their respective main receptors (Roux et al. 2011 and this study) and differences in 
the autophosphorylation status of the SERKs (Karlova et al. 2009, Roux et al. 2011) 
are observed that could support both ideas.
Evolutionary divergence in the SERK protein family and related 
functions
SERK3 or BAK1 is the only SERK family member in A. thaliana which displays a 
developmental as well as a PTI phenotype, and thus seems to be the most active 
signalling member. However, the SERKs from the non-vascular plant genomes and 
monocot genomes resemble the A. thaliana SERK1 and 2 proteins more. Also, the 
NJ-tree shows that the dicot SERK1 and SERK2 proteins are more closely related 
to monocot SERKs than to the dicot SERK3 and SERK4 proteins. Thus, it appears 
that AtSERK3, SERK4 and SERK5 are evolutionary later expansions of the protein 
family, and the additional functionality of SERK3 probably also evolved later. This 
is in line with the observation that SERK1 and 2 are the only SERKs involved in 
male sporogenesis, a signalling pathway from which the putative main receptor 
in that pathway, EMS1,has a homologue in the Physcomitrella genome, in contrast 
to BRI1 and FLS2 (Wang and Mao 2013). Members of both the early SERK1-2 
clade and the SERK3-4-5 clade have apparently been recruited by BRI1 receptor 
while only SERK3-4-5 clade members acquired advantageous mutations leading to 
neo-functionalisation in immune signalling and cell death control (He et al. 2007, 
Roux et al. 2011). However, although no BRI1 homologue is found in non-vascular 
plant genomes, brassinosteroids were found to induce growth in Selaginalla, and 
downstream signalling components are present (Cheon et al. 2013). Thus brassi-
nosteroid signalling probably does occur in non-vascular plant, albeit via different 
mechanisms, and SERKs could still function in brassinosteroid signalling in these 
evolutionary older genomes. 
The inability of SERK1 and 2 to substitute for SERK3 in the immune signalling 
might be due to the inability to recognise the signal properly and/or to couple to 
downstream signalling components. Residues involved in flg22 binding are con-
served between SERK1, 2 and 3 and the interaction between FLS2 and SERK1-2 
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is strongly ligand dependent, similar as reported for SERK3. Hence, it is unlikely 
that perception of the ligand is altered in the heterodimer formed by SERK1-2 and 
FLS2 receptors. None of the chimeric proteins rescues flagellin-related phenotypes, 
indicating a high stringency on both SERK3 extracellular domain and cytoplasmic 
domain for PTI signalling. The data presented here corroborates previous findings 
suggesting that heterodimerization would be regulated by a double-lock system in 
which both the extracellular domain and cytoplasmic domain would participate 
(Jaillais et al. 2011). Furthermore, it indicates that the usage of the SERK receptor 
is different depending of the pathway in which they are serving; the extracellu-
lar domain is essential for sporogenesis, the cytoplasmic domain for BR signalling 
and both extracellular domain and cytoplasmic domain for the PTI pathway. This 
is in line with the fact that the main receptors involved in these pathways have 
different mode of action, RD versus non-RD kinases. For instance, BRI1 kinase 
activity is necessary for ligand induced SERK3/BAK1-BRI1 oligomerization (Wang 
et al. 2008) while kinase activity of neither main receptor nor co-receptor is neces-
sary for ligand induced FLS2-SERK3/BAK1 or EFR-SERK3/BAK1 oligomerization 
(Schwessinger et al. 2011). Also, a C-terminal tag on SERK3/BAK1 was found to 
impair flagellin signalling, while it has a minor effect on BR signalling (Ntoukakis 
et al. 2011, Lozano-Duran et al. 2013). The data presented in this manuscript con-
firm those findings and further highlight major differences in the regulation of the 
pathways in which the SERKs are serving.
The cytoplasmic domain is not the sole cause of specificity
One attractive mechanism to employ the same SERK protein in different pathways 
in the same cell would be to slightly alter the auto- and transphosphorylation pat-
tern after activation by different ligand-perceiving main receptors (Wang et al., 
2008). However, our results indicate that there is only limited specificity in the 
cytoplasmic SERK domains, as the SERK3 cytoplasmic domain can fully substi-
tute for the SERK1 and SERK2 cytoplasmic domains in male sporogenesis signal-
ling. Thus, transphosphorylation specificity of the kinase domain cannot be the 
differential factor between SERK1/SERK2 and SERK3 for this pathway. For the 
PTI pathway, exchange of the cytoplasmic domains is not sufficient to acquire the 
capacity to relay the perception event into signalling output; the flagellin-related 
phenotypes could not be rescued by an exchange of the kinase domain between 
SERK1 or SERK2 and SERK3. Those studies established that swapping the intra-
cellular kinase domain does not reprogram the cellular response output. This is a 
strong indication that the kinase activity is not the sole cause for differences in spe-
cific downstream signal activation observed between the different SERKs. Similar 
studies using a chimera strategy have been used in animal and plant signalling to 
elucidate receptor kinase activation and downstream signalling mechanisms (e.g. 
Yin et al. 2004). Those studies clearly indicate that receptor kinases employ closely 
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related or identical mechanisms to transmit the signal across the plasma membrane 
to trigger cellular responses. They furthermore clearly show that the extracellular 
domain is conferring perception specificity of the ligand while the intracellular 
kinase domain defines downstream signalling specificity, receptor regulation and 
trafficking. In receptor chimera constructed from the major structural domains of 
the EGF and insulin receptors, the signalling output is defined by the origin of the 
intracellular kinase domain (Riedel et al., 1986; Riedel et al., 1989). Likewise, 
a chimeric receptor composed of the extracellular domain of the brassinosteroid 
receptor BRI1 fused to the intracellular kinase domain of the rice disease resistant 
receptor, XA21, initiates plant defense responses in rice cells upon treatment with 
brassinosteroids (He et al., 2000). In contrast, the data presented here with chi-
mera of genes from the same family, indicate that the kinase domain is not solely 
conferring downstream specificity, i.e they have different requirements for the ex-
tracellular and/or intracellular domain depending of the signalling output. Hence, 
we propose that the formation of SERK-main receptor heterodimers creates spe-
cific interaction platforms with combinatorial complement of downstream targets, 
which lead to distinct outcomes of stimulation.
Due to complex redundancy issues and the resulting lethality phenotypes, it is 
difficult to clearly assign specific role to the individual SERK members. We show 
that we can manipulate this specificity and created SERK1SERK3 chimers that split 
the brassinosteroid and PTI and SERK2 extracellular-SERK3 kinase chimers that 
split the brassinosteroid and sporogenesis pathways. The chimers will be instru-
mental to decipher individual SERK signalling pathways in the absence of other in-
terfering SERK, thereby greatly increasing our understanding of specificity within 
the SERK protein family.
Heteromerization is at the core of SERK activation and signalling 
Ligand-binding receptors possess all the necessary domains from perception of the 
external signal via the LRR region to its transduction into cytoplasmic signalling 
via the kinase. Regardless, a common mechanistic property associated with the 
activation of many receptor kinases, whether in the animal or plant kingdom, is 
their obligate homo- or heterooligomeric activated configuration. Homodimeriza-
tion of both BRI1 and FLS2 receptors has been documented (Wang et al. 2005b, 
Hink et al. 2008, Sun et al. 2012). However, it is unclear whether this represents 
functionally active complexes or whether they are part of a more elaborate struc-
ture, as BRI1-SERK3 hetero-oligomers partially exist with a size corresponding to 
a tetrameric configuration (Karlova et al. 2006). Recent crystal structures of the 
SERK1-BRI1 (Santiago et al. 2013) and SERK3/ BAK1- FLS2 (Sun et al. 2013) 
extracellular domain complexes have established the SERKs as true co-receptors 
that have interactions with both the main ligand binding receptor and the ligand 
itself. The residues that are involved in the interactions between SERKs and their 
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main receptor extracellular domains are well conserved among the SERK family 
members, even in the non-vascular plant genomes, which suggest that all SERKs 
have the ability to form these complexes. Indeed, we find that SERK2, although ge-
netically unlinked to BR signalling, can interact with BRI1 in systems such as pro-
toplasts (unpublished data). In addition, SERK1 and SERK2, for which no genetic 
evidence exists for a role in immunity signalling, can interact with FLS2 (Roux et 
al. 2011). The residues involved in the recognition of the ligand are also well con-
served in all the SERK members, including the SERK members present in non-vas-
cular genomes, lacking the BRI1 (Wang and Mao 2013) and the FLS2 receptors 
(data not shown). Hence, specificity conferred by SERK is not due the inability of 
some members to appropriately recognise the ligand. The recent structures of the 
extracellular domains of the main receptors BRI1 and FLS2 with their respective 
ligands further indicate that, at least for these receptors, ligand binding does not 
induce homodimerization of the main receptor, or large conformational changes to 
the extracellular domains (Hothorn et al. 2011, She et al. 2011, Sun et al. 2013). 
This indicates that for the initial ligand induced receptor activation an additional 
player, besides the ligand binding receptor, is needed. All current genetic, biochem-
ical, microscopic and structural data indicate that this role is fulfilled by members 
of the SERK co-receptor family (Albrecht et al. 2012, Gou et al. 2012, Bücherl et 
al. 2013, Santiago et al. 2013, Sun et al. 2013). As in EGF signalling, co-receptors 
most likely fulfill a structural role in generating and maintaining a structure to 
achieve the required transmembrane conformational changes to turn on kinase ac-
tivity (Zhang et al. 2006a, Campbell et al. 2010, Liu et al. 2012). In addition, they 
can modulate the signal initiated by ligand binding (van Esse et al. 2013) in such a 
way that it can precisely target the correct intracellular response.
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Supplemental Table 1  Primers used for genotyping
serk1-1 serk1-1 F CGTGACAACAGCAGTCCGTGGCACCATCGG
serk1-1 R CCCTTTTAATCGAACCATAGCAC
T-DNA R GCCTTTTCAGAAATGGATAAATAGCCTTGCTTCC
serk1-3 serk1-3 F AGCAATTTTGTTTTGCAGAAAAGT
serk1-3 R AGAGATATTCTGGAGCGATGTGACCGATGG
serk2 T-DNA R CCCATTTGGACGTGAATGTAGACAC
serk2 F CTCTGGTATGGGAAGATGGTAATGTGGTCTGAG
serk2 R CGGCTAGTAACTGGGCCGCATAGATCC
T-DNA R GCCTTTTCAGAAATGGATAAATAGCCTTGCTTCC
serk3-2 serk3-2 F GCCACTAAAGTACCATCAGC
serk3-2 R CAACACCAAGTTGACTCCCCTTCCTGC
T-DNA R GCGTGGACCGCTTGCTGCAACT
Supplemental Table 2  Primers used for producing chimers
S1ES3K S1ES3K F ACTGGAGCAATAGCTGGTGGAGTTGCTGCAGGTGCTGCTCTTC-
TATTTGCTGTTCCGGCCATTGCACTAGCTTGGTGG
S1ES3K R CCACCAAGCTAGTGCAATGGCCGGAACAGCAAATAGAAGAG-
CAGCACCTGCAGCAACTCCACCAGCTATTGCTCCAGT
S2ES3K S2ES3K F ACTGGAGCCATTGCGGGAGGAGTTGCTGCTGGTGCTGCTCTTC-
TATTTGCTGTTCCGGCCATTGCACTAGCTTGGTGG
S2ES3K R CCACCAAGCTAGTGCAATGGCCGGAACAGCAAATAGAAGAG-
CAGCACCAGCAGCAACTCCTCCCGCAATGGCTCCAGT
S3ES1K S3ES1K F ACTGGAGCGATTGCGGGAGGAGTTGCTGCAGGTGCTG-
CATTGCTCTTTGCTGCTCCTGCAATAGCCTTTGCTTGGTGG
S3ES1K R CCACCAAGCAAAGGCTATTGCAGGAGCAGCAAAGAGCAATG-
CAGCACCTGCAGCAACTCCTCCCGCAATCGCTCCAGT
S3ES2K S3ES2K F ACTGGAGCGATTGCGGGAGGAGTTGCTGCAGGTGCTGCATTAC-
TATTTGCTGCCCCTGCTTTAGCTTTTGCTTGGTGG
S3ES2K R CCACCAAGCAAAAGCTAAAGCAGGGGCAGCAAATAGTAATGCAG-
CACCTGCAGCAACTCCTCCCGCAATCGCTCCAGT
Supplemental Figure 1  SERK genes show unequal/only show partial redundancy.
A. Root growth measurements of seedlings grown on media containing different BL concen-
trations using various mutant combinations. Growth is represented relative to the untreated wild 
type. Results are average ± SE (n=10). All experiments were repeated at least twice with similar 
results. s1 stands for the serk1-1 allele, s2 for serk2-2 and s3 for serk3-2.
B. serk1-1 and serk3 but not serk2-2 mutants enhance the weak phenotype of bri1-119 mutant. 
Three weeks-old plants are shown.
C. Phenotype of the double serk1-1 serk2 double mutant. The serk1-1 serk2 double mutant 
does not produce pollen hence is male sterile. 1- A wild-type flower showing pollen grains. 2- A 
serk1-1 serk2 double mutant flower with shortened anther filament and no pollen grain. 
D. Seedling growth inhibition triggered by flg22 in Col-0, serk1-3, serk2-2, serk3-2 and fls mu-
tant seedlings and in the double mutants serk1-3 serk3-2 (s1s3), serk2-2 serk3-2 (s2s3). Growth 
is represented relative to the untreated wild type. Results are average ± SE (n=12). All experi-
ments were repeated at least twice with similar results.
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Supplemental Figure 2  SERK1, SERK2 and SERK3 expression patterns are largely overlap-
ping.
A. Semi-quantitative RT-PCR analysis of SERK1, SERK2 and SERK3 transcripts in different tis-
sues. The constitutively expressed cyclophilin gene, ROC5 (Chou and Gasser, 1997) was amplified 
simultaneously as a control. PCR products were collected after 28-30-32-34 cycles for SERK1, 
SERK2 and SERK3 and after 20-22-24-26 cycles for ROC5.
B. SERK1, SERK2 and SERK3 fluorescent fusion proteins localisation during root and anther de-
velopment.
C. Roots and anthers of transgenic plants harbouring the SERK1, SERK2 and SERK3 cDNAs fused 
to YFP and driven by their respective promoters are visualised by confocal microscopy. 1- Expres-
sion in the root tip. 2- Expression in the anther.
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Supplemental Figure 2bis  Expression profile of SERKs genes in various organs. 
The X axis indicates the level of gene expression. The various organs are indicated in Y axis. The data 
used in the Figures were retrieved from Genevestigator (https://www.genevestigator.ethz.ch; Zimmer-
mann et al. 2004).
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Supplemental Figure 3 Neo and/or sub-functionalisation of SERK genes is not determined by di-
vergence in cis-regulatory sequences.
A. Complementation of the male sterility phenotype.
1- Inflorescence of a serk1 serk2 double mutant, expressing the SERK3 gene under the SERK2 pro-
moter (PSERK2:SERK3-YFP), plant showing normal seedpods. Close–up on the flowers showing pollen 
grains. Expression of the transgene in the anther tissue is visualised by confocal microscopy. 2- Inflores-
cence of serk1-1 serk2 double mutant, expressing the SERK2 gene under the SERK3 promoter (PSERK3:-
SERK2-YFP), plant with small seedpods and no developing seeds. Close–up on the flowers showing no 
pollen grains. The transgene is visualised in the anther tissue by confocal microscopy.
B. Complementation of the brassinosteroid-related phenotypes.
Quantitative analysis of the hypocotyl length of serk3-2 mutants complemented with SERK2 under SERK2 
(P2s2) or SERK3 (P3s2) promoters and SERK3 under SERK2 promoter (P2s3) as compared to Col[0] 
and serk3-2. The seedlings are grown in the dark for 4 days. Each measurement represents an average of 
hypocotyl lengths of 20 seedlings. Error bars indicate standard deviation. All experiments were repeated 
at least twice with similar results * indicates significant differences from Col-0 wild type (p ≤0.05). ** 
indicates significant differences from the serk3-2 mutant (p ≤0.05). 
C. Rescue of the dwarf stature of the double mutant bri1-119 serk3 with various promoter swap con-
structs, SERK3 and SERK1 under the SERK2 promoter (PSERK2:SERK3 and PSERK2:SERK1 respectively) 
and SERK2 under the SERK3 promoter (PSERK3:SERK2). The transgenic lines are compared with Col[0], 
bri1-119 and bri1-119 serk3.
A
B
C
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Purification and Crystallisation attempts 
on the SERK protein family
M. aan den Toorn, S. van Aalst, M.E.E. Huijbers, J. Lukasiak, D.R. Boer, S. C. de Vries
Abstract
Receptor-like kinases are major players in plant signalling pathways. Recent crystal 
structures of extracellular domains of receptor kinases Brassinosteroid Insensitive 
1 and Somatic Embryogenesis Receptor Kinase 1 complex as well as the kinase 
domain of receptor BRI1-associated kinase 1 have provided the first insights in 
receptor structure-function relationships. To increase this knowledge it is impor-
tant to obtain more structures of these proteins, in different conformational and 
functional states. For this reason, we attempted to elucidate the three dimensional 
structure of the five members of the Somatic Embryogenesis Receptor-like kinases 
from Arabidopsis thaliana. We were successful in producing crystals of the SERK1 
kinase domain, but were unable to determine its protein structure. 
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Introduction
The elucidation of the atomic structures of proteins and other macromolecules has 
provided great insight into the molecular mechanisms by which cellular functions 
are achieved. One interesting question that these structures have started to answer 
is the manner in which extracellular signals are translated to cellular responses 
across the plasma membrane.
Often, signal transduction is initiated at the plasma membrane by receptor 
protein kinases that perceive the extracellular ligand, which leads to intracellular 
transphosphorylation events via conformational changes in receptor or signalling 
complex. Examples of such receptor kinases are the well-known animal receptor 
tyrosine kinases (RTKs), and the related plant receptor-like kinases (RLKs) (van 
der Geer et al. 1994; Shiu et al. 2001). The vast amount of RTK structures, in dif-
ferent conformational stages and with or without ligand, has provided a structur-
al basis for understanding receptor activation, complex formation and specificity 
(Hubbard et al. 2000), with the EGFR (epidermal growth factor receptor) as prime 
example (Ferguson et al. 2008; Bublil et al. 2010; Liu et al. 2012). In contrast, very 
little structural data is available on the plant counterparts of the RTKs, the RLKs. 
The largest group within the plant RLKs are those of the leucine-rich-repeat RLKs 
(LRR-RLKs), whose extracellular domain contains the LRR-motif (Torii 2004). In 
recent years, the first few crystal structures of LRR-RLK domains have been report-
ed, increasing our understanding of the molecular mechanisms of plant signalling. 
These crystal structures include the extracellular domain and cytoplasmic domain 
of members of an LRR-RLK subfamily known as the SERKs in complex with inter-
action partners. 
The Arabidopsis SERKs (somatic embryogenesis receptor kinases) are LRR-
RLKs, containing five extracellular leucine rich repeats and an intracellular kinase 
domain (Hecht et al. 2001; Shah et al. 2001). They are a family of five RLKs in A. 
thaliana that function in several different, seemingly unrelated, plant signalling 
pathways, such as hormone signalling, somatic embryogenesis, male sporogenesis, 
immune responses and cell death (Schmidt et al. 1997; Li et al. 2002; Albrecht et 
al. 2005; Chinchilla et al. 2007; He et al. 2007; Albrecht et al. 2008; Chinchilla et 
al. 2009). Although the SERK family members are highly homologous in sequence, 
they are not completely interchangeable in planta (see chapter 2 and (Albrecht et 
al. 2008)). SERKs function in these different pathways by forming specific higher 
order complexes with ligand binding LRR-RLKs, such as BRI1 (main ligand-binding 
receptor for the hormone brassinosteroid), FLS2 (main ligand binding receptor for 
bacterial flagellin) and EFR (main ligand binding receptor for the bacterial effector 
elongation factor Tu) (Nam et al. 2002; Russinova et al. 2004; Chinchilla et al. 
2007; Roux et al. 2011) and thus act as co-receptors. Transphosphorylation events 
between main receptor and co-receptor are important for proper signal transduc-
tion (Wang et al. 2008; Schulze et al. 2010; Gou et al. 2012). 
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The cytoplasmic domain of SERK3 (also called BAK1 for BRI1-associated kinase 
1) has been elucidated in its apo-form, and in complex with the SERK3/ BAK1 in-
teracting domain (BID) of the bacterial effector AvrPtoB (Cheng et al. 2011; Yan et 
al. 2012). AvrPtoB was shown to interact with the kinase domains of SERK3/ BAK1 
and FLS2, interfering with PAMP-triggered immunity (PTI) (Xing et al. 2007). The 
structure of the SERK3/ BAK1 kinase domain follows the basic structure found 
for eukaryotic protein kinases (ePK), which share a common catalytic core struc-
ture consisting of 12 subdomains and catalyse the transfer of the γ-phosphate of 
ATP to the hydroxyl group of serine, threonine, or tyrosine residues (Hanks et 
al. 1995; Stone et al. 1995). The ePK family can be divided in two groups, based 
on the ability to either transfer a phosphate to the phenol group of tyrosine resi-
dues (the protein tyrosine kinases) or to the alcohol group of serine and threonine 
residues (the serine/threonine kinases). Based on phylogenetic analysis and cer-
tain sequence motifs, the plant RLKs were grouped in the serine/threonine class 
of kinases, together with the animal Pelle and IRAK kinases (Shiu and Bleecker 
2001). However, some RLKs were found to phosphorylate both serine/threonine 
and tyrosine residues. These kinases are termed ‘dual specificity kinases’. Examples 
of these include the brassinosteroid insensitive 1 receptor (BRI1) and at least two 
members of the somatic embryogenesis receptor-like kinases (SERK1 and SERK3/ 
BAK1) (Shah et al. 2001; Oh et al. 2009; Oh et al. 2010). The SERK3/ BAK1 kinase 
domain shows the common two-lobed kinase structure consisting of a small N-ter-
minal lobe (mostly consisting of anti-parallel β-sheets) and the larger C-terminal 
lobe (consisting mostly of α-helices) and a catalytic cleft between the two lobes. 
The complex of SERK3/ BAK1 kinase with the BID domain of AvrPtoB shows that 
the bacterial effector probably inhibits SERK3/ BAK1 kinase function by interaction 
with the catalytic cleft, via contacts with the P+1-loop (in the substrate-binding 
region) (Cheng et al. 2011). Both the apo SERK3/ BAK1 kinase domain structure 
as well as the kinase in complex with AvrPtoB are in the active state, as similari-
ties to other active kinase structures indicate (Cheng et al. 2011; Yan et al. 2012). 
This active state is stabilised by two phosphorylated threonine residues, T455 and 
T450 (Yan et al. 2012). Although both these residues were found to be important 
for signalling activity of SERK3/ BAK1 in flagellin signalling, and (to lesser extent 
for T450) also for brassinosteroid signalling (Wang et al. 2008; Yan et al. 2012) 
most likely T455 is more important for inducing the active state of the SERK3/ 
BAK1 kinase domain, while T450 phosphorylation has a more complex influence 
on transphosphorylation specificity. T455A or T455D SERK3/BAK1 has lost almost 
all phosphorylation activity, while mutating T450 of SERK3/ BAK1 has only mi-
nor influence on SERK3/BAK1 autophosphorylation activity (Wang et al. 2008). 
SERK3/ BAK1 T450 found to be an essential residue for transphosphorylation on 
FLS2 (Wang et al. 2008; Yan et al. 2012), however, not for transphosphorylation 
on BRI1 in yeast (Yun et al. 2009). This seems to indicate that differential phospho-
rylation of the activation loop of SERK3/ BAK1 changes kinase substrate specificity. 
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In recent years the first crystal structures of LRR-RLK extracellular domains 
(ectodomains) have been resolved. In 2011 crystal structures of the BRI1 extracel-
lular domain, both in presence and absence of ligand were published (Hothorn et 
al. 2011; She et al. 2011). BRI1 contains 25 LRRs that, besides the normal LRR cur-
vature into a horse-shoe like structure, show a unique additional curvature to form 
a ‘super-helix’, different from animal LRR domains. The island domain, involved in 
ligand binding, folds back into the interior of the ‘super-helix’. Binding of ligand to 
the island domain causes some structural changes to this domain and connecting 
loops, however the rest of the extracellular domain does not undergo any confor-
mational changes upon ligand binding. Also, the BRI1 extracellular domain was 
found as a monomer in crystals and in solution, independent of ligand binding, 
thus ligand binding does not induce homodimerization of BRI1 extracellular do-
mains (Hothorn et al. 2011; She et al. 2011). Hothorn et al. hypothesised that 
ligand binding could induce the formation of a hydrophobic interaction platform, 
causing heterodimerization with co-receptors such as the SERKs, which in turn 
would create an active signalling complex. This hypothesis was proven by the elu-
cidation of the BRI1-SERK1 extracellular domain complex (Santiago et al. 2013). 
Heterodimerization between the SERK1 and BRI1 extracellular domains is ligand 
dependent, and the N-capping residues of SERK1 extracellular domain fold over 
the steroid ligand and dock onto the hydrophobic patch created by ligand binding. 
The finding that a ligand acts as a ‘molecular glue’ between main receptor and 
co-receptor, was further established by the elucidation of another SERK complex, 
consisting of the SERK3/BAK1 extracellular domain, the FLS2 extracellular domain 
and the flg22 ligand (a small peptide capable of inducing flagellin signalling (Sun 
et al.). Similar as reported for the SERK1-BRI1 complex, ligand binding to FLS2 
does not induce large conformational changes or FLS2 extracellular domain ho-
modimerization, but is essential for complex formation with the SERK3/ BAK1 ex-
tracellular domain. These reports, indicating that SERKs interacts not only with the 
main receptor but with the ligand as well, establish the SERKs as true co-receptors.
To understand the intricate ways in which plant signalling pathways are spec-
ified and intertwine, it is essential to gain a better insight in the atomic structures 
of the major players of the signalling cascades. The extracellular domain of BRI1, 
FLS2, SERK1, and SERK3/ BAK1, and the intracellular domain of SERK3/ BAK1 
begin to give us the important insights in the ways these signalling complexes are 
build up. To further this knowledge and to better understand how highly homol-
ogous co-receptors can be involved in such different signalling pathways, more 
three-dimensional structure of the different SERK family members need to be elu-
cidated. This chapter will discuss the attempts made to obtain crystal structures 
of different domains of the SERK proteins. The results indicate that these proteins 
do not crystallise readily, and are difficult to produce and purify. Although crystals 
diffracting to +/- 2.5 Å were obtained for the kinase domain of SERK1, structure 
elucidation was not possible at this time. 
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Materials & Methods
Constructs
Initial constructs for SERK1 were based on secondary sequence predictions of the 
amino acid sequence. Domain overview of these constructs can be seen in Figure 
1. Primers and number of amino acids of the different constructs can be found in 
Table 1 Initial SERK1 constructs
Construct Aa Primers
SERK1-A1 (26-198) - CAC CAA TTT GGA AGG TGA TGC TTT GCA T
- TCA GTTATTAGCAAAACTGATGGGTGTGA
SERK1-A2 (55-198) - CAC CGT GAA TCC TTG CAC ATG GTT C
- TCA GTTATTAGCAAAACTGATGGGTGTGA
SERK1-B1 (26-237) - CAC CAA TTT GGA AGG TGA TGC TTT GCA T
- TCA AGT TAT ACC ATA CCC ACT CGG GGT
SERK1-B2 (55-237) - CAC CGT GAA TCC TTG CAC ATG GTT C
- TCA AGT TAT ACC ATA CCC ACT CGG GGT
SERK1-C1 (26-262) - CAC CAA TTT GGA AGG TGA TGC TTT GCA T
- TCA GCC ACC AAG CAA AGG CTA TTG CA
SERK1-C2 (55-262) - CAC CGT GAA TCC TTG CAC ATG GTT C
- TCA GCC ACC AAG CAA AGG CTA TTG CA
SERK1-D1 (285-580) - CAC CGG ACA GCT CAA GAG GTT TTC T
- TCA CCC ATC TCC TTC CAG CAT CCT TAC A
SERK1-D2 (290-580) - CAC CTC TTT GCG GGA GCT ACA AGT
- TCA CCC ATC TCC TTC CAG CAT CCT TAC A
SERK1-D3 (285-end) - CAC CGG ACA GCT CAA GAG GTT TTC T
- TTA CCT TGG ACC AGA TAA CTC AAC GGC
SERK1-D4 (290-end) - CAC CTC TTT GCG GGA GCT ACA AGT
- TTA CCT TGG ACC AGA TAA CTC AAC GGC
SERK1-G1 (26-end) - CAC CAA TTT GGA AGG TGA TGC TTT GCA T
- TTA CCT TGG ACC AGA TAA CTC AAC GGC
SERK1-G2 (55-end) - CAC CGT GAA TCC TTG CAC ATG GTT C
- TTA CCT TGG ACC AGA TAA CTC AAC GGC
SERK1-G3 (26-580) - CAC CAA TTT GGA AGG TGA TGC TTT GCA T
- TCA CCC ATC TCC TTC CAG CAT CCT TAC A
SERK1-G4 (55-580) - CAC CGT GAA TCC TTG CAC ATG GTT C
- TCA CCC ATC TCC TTC CAG CAT CCT TAC A
SERK1-BL (263-605) - CAC CCG ACG AAG AAA GCC AC
- CCA ATC TTA GTT AGG ATT AGG ACT CAA ATC
SERK3-BL (250-591) - CAC CCG AAG GAA AAA GCC G 
- TTA ATG GTG GGT TGG GTA GTT G
SERK4-BL (255-597) - CAC CCT CAG AAG AAA ACC ACA GG
- CAG TCA GTG CCT TAA TGA GGA TAG G
SERK5-BL (236-578) - CAC CCT GAG AAG AAA ACT GCA GG
- CAG TGC CTT AAT GAG GAT AGG CTT G
84
Chapter 3
Table 1. The kinase domain constructs D1 and D3 were also produced as inactive 
variants by mutating the essential lysine 330 to a glutamic acid as was described 
before (Shah et al. 2001). Constructs A1-G4, and the constructs containing the in-
active D1k and D3k sequences were cloned into a pET151/D-TOPO vector (Invitro-
gen). The fusion protein of NUS - D3 was obtained by cloning the D3 construct into 
a pET43.1b (Novagen). Additional constructs were designed based on the crystal-
lised BAK1-KD in complex with AvrPtoB. These constructs are termed SERK1-5 BL 
(for BAK1-Like). The fusion proteins SUMO- SERK-BL were obtained by cloning the 
SERK-BL constructs into the pOPINS vector (OPPF).
Protein production and purification
All plasmids were transformed in E.coli strain BL21 (DE3), SERK4-BL and SERK5-
BL were additionally transformed in strain Rosetta 2. Bacterial cultures containing 
plasmid were grown in LB at 37 °C until OD600=0.8, after which the culture was 
cooled to 20 °C and protein production was started by addition of IPTG. After 20 
h cells were harvested. Cells were broken using a French Press or by passing them 
through a cell disruptor (Constant Systems Ltd) at 20 kpsi at 4 °C. The cell free 
extract was run over a Histrap tm HP (5ml, GE Healthcare) while present in 20 
mM Tris (pH 7.8), 300 mM NaCl, 10 mM imidazole, 10 mM MgCl2. Protein was 
eluted in the same buffer supplemented with 300 mM imidazole. Subsequently, the 
protein sample was desalted, 1 mM DTT was added and the sample was run over 
a HiTrapQ XL (5ml, GE Healthcare). Protein was eluted of the HiTrap using a salt 
gradient (NaCl, 0-1 M). Final purification of the sample was done via gel filtration 
using a superdex 75 26/60 column, in 20 mM Hepes (pH 7.4) 150 mM NaCl, 10 
mM MgCl2 1 mM DTT. Protein samples were concentrated using Vivaspin 5000 
MWO PES membrane (Satorius). 
Dephosphorylation experiments were performed using Antartic Phosphatase 
(New England Biolabs) and PP1 (New England Bioloabs). The reactions were per-
formed in the provided reaction buffers at 30 °C for one hour. 
Protein bands visible on SDS were analysed by nanoHPLC-MS/MS analysis 
performed by the Plataforma de Proteòmica of the Parc Científic de Barcelona (Bar-
celona).
Crystal screens 
Protein constructs D1, D3, D1k, D3k, NUS-D3, S1-Bl and S4-BL were used for crys-
tal screening, using screens depicted in Table 2. Protein concentration was varied 
between 5 mg/ml and 20 mg/ml. Crystallisation screens were performed using 
the sitting-drop-vapour-diffusion technique on 96-wells two-drop-MRC crystalli-
sation plates (MRC laboratory of molecular biology). Plates were set up using the 
Phoenix System (Art Robbins, USA) and the CARTESION Microsys 400 XL (Bruker 
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Nonius). Screenings were performed by combining 100 nl protein sample with 100 
nl crystallisation buffer and equilibrating this against 90 µl crystallisation buffer. 
Optimisations were set up by adding 200 nl protein sample to 200 nl crystallisation 
buffer, which was equilibrated against 80 µl crystallisation buffer. Plates typically 
were stored at 20 °C, although some initial screens were performed at 4°C, and 
monitored by Crystalfarm (Bruker Nonius) and manually. 
Table 2 Crystal screens 
The different crystal screens used for SERK protein constructs. A cross depicts that this screen 
was used for that protein sample, a circle that this screen was used in the presence of 10 mM AT-
PgS (an ATP analogue) and a minus sign indicates that the screen was set up in the presence of a 
phosphatase.
Crystal screen D1 D3 D1k D3k NUS-D3 S1-BL S4-BL
Crystal screen I&II (Hampton Research) x xº- x x x X
Wizard I&II (Emerald BioSystems) xº x x x
Index (Hampton Research) x- x x x
Salt RX (Hampton Research) x xº- x x x X
A/S Ion & AmSo4 & Quick phosph. (inhouse 
screen)
x x x
PEG 6000 & 6000/LiCl, PEG400 & 400/
LiCl (inhouse screen)
x
Crystal screen Lite & Crystal screen Cryo 
(Hamptons Research)
x x x
PEG-ion & MPD & NaCl (inhouse screen) x x x
Protein-DNA screen (KeraFAST) x x x
Membfac & MemPlus (Molecular Dimen-
sions)
x xº- x x X
Memstart & Memsys (Molecular Dimens-
tions)
x
Cryo Wizard I &II (Emerald BioSystems) x
JBS 1-4 (Jena Bioscience) xº
Citrat screen & Mc Pherson screen & Clear 
strategy I&II (Molecular Dimensions)
- x X
Pact Premier HT-96 (Molecular Dimensions) x x x
Pi-PEG screen (Jena Bioscience) x x x
Pi-minimal screen (Jena Bioscience) x x x x
Kinase screen (Jena Bioscience) x x
Crystal growth and diffraction
The protein construct D3 grew to crystals in 100 mM Bis-Tris propane pH7, 1.2 M 
DL-malic acid. The crystals were frozen in liquid nitrogen after addition of 15% 
glycerol to the crystallisation buffer for cryoprotection. The X-ray diffraction pat-
tern was measured at beamline ID14-1 at the ESRF (Grenoble, France), with Δϕ = 
1° at a temperature of 100K. 180 images were recorded. 
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Suitable crystals of SERK1-BL grew in 2M ammonium sulphate, 100 mM Bis-
Tris pH 5.5, (3) 1M tri-sodium citrate/ citric acid pH 7.0. The crystals were frozen 
in liquid nitrogen after moving to crystal buffer supplemented with 15% glycerol. 
The X-ray diffraction pattern was obtained at beamline ID23-2 at the ESRF with the 
following settings; Δϕ= 0.35°, temp: 100K, 160 images were collected.
Data analysis
The program MOSFLM 7.04 (Leslie et al. 2007) and scaling program SCALA 3.3.18 
(Evans 2006) were used for integration of the diffraction data and initial assign-
ment of space group (see Table 3). Molecular replacement for structure elucidation 
was done using PHASER 2.5.5 (Mccoy et al. 2007) from the CCP4 software suite 
(Winn et al. 2011). Inspection of the resulting density maps was done with COOT 
(Emsley et al. 2010). 
Table 3 XDATA. Data statistics of reasonably diffracting crystals of SERK constructs.
 S1-D3 S1-BL (C2)* S1-BL (H32)*
Space group P6n22 C2 H32
Collected at ID14-1(ESRF,Grenoble) ID23-2 (ESRF, Grenoble)
Cell dimensions a=b=61.49 Å c=168.57 
Å
a=154.1 Å, b=233.2 Å 
c=111.1Å
a=b=233.2 Å 
c=111.1 Å
90º, 90º, 120º 90º, 118.7.º, 120º 90º, 90º, 120º
Resolution (Å) 30.0-2.35 (2.48-2.35) 58.3-3.3 (3.48-3.3) 58.3-3.1 (3.3-3.1)
Rmerge 0.28 (0.93) 0.19 (0.57) 0.23 (0.80)
Rmeas 0.29 (0.96) 0.27 (0.81) 0.32 (1.1)
<I / σ(I)> 9.8 (3.7) 3.5 (1.4) 3.5 (1.1)
Completeness (%) 100 (100) 61.5 (65.7) 97.1 (98.3)
Multiplicity 20 (21) 1.5 (1.4) (1.8)
* These datasets are from the same diffraction experiment, but processed in different space groups
Results
Production of SERK1-A - G
Initially, 14 constructs of different parts of the SERK1 protein were designed based 
on secondary structure features predicted from the amino acid sequence (see Fig-
ure 1 A-G and Table 1 A-G).
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Figure 1 Domain overview of SERK and construct design 
Graphical representation of domain structure of a typical SERK protein. Numbers under the di-
agram indicate approximate amino acid residues as found in SERK1. EC= extracellular domain, 
IC= intracellular domain. SP= signal peptide, LZ= leucine zipper/N-capping residues, LRR= leu-
cine-rich-repeats, TM= transmembrane helix, JxM = juxtamembrane domain, KD= kinase domain, 
C= C-terminal tail domain. See Table 1 for precise amino acid numbers included in the different 
constructs.
Figure 2 Phosphorylation activity of NUS-D3, SERK-D3 and SERK-D1
Autoradiograph of Nus-D3 (A), SERK1-D3 (B) and SERK1-D1 (C) after 30 min. incubation in activ-
ity buffer containing 5 μCi [γ-32P] ATP to assess autophosphorylation activity. Al constructs show 
autophosphorylation activity and thus contain active kinase domain. Marker positions were as-
sessed from corresponding SDS-PAGE.
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When bacterial cultures were grown at 37°C with 5 hour induction, all recombinant 
protein was found in the pellet fraction of the cell free extract, most probably as 
part of inclusion bodies. Optimisation included varying the temperature, induction 
time and media composition. A 20 hour induction at 20°C in LB-media resulted in 
soluble protein for the constructs B1, D1, D3 and D4. For the kinase domain con-
structs (D-constructs) approximately 50% of the recombinant protein was found 
in the soluble fraction, while only a small amount (+/- 25%) of the recombinant 
extracellular domain (B1) was found in the soluble fraction. The D4 construct is 
similar to D3, except the D4 construct is 5 amino acids shorter in the N-terminus. 
For this reason we decided to continue with the D1 (complete kinase domain) 
and D3 (complete kinase domain with C-terminal tail) constructs for purification. 
To increase protein yield, an additional fusion construct was created of D3 fused 
N-terminally to NUS, a bacterial protein that is highly soluble in E. coli (Davis et al. 
1999). The D1, D3 and NUS-D3 constructs produced active kinase domains with 
autophosphorylating activity (see Figure 2).
Purification of D1, D3 and NUS-D3
Purification of the kinase domain constructs started with a metal affinity column, 
followed by ion exchange chromatography and as a final step a gel filtration col-
umn. Initial tests excluded the ion exchange chromatography step, but this resulted 
in a sample that was relatively pure on protein level, but contained high amounts 
of DNA/RNA. Ion exchange chromatography was successful in removing the DNA/
RNA from the sample, although it did not increase the purity of the sample greatly 
in respect to protein contaminants. The final sample resulting from this purification 
was approximately 90-95% pure (see Figure 3A). The protein eluted from the size 
exclusion column as a monomer, however at a slightly smaller elution volume than 
could be expected based on theoretical size. Consistent co-purification of impuri-
ties was observed; most prominently two bands at approximately 30 kD and one 
band at approximately 64 kD (see Figure 3C). Removal of these impurities varied 
greatly in its successfulness. The impurities were identified by MS/MS analysis as 
E. coli Chain A of the Catabolite-gene-activator protein (CAP)-DNA-complex (the 
30 kD bands) and E. coli transcription termination factor Rho (the 64 kD band).
The kinase constructs eluted as multiple peaks from the ion exchange column 
and were often detected as multiple bands on SDS-PAGE (see Figure 3C). This is 
probably due to differential phosphorylation statuses of the kinase, which contains 
24 possible phosphorylation sites. This heterogeneity of the sample could interfere 
with further crystallisation attempts. For this reason inactive variants of the D1 
and D3 constructs were constructed, where an essential lysine was changed to a 
glutamic acid (K330E), referred to as D1k and D3k. Although these constructs did 
not show the multiple protein bands on SDS-page characteristic for phosphorylat-
ed kinase, the yield or purity (in respect to other proteins) of the inactive variants 
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was not higher compared to the active constructs. Attempts to remove phosphate 
groups from the active D1 and D3 constructs with Antarctic phosphatase and PP1 
resulted in very low yield. This could be due to destabilisation of the protein sam-
ple, caused by the relatively high temperature (30°C) of the dephosphorylation 
reaction. 
Figure 3 Purified SERK1-D1 and D3
SERK1-D1 and D3 were purified with a three-step protocol, starting with a metal affinity column, 
followed by ion exchange chromatography and finally gel filtration chromatography. The resulting 
sample was 90-95% pure, this varied slightly between different purifications. Examples of typical 
end results of purification are depicted above, with in lane (A) SERK1-D1 and in (B) and (C) 
SERK1-D3. Lane C depicts the multiple bands often observed for a kinase construct, and the 
impurities at +/- 30 kDa and 64 kDa. (M)= marker lane with to the left the weight in kDa of the 
different marker lines. 
Crystallisation screens and crystal evaluation of D1 (k), D3 (k) and 
NUS-D3 
Crystallisation screens of the initial SERK1 kinase domain constructs were set up at 
varying protein concentrations (5-20 mg /ml) and at 4 and 20°C. The samples were 
present in 20 mM Hepes, 150 mM NaCl, 10 mM MgCl2 and 1 mM DTT and this 
was mixed 1:1 with crystallisation buffer. All constructs were screened using com-
mercial crystal screens (see Table 1 for an overview of crystal screens used for the 
different protein samples) using the sitting-drop-vapour-evaporation technique. 
Promising conditions were further optimised by varying protein concentration, 
buffer composition, pH and additives. The S1-D3 construct was also screened with 
the addition of 10 mM ATPγS (an ATP analog) and in the presence of phosphatase. 
However, addition of these compounds did not induce crystal growth. 
Of the inactive kinase constructs D1k and D3k no conditions were found that 
yielded suitable crystals for further analysis. Nus-D3 showed crystals in two con-
ditions; (1) 0.2 M CaAc, 100 mM MES 6.5, 10% PEG 8K and (2) 0.2M M MgCl2, 
100 mM Tris 7.0, 14% PEG 8K. The best diffracting crystal was grown in the latter 
condition, which was slowly mixed with cryobuffer (30% glycerol added to the 
crystalbuffer) before freezing in liquid nitrogen. The crystal diffracted to a resolu-
tion of approximately 10 Å, which was insufficient to solve the protein structure. 
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The D1 construct yielded crystals in three different conditions; (1) 100 mM 
imidazole pH 8.0, 11% ethyleneglycol, 5% PEG 5K MME, 10 mM Cl3Si, (2) 100 
mM Hepes pH 7.0, 7% ethyleneglycol, 5% PEG 5K MME and (3) 100 mM Hepes 
pH 7.5, 14% ethyleneglycol, 5% PEG5K MME. The crystals from (2) did not show 
diffraction. The crystals from (1) and (3) gave crystals which diffracted but only 
to low resolution (less than 20 Å). The manner of introducing the crystals to cryo 
buffer was varied for these crystals (slow and fast introduction to cryo buffer, and 
flash freezing after addition of 25% glycerol) but this was not found to improve 
diffraction. 
The D3 construct grew to crystals in one condition; 100 mM Bis-Tris propane 
pH7, 1.2 M DL-malic acid (see Figure 4). The crystals were slowly introduced to 
cryo buffer (crystallisation buffer +15% glycerol) and flash frozen in liquid nitro-
gen. This crystal diffracted to approximately 2.5 Å and a full dataset was collected 
at beam line ID14-1 at the ESRF, with Δϕ = 1° at a temperature of 100K.
Figure 4 Crystals of SERK1-D3
SERK1-D3 grew to crystals in 100 mM Bis-Tris propane pH7, 1.2 M DL-malic acid after 1 month at 
20 °C, using the sitting-drop-vapour-evaporation method. The crystals diffracted to approximately 
2.5 Å resolution. 
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Data-analysis of SERK1-D3 diffraction data
With use of MOSFLM (Leslie and Powell 2007) and scaling program SCALA (Ev-
ans 2006), the dataset of D3 was analysed to belong to one of the P6n22 space 
groups, with cell parameters: (a), 61.49 Å (b) 61.49 Å (c) 168.57 Å, (α) 90° (β) 
90° (γ) 120° (see Table 3). Cell content analysis indicated that the cell dimensions 
were not big enough to contain the protein structure. Attempts to solve the struc-
ture using molecular replacement making use of the program PHASER (Mccoy et 
al. 2007) and the published structures of BAK1 (pdb: 3TL8, 3UIM), IRAK4 (pdb: 
2O8Y) and Pto kinase (2QKW) failed. 
Production of SERK#-BL
Since the initial kinase structures of SERK1 did not result in the elucidation of a 
protein structure, we decided to mimic the constructs from Yan et al. 2012 (Yan et 
al. 2012), which yielded a 2.2 Å structure of BAK1 (SERK3) kinase domain. The 
constructs were designed using the alignment of amino acid sequence of SERK1-
5. This resulted in the constructs SERK1-BL (SERK1 BAK-like), SERK1-BLk (con-
taining the K330E inactivating mutation), SERK3-BL, SERK4-BL and SERK5-BL. 
For exact amino acid composition of the constructs see Table 1. Cloning of the 
SERK2-BL construct failed. Protein production was performed similar to the D1/3 
constructs. Since SERK4-BL and SERK5-BL showed no protein production under 
these conditions in the E. coli BL21 (DE3) strain, these constructs were introduced 
in the Rosetta 2 strain. The Rosetta 2 strain produced soluble SERK4-B protein, but 
no SERK5-BL. In addition, to improve protein production and aid purification, the 
SERK1-BL construct was cloned into the pOPINS plasmid, introducing a cleavable 
N-terminal HIS-SUMO tag. 
Purification of SERK#-BL
The SERK#-BL constructs were purified following the same protocol as the D-con-
structs, with a HistrapTM HP column for metal affinity purification, a HitrapTM col-
umn for ion exchange chromatography and gelfiltration using a superdex 75 GL 
(see Figure 5). Similar to the initial constructs, a multiple peaked elution profile 
during ion exchange chromatography, and often multiple bands on SDS-gel were 
observed (see Figure 5). The 6xHIS-tag was removed using a TEV protease, and the 
HIS-SUMO-tag using an inhouse-made SUMO protease treatment. The HIS-SUMO 
tag was removed o/n at 4 °C, followed by removal of uncleaved protein using a 
HistrapTM HP column. 
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Crystallisation screens and crystal evaluation of SERK#-BL
After purification, protein samples were present in 20 mM Hepes, 150 mM NaCl, 
10 mM MgCl2 and 1 mM DTT. Samples were mixed 1:1 with crystallisation buffer. 
Of all SERK#-BL constructs, only SERK1-BL crystallised. In an attempt to recreate 
the results from Yan et al. 2012, SERK3-BL protein sample was added to the con-
ditions described previously, however in our hands this did not result in crystal 
growth. In addition, an optimisation screen was designed based on the crystallisa-
tion conditions described (Yan et al. 2012), which included an experiment in which 
the sample was supplemented with 0.5 mM of ATPγS. None of the optimisation 
plates showed crystal formation. 
The three buffer conditions that resulted in crystals for SERK1-BL were (1) 
2M ammonium sulphate, 100 mM tri sodium citrate pH 5.5, (2) 2M ammonium 
sulphate, 100 mM Bis-Tris pH 5.5, (3) 1M tri-sodium citrate/ citric acid pH 7.0 
(see Figure 6). Removal of the HIS-tag produced an additional condition in which 
crystal growth was observed; (4) 200 mM di ammonium tartrate, 20% PEG 3350 
Figure 5 Purified samples of SERK-BL
SDS-PAGE of final samples of different SERK1-BL purifications. In (A) four samples of increasing 
protein concentrations are loaded onto the gel. At higher concentrations the consistent copurified 
impurities at 30 and 64 kDa are visible, which were identified by MS/MS as E. coli proteins. The 
impurity at 16 kDa was not identified. In (B) the double protein band, which was often observed for 
the kinase domain samples, is depicted. 
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(see Figure 6). Of these four crystals, only the crystals from (2) diffracted to a 
reasonable resolution (2.5-3 Å) (frozen in liquid nitrogen after moving to crystal 
buffer supplemented with 15% glycerol) and a full data set was obtained at beam 
line ID23-2 at the ESRF with the following settings; Δϕ= 0.35°, temp: 100K (see 
Table 3 and the discussion below). Optimisation screens were performed on all 
four SERK1-BL crystal conditions (see Figure 7 for optimisation conditions). 
Figure 6 Crystals of SERK1-BL
SERK1-BL grew to crystals in conditions (A) 2M ammonium sulphate, 100 mM tri-sodium citrate 
pH 5.5 after sixteen days, (B) 2M ammonium sulphate, 100 mM Bis-Tris pH 5.5 after 5 days, (C) 
1M tri-sodium citrate/ citric acid pH 7.0 after 9 days and (D) 200 mM di ammonium tartrate, 20% 
PEG 3350 after 5 days. All crystals grew at 20°C using the sitting-drop-vapour-evaporation method. 
Crystals in condition (D) grew from a sample which had had its 6xHIS-tag removed. Only crystals 
from (B) diffracted to a reasonable resolution, namely 2.5-3 Å.
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Figure 7 Optimisation plate designs of SERK1-BL and SERK3-BL 
Plates designed to optimise crystallisation conditions based on SERK1-BL crystals grown in 2M 
ammonium sulphate, 100 mM tri-sodium citrate pH 5.5 and 2M ammonium sulphate, 100 mM Bis-
Tris pH 5.5 (A), 1M tri-sodium citrate/ citric acid pH 7.0 (B), 200 mM di ammonium tartrate, 20% 
PEG 3350 (C). The plate depicted in (D) was based on the crystallisation conditions described by 
Yan et al, 2012, for the SERK3/ BAK1 kinase domain (Yan et al. 2012). 
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Data-analysis
Due to loss of diffraction resolution during the data acquisition of the SERK1-BL 
diffraction pattern, only the first 120 images (corresponding to an accumulated 
crystal rotation of 42°) were of sufficient quality for analysis. Using the MOSFLM 
(Leslie and Powell 2007) and scaling program SCALA (Evans 2006), the dataset 
was analysed to belong to two possible space groups (see Table 3); either a mon-
oclinic C2-cel with parameters (a) 154.1 Å, (b) 233.2 Å (c) 111.1 Å (α) 90° (β) 
119° (γ) 90°, or a hexagonal H32 cell with parameters (a) 233.2 Å, (b) 233.2 Å, (c) 
111.1 Å (α) 90° (β) 90° (γ) 120°. Structure elucidation in the C2 space group was 
hampered due to the fact that for this space group the data corresponded to only 
60% completeness of the structure. There was sufficient data to attempt structure 
elucidation based on a H32 cell. To solve the structure a similar approach as for the 
SERK-D3 crystal was used, with molecular replacement making use of the program 
PHASER and the published structures of BAK1 (pdb: 3TL8, 3UIM), IRAK4 (pdb: 
2O8Y) and Pto kinase (2QKW). However, this did not yield any reliable solution, 
which might be an indication that this is not the correct space group for this crystal. 
Unfortunately there was not enough data to solve the structure based on the mono-
clinic C2-cell. Attempts to recreate the SERK1-BL crystals grown in 2M ammonium 
sulphate, 100 mM Bis-Tris pH 5.5 failed. 
Discussion & Conclusion
Atomic level understanding of receptor structure has proven invaluable for the 
understanding of signalling pathways. An example of this is epidermal growth fac-
tor signalling, where crystal structures of numerous constructs and conformations 
have given a detailed impression of receptor activation (Ferguson 2008; Bublil 
et al. 2010; Endres et al. 2011; Liu et al. 2012). The recent structures on plant 
LRR-RLKs give a first impression of receptor function and regulation in plant sig-
nalling. The crystal structure of the brassinosteroid receptor BRI1 indicates that 
ligand binding on its own does not induce clear conformational changes in the 
extracellular domain (Hothorn et al. 2011; She et al. 2011) and that, in contrast 
to many animal receptors, ligand induced homo-dimerization is unlikely (Hothorn 
et al. 2011). Activation of the receptor needs additional players in the form of 
SERK co-receptors (Gou et al. 2012) which form complexes with the main recep-
tor (Russinova et al. 2004; Karlova et al. 2006; Santiago et al. 2013). For the 
BRI1-SERK1 and FLS2-SERK3/ BAK1 extracellular domain complexes, it has now 
been proven that the co-receptors also interact with the ligand (Santiago et al. 
2013). Further investigations of other co-receptor and main receptor complexes 
would provide us with the answer whether this is really a common mode of action, 
and whether these extracellular domain interactions are the cause of the observed 
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SERK specificity and whether the co-receptors adopt different conformations in the 
different complexes. 
In addition to the extracellular domains of the co-receptors, elucidating ad-
ditional structures of the kinase domains could also greatly help with our under-
standing of the specificity of these proteins. Protein phosphorylation and dephos-
phorylation are key regulatory elements to cellular signal transduction. Almost 
every known signalling pathway includes a protein kinase or phosphatase at some 
point in the cascade (Graves et al. 1999). The structure of kinase domains and 
their regulatory flanking regions can help in our understanding of their signalling 
properties. For the SERK3/ BAK1 kinase domain it is known that different phos-
phorylation sites are important for different signalling pathways (Wang et al. 2008; 
Yan et al. 2012), and the pT450 changes the activation loop conformation (Yan 
et al. 2012). Specific phosphorylation sites are thus closely related to structural 
changes, which link to kinase function and specificity. Our attempts to crystallise 
different kinase constructs for the SERK proteins were hampered by low protein 
yield in E. coli. In addition approximately 50% of produced protein was present in 
the insoluble fraction of cell free extract (probably due to inclusion bodies). One 
way to overcome such problems is by fusing the problem protein to a soluble tag, 
which often increases the solubility of the fusion protein. We made attempts of 
this by fusing the kinase domain and C-terminal tail (residues 285-625) of SERK1 
to the NUS protein (Davis et al. 1999) and the kinase domains of SERK 1,3,4,5 
(residues 263-605 of SERK1 and corresponding residues from SERK3, 4, 5) to the 
SUMO protein. The fusion proteins were produced and the NUS fusion protein was 
catalytically active, before and after removal of the tag. However, the yield of the 
fusion proteins was not substantially higher than upon using the construct without 
fusion tag, and removal of the tag often was problematic resulting in massive loss 
of protein. There are several possible reasons for the low yield of these constructs. 
First of all, the kinase constructs code for an active protein with auto- and trans-
phosphorylation activity (Aan den Toorn et al. 2012) which may create toxicity 
problems for the bacterial host. To circumvent this problem, inactive variants of 
the kinase constructs were designed and produced. This, however, did not increase 
protein yield. It is possible that codon usage in the constructs is not suitable for E. 
coli, and codon optimisation for E. coli or changing the host organism might im-
prove protein production. Purification of the kinase domains was also not straight-
forward. The kinase domain of SERK1 did not elute as a single peak from the 
anion exchange column, but showed a broad, three peaked elution profile. Most 
likely this is due to the differential phosphorylation states of the protein sample, 
which was also evident by the multiple bands visible on protein gel. SERK1 has 24 
possible phosphorylation sites, three of which can also be phosphorylated by E. 
coli kinases (Karlova et al. 2009), which is probably why even the inactive kinase 
constructs showed this behavior. 
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We obtained crystals of two different SERK1 kinase domain constructs, both 
diffracting to roughly 2.5 Å. The conditions under which the proteins crystalise are 
rather different from each other, and from the reported conditions for the SERK3/ 
BAK1 apo-structure (Yan et al. 2012). Our attempts to recreate the reported 
SERK3/ BAK1 crystals, by incubating the SERK3-BL protein in the same conditions, 
did not induce crystal growth. In our hands, these conditions resulted in heavy 
precipitation of the protein, indicating that protein instability and denaturation is 
the most likely cause for the failure to crystallise. 
The crystal cell parameters that were found for the SERK1-D3 crystal corre-
sponded to a crystal cell too small to contain the SERK1 kinase domain. This in-
dicates that either the selected space group was not correct, which might indicate 
twinning of the crystal, or the protein has been degraded and only part of the 
protein is present in the crystal. Attempts were made to search for a solution with 
molecular replacement using only part of a kinase domain as template, however 
this also did not yield any reliable solution. Finally, the too small crystal cell might 
indicate that the crystal was grown from a contaminant in the protein sample in-
stead of the actual SERK1-D3 protein itself. The second construct that grew to 
suitable crystals was the SERK1-BL construct. This protein construct crystallised 
under more conditions than any of the other constructs, and four diffracting crys-
tals were found during the screens. Only one of these diffracted to a sufficient 
resolution for structure elucidation. Calculations on the diffraction data indicated 
that the crystal cell could contain up to nine kinase domains. However, molecular 
replacement again yielded no suitable solution. To circumvent this problem in the 
future, SeMet incorporation could be used for structure elucidation without the 
need for molecular replacement. Unfortunately, the diffraction data obtained for 
SERK1-BL deteriorated during data collection. These crystals were relatively small 
and crystals of this size are difficult to focus in the beam-line, generally show little 
diffraction and are substantially more damaged by the X-ray beam, which could be 
an explanation for the deterioration of the diffraction. Another possibility could be 
anisotropic diffraction of the crystal. Anisotropic diffraction is seen when the dif-
fraction quality is orientation dependent. Some crystals show intrinsic differences 
in order (and thus diffraction) in different directions throughout the crystal caused 
by e.g. tighter contacts in certain directions.
The reproducibility of both the purifications and the crystallisation is low; of-
ten crystal growth could not be duplicated with different batches of purified pro-
tein. This might be due to the heterogeneity of the sample caused by differential 
phosphorylation status. To circumvent this problem, phosphatase was added to the 
crystal drops, in the hopes that dephosphorylation would increase the homogeneity 
of the sample and at a certain point induce crystal growth. The drops containing 
phosphatase showed a lot of denaturation and no crystal growth. 
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Concluding remarks
Unfortunately, although many attempts were made, and crystals were obtained, 
structure elucidation of the SERK kinase domains was not possible at this time. 
Likely reasons for this are the heterogeneity of the sample, as also evident from 
the ion exchange chromatography elution pattern, and intrinsic instability of the 
protein, as also evident from the precipitation often observed in the crystallisation 
drops. Chances of successful crystallisation could be increased by increasing pro-
tein stability, for instance via co-crystallisation with an interaction partner (where 
complex formation would increase stability). Sample homogeneity could be in-
creased by targeted mutation of highly phosphorylated sites. In addition, gene op-
timisation for production in E. coli, or the choice for a different host for protein 
production (e.g. Pichia pastoris) could increase protein yield, which would greatly 
benefit the screening and optimisation of many crystallisation conditions. Finally, 
improving the purification protocol could increase the purity of the final sample. 
For instance, the purity could increase by adding ATP in the lysis buffer, or chang-
ing salt concentration or pH during chromatography. 
Although this study did not result in a high resolution structure of a SERK ki-
nase domain, the purification protocol and crystallisation conditions described in 
this Chapter can serve as leads for future structural studies on the SERK proteins.
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The Arabidopsis thaliana SERK1 Kinase 
Domain Spontaneously Refolds to an 
Active State In Vitro
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Abstract
Auto-phosphorylating kinase activity of plant leucine-rich-repeat receptor-like ki-
nases (LRR-RLK's) needs to be under tight negative control to avoid unscheduled 
activation. One way to achieve this would be to keep these kinase domains as in-
trinsically disordered protein (IDP) during synthesis and transport to its final loca-
tion. Subsequent folding, which may depend on chaperone activity or presence of 
interaction partners, is then required for full activation of the kinase domain. Bac-
terially produced SERK1 kinase domain was previously shown to be an active Ser/
Thr kinase. SERK1 is predicted to contain a disordered region in kinase domains 
X and XI. Here, we show that loss of structure of the SERK1 kinase domain during 
unfolding is intimately linked to loss of activity. Phosphorylation of the SERK1 ki-
nase domain neither changes its structure nor its stability. Unfolded SERK1 kinase 
has no autophosphorylation activity and upon removal of denaturant about one 
half of the protein population spontaneously refolds to an active protein in vitro. 
Thus, neither chaperones nor interaction partners are required during folding of 
this protein to its catalytically active state.
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Introduction
Plant Receptor-like Kinases (RLK’s) belong to a large gene family (Shiu and Bleeck-
er 2001b) involved in perceiving developmental cues and environmental changes. 
Activation of receptor-like kinases is thought to occur upon ligand induced com-
plex formation, followed by activation of downstream associated proteins (Shiu 
and Bleecker 2001a). In inactive receptors, activity of the kinase domain is often 
regulated by several methods of control, such as (release of) inhibitors (Jaillais et 
al. 2011), dimerization (Bublil et al. 2010), activation segment phosphorylation 
(Nolen et al. 2004), and changes in sub-cellular localisation (Rey et al. 2004). 
Although a huge variety in modes of regulation exist among RLK’s, activation of 
protein kinases is usually coupled to conformational changes in protein structure 
(Huse and Kuriyan 2002).
Here, we focus on an RLK from Arabidopsis thaliana, the Somatic Embryogen-
esis Receptor-like Kinase 1 (SERK1). SERK1 is part of a protein family consisting 
of five highly conserved leucine-rich-repeat receptor-like kinases that function in 
plant signalling pathways (Hecht et al. 2001, Albrecht et al. 2008 , Chinchilla et 
al. 2009). SERK proteins are co-receptors, which are required for transmission of 
signal (Gou et al. 2012). The SERK1 domain overview is shown in Figure 1. 
Previous studies show that the kinase domain of SERK1 (SERK1-KD) is active 
in vitro (Shah et al. 2001), and has the highest autophosphorylation activity of the 
SERK protein family (Karlova et al. 2009). SERK1 has been implicated to function 
in somatic embryogenesis, male sporogenesis and brassinosteroid (BR) signalling in 
Arabidopsis thaliana (Hecht et al. 2001, Albrecht et al. 2008 , Albrecht et al. 2005, 
Kwaaitaal et al. 2005). The three-dimensional structure of the kinase domain of 
a close paralog of SERK1, BAK1 (also called SERK3) in complex with AvrPtoB has 
been elucidated (Cheng et al. 2011). This structure is similar to the one adopted 
by several tyrosine kinases. BAK1 seems to belong to the IRAK family of kinases, 
because it contains a tyrosine as “gatekeeper” residue (Cheng et al. 2011). The 
“gatekeeper” controls access to a hydrophobic pocket behind the ATP-binding site, 
Figure 1 Domain architecture of SERK1.
SP = signal peptide, LZ = leucine zipper, LRR = leucine-rich-repeats, SPP = serine-proline rich do-
main, TM = single pass transmembrane domain, JxM = juxtamembrane domain, KD = kinase do-
main, C = C-terminal tail, EC = extracellular domain, and IC = intracellular domain. Two cysteine 
pairs in the extracellular domain are depicted with *, and numbers below the graph indicate amino 
acid residues.
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and probably plays a role in selectivity of a kinase with regard to small-molecule, 
ATP-competitive inhibitors (Wang et al. 2006). The tyrosine gatekeeper identified 
in BAK1 (i.e., Y363) is conserved in the SERK1 sequence (i.e., Y376), indicating 
that SERK1-KD is a member of the IRAK family of protein kinases.
SERK1 functions in an oligomeric complex with other RLK’s such as BRI1, the 
main ligand binding receptor for BRs (Li and Chory 1997), and transphosphoryla-
tion occurs between these receptors (Wang et al. 2008, Karlova et al. 2009). For the 
BR signalling pathway, SERK co-receptors are required for BRI1-mediated signal 
transduction, and whole seedlings lacking three of five family members completely 
lack dephosphorylation of the transcriptional regulator BES1 as a read-out of BR 
signalling (Gou et al. 2012). Interaction between BRI1 and SERK proteins involves 
the extracellular domains of both proteins, and is hypothesised to be induced upon 
ligand binding to the extracellular domain of BRI1 (Hothorn et al. 2011). Fluores-
cence Correlation Spectroscopy (FCS) shows that in protoplasts that have not been 
treated with BRs, about 15 % of SERK1 proteins exist as dimers (Hink et al. 2008). 
SERK1 interacts with PP2C type phosphatase KAPP, CDC 48 and 14-3-3 protein 
GF14λ (Shah et al. 2002, Rienties et al. 2005).
Since RLK activation is often the first response to a signal, RLK’s need to be 
kept in the non-responsive or “off”-state in absence of activating ligands. One way 
to achieve this would be to keep these RLK’s disordered during synthesis and trans-
port to their final location. Many proteins are intrinsically disordered and fold, in 
whole or in part, upon binding to their physiological targets (Dyson and Wright 
2005, Wright and Dyson 2009, Uversky and Dunker 2010). Protein phosphoryla-
tion often occurs within intrinsically disordered protein regions (Iakoucheva et al. 
2004). Even in protein complexes significant regions of intrinsic disorder can exist 
(Fong et al. 2009). Especially in eukaryotes many proteins seem to contain un-
structured regions of significant size (>50 residues) or are completely disordered 
(Dunker et al. 2002, Uversky 2002, Uversky and Dunker 2010). IDP’s function 
in transcription, translation, signal transduction and protein assembly (Uversky 
2011,Iakoucheva et al 2002.). These unstructured proteins do not fold until their 
activity is required and folding is triggered by, for instance, binding of a substrate 
or a dimerization partner, or a change in subcellular localisation (Dyson and Wright 
2005). For the Arabidopsis thaliana proteome, it has been predicted that 29 % of its 
proteins contain intrinsically disordered regions, and 8 % of its proteome consists 
of completely disordered proteins (Dunker et al. 2000).
An example of IDP’s in plants is the GRAS-protein family of transcriptional reg-
ulators (Sun et al. 2011). This protein family functions in several pathways in plant 
development and signal transduction, including the brassinosteroid pathway (Sun 
et al. 2011). Disordered regions of these proteins are thought to enable a particular 
protein to interact with different partners and as a result it can function in different 
signalling pathways (Sun et al. 2012). Also, plant specific plasma membrane-lo-
cated remorin proteins, part of signal transduction cascades, have intrinsically 
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disordered regions (Marin and Ott 2012). For both GRAS proteins and remorins, 
phosphorylation is an important component during their modulation (Sun et al. 
2011),(Marin and Ott 2012).
In this study we show that use of a disorder analysis computer program pre-
dicts that the kinase domain of SERK1 (SERK1-KD) possibly contains a disordered 
region. We report experimental data of folding, stability and folding-induced phos-
phorylation activity of SERK1-KD in vitro. These data show that SERK1-KD pre-
dominantly is a structured protein at ambient condition. Loss of this structure is 
intimately linked to loss of activity of SERK1-KD. In vitro, unfolded SERK1-KD 
spontaneously refolds to an active state in absence of transphosphorylating part-
ners or chaperones.
Materials and Methods
Disorder analysis
Kinase domains and C-terminal tails of SERK1 (AT1G71830, residues 295-625), 
SERK3/BAK1 (AT4G33430, residues 282- 615), FLS2 (AT5G46330, residues 863-
1173), BRI1 (AT4G39400, residues 877-1196), MPK3 (AT3G45640, residues 30-
370), EFR (AT5G20480 residues 705-1031) and BSK1 (At4G35230, residues 66-
413) were defined by sequence alignment using Clustal Omega (version 1.1.0) 
from the EBI web server (www.ebi.ac.uk/Tools/msa/clustalo/). Potential presence 
of disordered regions within these protein sequences was analysed using PONDR® 
VL-XT (www.pondr.com) (Romero et al. 1997, Li et al. 1999, Romero et al. 2001), 
VSL2B (www.dabi.temple.edu/disprot/) (Obradovic et al. 2005, Peng et al. 2006) 
and IUPred (iupred.enzim.hu/) (Dosztanyi et al. 2005).
Protein purification and sample preparation
SERK1-KD (residues 285-625) was cloned into the pET151 bacterial expression 
vector and contains an N-terminal His-tag (Invitrogen). Primers used for cloning 
were CAC CGG ACA GCT CAA GAG GTT TTC T and TTA CCT TGG ACC AGA TAA 
CTC AAC GGC. Escherichia coli BL21* (Invitrogen) cells containing plasmid were 
grown in LB at 37 °C until OD600=0.8, after which the culture was cooled to 20 
°C and protein production was started by addition of IPTG. After 20 h cells were 
harvested. Cells were broken using a French Press. The protein was purified by run-
ning cell free extract over a HIS-pure cobalt column (Pierce Biotech, bed volume 
of 8ml). Subsequently, protein was further purified through use of a SourceQ-15 
column. Final purification was achieved by analytical gel filtration on a Super-
dex 75 10/300 GL (see supplementary Figure S1). Purification of SERK1-KD was 
followed by standard sodium dodecyl sulfate polyacrylamide gel electrophoresis 
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(SDS-PAGE). Purified protein was suspended in 20 mM Hepes, 150 mM NaCl, 10 
mM MgCl2, 1 mM DTT, pH 7.4. All measurements were performed in this buffer, 
unless stated otherwise. A total of about 5 mg of pure fusion protein was obtained 
from 6 L of culture. Figure S2 shows that SERK1-KD produced in E. coli has the 
ability to autophosphorylate itself, and to transphosphorylate artificial substrate 
casein (Sigma).
Phosphorylated SERK1-KD was obtained by incubating 24 µM SERK1-KD with 
3 mM ATP for 45 min at 30 °C. ATP was subsequently removed using a P-10 desalt-
ing column (Amersham Biosciences). For determination of phosphorylation status, 
SERK1-KD after autophosphorylation was subjected to immunoblotting with an-
ti-Phosphoserine, anti-Phosphothreonine and anti-Phosphotyrosine antibodies (BD 
biosciences).
Fluorescence spectroscopy
Fluorescence was measured using a Varian Cary Eclipse Fluorescence Spectropho-
tometer.
For denaturant induced unfolding, 0.24 µM SERK1-KD was incubated for 6 h 
at room temperature at various concentrations of urea, after which fluorescence 
spectra were recorded. For refolding, 12 µM SERK1-KD was first unfolded in 4.5 M 
urea for a period of 6 h. Subsequently, the sample was diluted 50 fold with buffer 
containing no urea and refolding took place during a period of 30 min at room 
temperature. Fluorescence emission was acquired from 290 to 600 nm, using an 
excitation wavelength of 280 nm with emission and excitation slits set to 10 nm. 
For each measurement, 5 scans were averaged and every nm a data point was col-
lected. All spectra were recorded at 20 °C in 10 mm quartz cuvettes.
Fluorescence emission of SERK1-KD was also recorded during its temperature 
induced unfolding, which was achieved by increasing temperature from 15 °C to 
70 °C at a rate of 1 °C/min. Data points were collected every 0.5 °C. Protein con-
centration of both phosphorylated and native SERK1-KD was approximately 0.24 
µM. Excitation was at 280 nm, and fluorescence emission was recorded at 340 nm. 
Emission and excitation slits were set to 10 nm. The thermal midpoint of unfold-
ing as reported by fluorescence spectroscopy was determined by using a two state 
model of unfolding (Nabuurs et al. 2009).
Circular dichroism (CD)
Far-UV CD data were acquired on a Jasco J-715 Spectropolarimeter. Spectra were 
recorded at 20 °C using 1 mm quartz cuvettes. All spectra were corrected by sub-
tracting spectra of corresponding blank solutions. Buffer is 10 mM NaPi, pH 7.4, 
unless stated otherwise.
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For acquisition of far-UV CD spectra of native and phosphorylated SERK1-KD, 
samples had a protein concentration of 5 µM and 5.5 µM respectively. Spectra were 
obtained by averaging 20 wavelength scans acquired from 185 to 260 nm. A data 
point was collected every 0.2 nm.
For acquisition of far-UV CD spectra of native SERK1-KD in 0.45 M urea, 1.5 
µM protein was incubated with 0.45 M urea. For spectra of unfolded SERK1-KD, 
2.4 µM protein was incubated with 4.5 M urea. Both samples were kept at room 
temperature for 6 h before measurements commenced. For spectra of refolded 
SERK1-KD, native SERK1-KD at a concentration of 17 µM was first unfolded by 
incubation with 4.5 M urea for 6 h at room temperature. Subsequently, the sample 
was diluted 10 fold with buffer containing no urea and refolding took place dur-
ing a period of 30 min at room temperature. Far-UV CD spectra were obtained by 
averaging 20 wavelength scans acquired from 210 to 260 nm. Below 210 nm the 
presence of urea causes considerable scatter of the CD signal. A data point was 
collected every 0.2 nm.
Thermal unfolding of 5 µM native and 5.5 µM phosphorylated SERK1-KD was 
followed at 210 nm. Temperature was increased from 15 °C to 80 °C at a rate of 1 
°C/min and a data point was collected every 0.5 °C. The thermal midpoint of un-
folding as reported by far-UV CD spectroscopy was determined by using a two state 
model of unfolding (Nabuurs et al. 2009).
Kinase phosphorylation assay
For each measurement of SERK1-KD autophosphorylation, 0.5 µM SERK1-KD was 
incubated at a particular concentration of urea (ranging from 0 M to 3 M urea). All 
samples were kept at room temperature for 6 h before the assay was started. For 
refolding, 8 µM SERK1-KD was first unfolded in 3 M urea for 6 h at room tempera-
ture. Subsequently this sample was diluted with buffer containing no urea to a final 
concentration of 0.18 M urea and 0.5 µM SERK1-KD. Refolding took place during 
a period of 30 min at room temperature.
To measure kinase phosphorylation activity, cold ATP and 500 µCi 32P-γATP 
(Perkin Elmer) was added to the samples. Final concentration of ATP in each sam-
ple was 50 µM. Phosphorylation took place for 30 min at 30 °C and was stopped 
by addition of SDS-loading buffer. Samples were subsequently boiled for 3 min at 
100 °C and separated by SDS-PAGE. Incorporated radioactive phosphate was deter-
mined using a PhosphorImager. Relative intensities of radioactive bands were ana-
lysed using ImageJ software (ImageJ 1.45s). Background intensity was subtracted 
and intensity at 0 M urea was set to 100 %.
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Figure 2
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Results
SERK1-KD potentially contains disordered segments
To identify possible regions of disorder within SERK1-KD, we use disorder predic-
tors PONDR® VL-XT, VSL2B and IUPred. SERK1-KD consists of the catalytic kinase 
domain (residues 295- 581) and a C-terminal region (the C-terminal tail) of 45 
amino acids. Figure 2a shows that although SERK1-KD seems to be largely struc-
tured several short segments of its primary sequence are potentially disordered, as 
suggested by PONDR® VL-XT. These segments include its final C-terminal residues 
and a segment of more than 40 amino acids in the C-terminal part of the catalytic 
domain of SERK1-KD (residues 540-580).
As a comparison, disorder predicted for several other plant kinases is also ana-
lysed. Sequence alignment identified the catalytic kinase domain and the C-termi-
nal tail of these proteins. BAK1 (SERK3) is a close paralog of SERK1. Its disorder 
profile (see Figure 2B) strongly resembles the one of SERK1.
BRI1, FLS2 and EFR are the main ligand binding LRR-RLK’s for brassinoster-
oid, flagellin and EF-Tu respectively (Li and Chory 1997, Gómez-Gómez and Boller 
2000, Zipfel et al. 2006). All three receptors potentially contain a disordered C-ter-
minal tail (see Figure. 2C to E). PONDR® VL-XT suggests that only FLS2 has a dis-
ordered segment of more than 40 amino acids in the C-terminal part of its catalytic 
domain, just as SERK1.
BSK1 and MPK3 are cytoplasmic kinases functional in brassinosteroid and 
flagellin signalling, respectively (Asai et al. 2002, Tang et al. 2008). Both proteins 
apparently have no disordered segments of more than 40 amino acids (see Figure 
2F and G). BSK1 does contain several short segments of predicted disorder, includ-
ing disorder of its final C-terminal residues, whereas MPK3 is much more ordered 
(see Figure 2F and G).
Protein phosphorylation is thought to occur predominantly within disordered 
regions of a protein (Iakoucheva et al. 2004). Figure 2a shows that SERK1-KD con-
tains many phosphorylation sites (Karlova et al. 2009), however, no bias towards 
disordered regions exists.
Figure 2 Predicted disorder within plant kinases using various disorder analyses  programs. 
A disorder score lower than 0.5 indicates that a region is predicted to be ordered, whereas scores 
above 0.5 predict disordered protein sequences. Schematic above the graph indicates which part of 
the primary sequence belongs to the catalytic kinase domain (KD) or to the C-terminal tail (C). Dis-
order prediction of PONDR® VL-XT is depicted in black, VSL2B disorder analysis is depicted in light 
grey and IUPred disorder analysis in dark grey. (A) Disorder prediction for SERK1-KD. White dots 
indicate phosphorylation sites identified in vitro, grey dots indicate phosphorylation sites identified 
in planta (Karlova et al. 2009). Disorder profiles are also shown for kinase domains of (B) BAK1 
(SERK3), a close paralog of SERK1, (C) BRI1, (D) FLS2 and (E) EFR, three main ligand binding 
plant RLK’s, and for (F) BSK1 and (G) MPK3, two cytoplasmic kinases.
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Phosphorylation hardly affects the structure of SERK1-KD
Phosphorylation of the activation loop is a major event in kinase activation and 
involves extensive structural movements (Huse and Kuriyan 2002). SERK1-KD pu-
rified from E. coli is referred to here as native SERK1-KD. To assess whether phos-
phorylation of the kinase domain of SERK1 alters protein structure, and to obtain 
insight into potential control mechanisms of kinase activity in planta, we acquired 
far-UV CD spectra of native SERK1-KD and of in vitro autophosphorylated SERK1-
KD. Phosphorylation status of SERK1-KD is assessed with antiphospho Ser/Thr/
Tyr-antibodies. Native SERK1-KD turns out to be only marginally phosphorylated 
compared to in vitro autophosphorylated proteins (see supplementary Figure S3).
Far-UV CD (see Figure 3A) shows that SERK1-KD purified from E. coli is well 
structured, because it has a spectrum that is typical for α+β proteins and is similar 
to the far-UV CD spectrum of BAK1-KD (Cheng et al. 2011). In vitro autophospho-
rylation of SERK1-KD is maximal after 35 min of incubation (Shah et al. 2001). 
After 45 min of autophosphorylation activity, little change in secondary structure 
of SERK1-KD is observed (see Figure 3A). SERK1-KD has five tryptophan residues, 
which are distributed across the protein. Fluorescence emission reports the local 
microenvironment of tryptophan. Figure 3B shows that phosphorylation does not 
result in detectable change in tertiary structure of the protein, as is shown by the 
unaltered fluorescence emission maximum at 340 nm and the constant shape of 
the fluorescence emission spectrum. In interpreting these data, it is important to 
note that after auto-phosphorylation both phosphorylated and non-phosphorylated 
residues are present for most SERK1 phospho-sites (Karlova et al. 2009).
Figure 3 Phosphorylation hardly affects the structure of SERK1-KD. 
(A) Far-UV CD spectra of native SERK1-KD (black) and phosphorylated SERK1-KD (grey) at 15 
°C. (B) Fluorescence emission spectra of 22 μM native SERK1-KD (black) and of 25 μM of phos-
phorylated SERK1-KD (gray), both acquired at 20 °C. Overlay of both spectra is obtained upon 
correcting for protein concentration difference.
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Phosphorylation hardly alters the stability of SERK1-KD against 
unfolding
Although phosphorylation in vitro does not affect the structure of SERK1-KD, phos-
phorylation might alter SERK1 kinase stability against unfolding and thereby influ-
ence its function in planta. To probe this phenomenon, thermal unfolding of native 
and autophosphorylated SERK1-KD is followed by fluorescence spectroscopy (see 
Figure 4A). This method probes the tertiary microenvironment of tryptophan and 
tyrosine residues within a protein, and loss of fluorescence intensity at 340 nm 
upon excitation at 280 nm indicates loss of tertiary structure. In addition, far UV-CD 
spectroscopy is used to probe loss of secondary structure upon thermal unfolding of 
SERK1-KD (see Figure 4B). Fluorescence emission of SERK1-KD drops in the 15 to 
35 °C temperature range (see Figure 4A), whereas ellipticity is hardly altered in the 
native baseline part of the thermal unfolding curve, as indicated by far-UV CD (see 
Figure 4B). Global protein unfolding occurs in the 35 to 45 °C temperature range, 
as cooperative unfolding transitions in both far-UV CD and fluorescence spectros-
copy data show. Fluorescence of free tryptophan is rather sensitive to temperature, 
with fluorescence decreasing upon increasing temperature (Schmid 1989). In case 
of SERK1-KD, sensitivity of tryptophan fluorescence to temperature results in the 
slope of the native baseline of its thermal unfolding curve being negative. Possibly, 
Figure 4 Effect of phosphorylation on stability of SERK1-KD against thermal unfolding. 
Top: Thermal unfolding monitored by the change in fluorescence emission at 340 nm, upon excita-
tion at 280 nm. Bottom: Thermal unfolding monitored by the change in ellipticity at 210 nm. Data 
of native SERK1-KD are shown in black, and data of phosphorylated SERK1-KD are shown in grey.
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Figure 5 Denaturant-dependent folding of SERK1-KD. 
(A) Urea induced unfolding of SERK1-KD followed by fluorescence spectroscopy. Fluorescence 
intensity of 0.24 μM of SERK1-KD is measured at 340 nm, upon excitation at 280 nm. The native 
baseline ranges from 0 to about 0.5 M urea. Above 2 M urea, the unfolded baseline commences. 
The transition region of urea-induced protein unfolding ranges from about 0.5 to 2.0 M. (B) Fluo-
rescence emission of native, unfolded and of refolded SERK1-KD. Black: native SERK1-KD in 0.09 
M urea. Dark grey: unfolded SERK1-KD in 6 M urea. Light grey: refolded SERK1-KD, obtained by 
unfolding the protein for a period of 6 hours in 4.5 M urea, and subsequent dilution of denaturant to 
0.09 M urea. Refolding took place during a period of 30 min at room temperature. Refolded SER1-
KD has a fluorescence maximum at 340 nm, indicative of folded protein. Approximately 80 % of 
unfolded SERK1-KD properly refolds, according to the difference in fluorescence intensity between 
native and refolded protein. (C) Far-UV CD spectra of native, unfolded and of refolded SERK1-KD. 
Black: native SERK1-KD in 0.45 M urea. Dark grey: unfolded SERK1-KD in 4.5 M urea. Light grey: 
refolded SERK1-KD, obtained by unfolding the protein for a period of 6 hours in 4.5 M urea, and 
subsequent dilution of denaturant to 0.45 M urea. Refolding took place during a period of 30 min 
at room temperature.
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increased conformational flexibility of native protein upon increasing temperature 
may cause this decrease in fluorescence.
Figure 4 shows that autophosphorylation hardly affects the stability of SERK1-KD 
against thermal unfolding. Midpoints of unfolding of native and phosphorylated 
SERK1-KD as determined by fluorescence spectroscopy are 40.2 °C and 39.4 °C, re-
spectively. The corresponding midpoints of unfolding as determined by far-UV CD 
are 42.7 °C and 43.7 °C, respectively. Upon cooling, thermally unfolded SERK1-KD 
protein is not able to regain its native structure or its catalytic activity (see Figure 
S4 and data not shown).
Unfolding of SERK1-KD is intimately linked to loss of its 
phosphorylation activity
Unfolding of SERK1-KD is also investigated by adding urea and subsequent deter-
mination of its spectroscopic and catalytic properties. Before measurements, sam-
ples are kept at room temperature for 6 hours to ensure achieving thermodynamic 
equilibrium.
Upon urea-induced unfolding of SERK1-KD fluorescence at 340 nm decreases 
(see Figure 5A) and the maximum of fluorescence emission shifts from 340 to 
350 nm (see Figure 5B). Up to urea concentrations of about 0.5 M, fluorescence 
intensity of the sample is large, indicating that this region of the unfolding curve of 
SERK1-KD is the native baseline (see Figure 5A). In this denaturant range, virtually 
all SERK1-KD molecules are in the native state. Upon increasing the denaturant 
concentration, the ratio of molecules in the native state to those in the unfold-
ed state drops, and as a result fluorescence emission decreases. This decrease in 
fluorescence highlights the transition region of urea-induced SER1-KD unfolding, 
which ranges from about 0.5 to 2.0 M urea. Above 2 M urea, SERK1-KD molecules 
are in the unfolded state, giving rise to the unfolded baseline in the fluorescence 
unfolding curve of Figure 5A.
To assess whether diminishing of the population of the native state during urea 
induced unfolding is linked to loss of phosphorylation activity of SERK1-KD, pro-
tein activity is measured at increasing denaturant concentrations (see Figure 6). Up 
to 0.5 M urea, autophosphorylation activity only marginally decreases, most likely 
because all SERK1-KD molecules are in the native state. Upon increasing urea con-
centration above 0.5 M, loss of kinase activity happens gradually (see Figure 6). 
This denaturant-dependent loss of activity coincides with the observed diminished 
population of the native state of SERK1-KD, as reported by fluorescence emission 
(see Figure 5A). Above 2 M urea no incorporation of radioactive phosphate is ob-
served, because SERK1-KD is unfolded and thus inactive.
The above data show that unfolding of SERK1-KD is intimately linked to loss 
of its phosphorylation activity.
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Upon spontaneous refolding in vitro, SERK1-KD regains native 
structure and catalytic activity
To investigate whether urea-induced unfolded SERK1-KD is able to spontaneously 
refold in vitro, the protein is first unfolded at high concentration denaturant (i.e., 
above 2 M urea, see Figure 5A). To induce refolding, urea concentration is then 
lowered to a value at which SERK1-KD molecules are in the native state (i.e., below 
0.5 M urea; see Figure 5A). Subsequently, we determine spectroscopic and catalytic 
properties of refolded SERK1-KD, to probe whether refolded protein has native 
three-dimensional structure.
Fluorescence emission of refolded SERK1-KD has its maximum at 340 nm, 
typical for native SERK1-KD (see Figure 5B). Approximately 80 % of unfolded 
protein refolds properly, as comparison of fluorescence intensity of native and re-
folded protein indicates. The remaining fraction is most likely aggregated. Far-UV 
CD confirms that the large majority of unfolded SERK1-KD spontaneously refolds 
in vitro to native protein (see Figure 5C) because CD spectra of native and refold-
ed SERK1-KD are similar. Again, due to some aggregation, the amplitude of the 
CD signal of refolded protein is slightly less than that of native protein. To eval-
uate whether refolded SERK1-KD also regains catalytic activity, incorporation of 
radioactive phosphate is probed. Figure 6 shows that refolded SERK1-KD indeed 
autophosphorylates, which is the hallmark for properly folded, catalytically active 
Figure 6 Dependence of SERK1-KD kinase activity on urea concentration. 
(A) Autoradiograph of autophosphorylation activity of SERK1-KD at different concentrations of 
urea. R: Refolded SERK1-KD, obtained by unfolding the protein for a period of 2 hours in 3 M urea 
and subsequent dilution of denaturant to 0.18 M urea. Refolding took place during a period of 30 
min at room temperature. (B) Urea-dependent loss of phosphorylation activity of SERK1-KD. The 
gel presented in (A) is analysed with ImageJ to quantify intensities of the bands observed, which 
correlates with incorporation of radioactive phosphate. Loss of kinase activity happens gradually 
upon increasing urea concentration above 0.5 M. Phosphorylation activity is completely lost at 
concentrations urea above 2 M.
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SERK1-KD. Compared to native SERK1-KD about 50 % of autophosphorylation 
activity is recovered.
Protein concentration in the initial refolding sample (i.e., before dilution of 
denaturant) is an important parameter determining refolding efficiency, since ag-
gregation highly depends on protein concentration. This concentration is highest in 
the refolding sample used for activity determination, explaining the lower refold-
ing efficiency observed (see Figure 6) compared to refolding detected by spectro-
scopic techniques (see Figure5B and C). Nevertheless, we conclude that fully active 
SERK1-KD can be obtained in the absence of any cellular context.
Discussion
In this work we addressed whether the catalytic activity of LRR-RLK SERK1 from 
Arabidopsis thaliana is an inherent property of its kinase domain. Our results show 
that SERK1-KD regains its catalytic activity upon refolding in vitro, indicating that 
the protein has the intrinsic capacity to become active. Because in planta SERK1 
RLK is a non-ligand binding co-receptor functioning in several signalling pathways, 
maintaining the inactive status of the kinase domain is necessary to prevent un-
scheduled signalling. Inactivation of the kinase domain could be achieved by either 
intra- or intermolecular inhibitory elements. One way by which such an inhibitory 
element could act is by maintaining parts of the protein disordered until activity 
is required.
The bioinformatics tool PONDR® VL-XT predicts that SERK1-KD is largely 
structured, with one extended region of disorder. This disordered region compris-
es part of its C-terminal tail and 41 amino acids in domains X and XI, regions 
previously identified as essential for both in vitro kinase phosphorylation activity 
and in planta function of SERK1 (Albrecht et al. 2005). Disorder analysis of six 
other plant kinases indicates that the C-terminal tail of plant kinases functioning 
in signalling often is disordered. The C-terminal tail of BRI1 has been identified as 
an auto-inhibitory element for BRI kinase activity (Wang et al. 2005). This could 
indicate that the C-terminal tail is a more common regulatory element in plant ki-
nases. An extended region of disorder (i.e. more than 40 residues) in the catalytic 
kinase domain was only predicted for FLS2 and SERK1. Such a region can function 
as another form of kinase regulation, as was previously identified for epidermal 
growth factor receptor (EGFR). Molecular dynamics studies identified a region of 
disorder in the kinase domain of EGFR. This region is shown to be important for 
dimerization between two kinase domains after which it becomes more ordered 
(Shan et al. 2012). SERK1 can form homo- and hetero-oligomers in planta (Hink 
et al. 2008). While it has been proven that EGFR only functions as a dimer, it is not 
clear whether homodimerization plays a role in controlling the catalytic activity of 
SERK1, because purified SERK1-KD, which is monomeric according to analytical 
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gelfiltration, is already catalytic active. The predicted disordered regions of SERK1 
might have a function in interaction with ligand-perceiving RLK’s with which mem-
bers of the SERK family form hetero-oligomers (Karlova et al. 2006).
Phosphorylation sites are often found in disordered regions of proteins, prob-
ably due to easy access of these sites (Iakoucheva et al. 2004). Phosphorylation 
can induce structuring in disordered regions (Espinoza-Fonseca et al. 2007, 2008, 
Garza et al. 2010), or hardly influences these regions (Ganguly and Chen 2009, 
Mittag et al. 2008). In addition, phosphorylation can change the ability of these 
regions to undergo protein-protein interactions (Mittag et al. 2010). The num-
ber of phosphorylation sites differs vastly between SERK1 and its close paralogs 
SERK2 and BAK1 (SERK3) (Karlova et al. 2009). Comparison of previously identi-
fied phosphorylation sites of SERK1 and predicted disorder indicates that there is 
no bias towards phosphorylating disordered regions. More strikingly, seven of eight 
phosphorylation sites identified in planta are in predicted structured parts of the 
protein. Four of these sites are found in the activation loop of SERK1-KD (Thr459, 
Thr462, Thr463 and Thr468), of which phosphorylation is known to be important 
for kinase activity (Huse and Kuriyan 2002).
Fluorescence, far-UV CD and activity data presented in this paper show that 
SERK1-KD is largely structured and active in vitro. The observed coincidence of 
loss of activity and three-dimensional protein structure upon denaturant induced 
unfolding demonstrates that properly folded structure is essential for SERK1-KD to 
be active. Upon lowering denaturant concentration, unfolded SERK1-KD is able to 
refold to its native structure and regains catalytic activity. Thus, SERK1-KD folds to 
active kinase, while its cellular context comprising chaperones, membrane compo-
nents and interaction partners, is absent. However, to counteract aggregation and 
make folding more efficient in the hugely crowded cellular context (Gershenson 
and Gierasch 2011), chaperones most likely assist in folding SERK1-KD molecules 
in vivo.
For organisms it is important to keep RLK’s inactive until their signalling is 
required to properly respond to signals. For plant RLK’s this issue has not received 
much attention. We observe that SERK1-KD autonomously folds to its active state 
within 30 minutes. This observation suggests that in planta SERK1 already contains 
an active kinase domain before it is transported to its proper location, the plas-
ma membrane (Shah et al. 2002), or incorporated in the correct protein complex 
required for signalling activity. Thus, mechanisms are likely needed in planta to 
keep kinase activity of SERK1 in check. For other plant RLK’s candidate inhibitory 
proteins have indeed been identified, such as BKI1 or protein phosphate 2A for 
BRI1 (Jaillais et al. 2011, Wu et al. 2011). Dephosphorylation of specific residues 
essential for phosphorylation activity has also been proposed to deactivate RLK’s 
(Oh et al. 2012). A possible candidate inhibitor of SERK1 is KAPP, the PP2C protein 
phosphatase (Shah et al. 2002). Finally, endoplasmatic reticulum associated pro-
tein degradation (ERAD) potentially plays a role during incorporation of SERK1-
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KD into correctly assembled receptor complexes, because ERAD also is important 
during biogenesis and quality control of other plant receptor complexes (Li et al. 
2009, Nekrasov et al. 2009, Su et al. 2011). The next challenge is to elucidate 
whether and how the above mechanisms contribute to keeping SERK1-KD inactive 
in planta, until its activity is required. 
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Supplemental material
Supplemental Figure S1  SDS-PAGE and Western blot of SERK1-KD. 
Left: SDS-PAGE of aliquots taken at different steps during SERK1-KD purification. Lane 1, cell 
extract from BL21* E. coli cells expressing 6xHIS-SERK1-KD; lane 2; eluate from HIS-pure cobalt 
column; lane 3, eluate from SourceQ-15; lane 4, eluate from Superdex 75 10/300 GL (i.e., final, 
purified sample); lane 5, Marker. Right: Western blot of final purified protein, using anti- His-tag 
antibodies. Lane 1, purified SERK1-KD; lane 2, Marker.
Supplemental Figure S2  SERK1-KD phosphorylation properties.
Left: Autophosphorylation of SERK1-KD (1 µg); Right: Transphosphorylation of casein (1 µg) by 
SERK1-KD (0.2 µg). Aliquots are taken at the time points indicated (in minutes) and subsequently 
separated by SDS-PAGE. Incorporation of 32P-yATP is visualised using a PhosphoImager.
Supplemental Figure S3  Phosphorylation status of native and autophosphorylated SERK1-
KD. 
Anti- Phosphoserine, -threonine and -tyrosine antibodies are used to probe the phosphorylation 
status of SERK1-KD. Lane 1, 0.75 µg of SERK1-KD after 45 min of incubation with ATP; lane 2, 
0.75 µg of SERK1-KD as purified from E. coli; M, marker.
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Supplemental Figure S4  Far-UV CD spectrum of refolded SERK1-KD. 
SERK1-KD was first heated to 85 °C and subsequently cooled to 15 °C. The far-UV CD spectrum 
of this protein differs from the corresponding spectrum of native SERK1-KD shown in Figure 2, and 
consequently thermally unfolded SERK1-KD does not properly refold upon lowering temperature.
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Chapter 5
M. aan den Toorn, S.J. Hutten, G. W. van Esse, A. Nolles, J. Hohlbein, S.C. de Vries
Visualisation of SERK3 and BRI1 Plasma 
Membrane Distribution using VAEM
Abstract
The brassinosteroid plant hormones (BRs) are perceived by the main ligand bind-
ing receptor BRI1. BRI1 forms hetero-oligomeric complexes with co-receptors of 
the SERK protein family, amongst which SERK3/ BAK1. The plasma membrane 
(PM) constitutes the main site of BR signalling, as this is where the SERK3-BRI1 
hetero-oligomeric complexes are present and ligand binding occurs. The PM is 
highly organised, and many proteins show a distinct distribution within this lipid 
bilayer. 
In this chapter, the plasma membrane distribution of BRI1 and SERK3 is 
visualised using Variable Angle Epifluorescence Microscopy (VAEM). This tech-
nique, which allows for selective illumination of a thin surface layer, can be used to 
visualise fluorescent molecules in the plant plasma membrane (PM) and to study 
intracellular membrane compartments in close proximity to the PM. Both BRI1 and 
SERK3 show an inhomogeneous distribution on the PM, forming distinct clusters. 
Surprisingly, the density of these nanoclusters is not influenced by depletion of 
endogenous ligand or signal activation. On average, each nanocluster contains 6 
BRI1-GFP and 2 SERK3-GFP receptor molecules. Overexpression of BRI1 resulted 
in up to 22 receptor molecules in a nanocluster, but not in more clusters per µm2 
PM. Tyrphostin A23 treatment, which inhibits endocytosis of ligand-bound BRI1, 
reduces the overall fluorescence intensity on the PM but did not influence the 
cluster density. Thus, whereas the number of receptor molecules per nanocluster 
varies, the number of clusters remains constant. We propose that the formation 
of nanoclusters in the plant PM is subjected to biophysical restraints, while the 
stoichiometry of receptors inside the clusters is a variable entity affecting signal 
transduction.
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Introduction
Brassinosteroids (BRs) are plant steroid hormones that regulate cellular expansion, 
differentiation and proliferation (Clouse 2001). The brassinosteroid signalling 
pathway starts at the plasma membrane (PM), where BRs bind to the island domain 
in the extracellular part of the leucine-rich-repeat receptor like kinase (LRR-RLK) 
brassinosteroid insensitive 1 (BRI1). Ligand binding to the extracellular domain 
of BRI1 induces the phosphorylation and subsequent disassociation of the inhib-
itor protein BRI1 Kinase Inhibitor 1 (BKI1) from its cytoplasmic kinase domain 
(Wang et al. 2006; Jaillais et al. 2011). BKI1 prevents BRI1 from interacting with 
its co-receptor SERK3/ BAK1 (Somatic Embryogenesis Receptor Kinase 3/ BRI1 As-
sociated Kinase 1) (Jaillais et al. 2011). The hetero-oligomerization between BRI1 
and its SERK co-receptor causes sequential transphosphorylation events on their 
cytoplasmic kinase domains (Wang et al. 2008) and is a prerequisite for proper 
BR signal transduction (Gou et al. 2012). Transphosphorylation events between 
SERK3/ BAK1 and BRI1 lead to full activation of the kinase domains and subse-
quent phosphorylation of downstream signalling components (Tang et al. 2008; 
Kim et al. 2011) which relay the signal further to transcription factors BZR1 and 
BES1, resulting in regulated expression of BR- responsive genes. Recent investiga-
tions suggest that hetero-oligomers between BRI1 and SERK3/ BAK1 are, at least 
in part, preformed in absence of ligand, as a functional unit to perceive BRs and 
initiate downstream signalling (Bücherl et al. 2013). Extracellular domain interac-
tions between SERK1 (a highly homologous family member of SERK3/ BAK1) and 
BRI1 are ligand dependent (Santiago et al. 2013), suggesting that other domains 
(such as the transmembrane domain or cytoplasmic domains) are essential for the 
observed ligand independent hetero-oligomers. 
Although there are indications of some endosomal BR signalling (Geldner et 
al. 2007), the initial recognition of BRs and activation of the receptor complex via 
ligand binding occurs at the PM (Irani et al. 2012). The PM is a highly organised 
lipid bilayer interspersed with proteins. Most PM located proteins do not diffuse 
unrestricted through the lipid bilayer and some show clear inhomogeneous pat-
terning across the PM (Jaqaman et al. 2012, and references therein). Proteins in 
the PM can be restricted in their movement via for example the cortical cytoskel-
eton, protein ‘crowding’, interaction between membrane components and inho-
mogeneity in membrane composition and state (Jaqaman and Grinstein 2012). In 
Arabidopsis, the lateral movement of PM localised proteins is also restricted by the 
presence of the cell wall, although not necessarily due to direct interactions (Mar-
tinière et al. 2012). As a result of these restrictions, protein distribution across the 
membrane is inhomogeneous and cluster formation can occur. In animal cells, the 
presence of so-called nanoclusters of receptor proteins in the PM has been estab-
lished. Organisation of receptors into these clusters would be essential for signal 
transduction. In addition, relocalisation of receptors upon ligand binding has been 
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reported, via endocytosis to specific endosomal locations (Di Fiore et al. 2001) but 
also relocalisation within the PM itself (Wilson et al. 2011). This chapter describes 
the visualisation of PM distribution of two LRR-RLK’s involved in the brassinoster-
oid-signalling pathway, namely BRI1 and SERK3/BAK1, in high resolution in live A. 
thaliana epidermal root cells. The epidermal cell layer has a fundamental role for 
executing BR signalling and regulating BR-related developmental processes in root 
and shoot (Savaldi-Goldstein et al. 2007; Hacham et al. 2011). For the visualisation 
of receptor distribution on the PM we use Variable Angle Epifluoresence Micros-
copy (VAEM), a technique closely related to Total Internal Reflection Fluorescence 
(TIRF) microscopy (Konopka et al. 2008). In objective -type TIRF microscopy, the 
laser light is focussed into the rim of the backfocal plane of a microscope objective 
with high numerical aperture instead of the centre, as it is the case for conventional 
widefield microscopy. As a result, the strong inclination of the passing laser light 
can lead to the phenomena of total internal reflection at the interface between the 
cover slide and the sample medium due to the lower refractive index of the sample 
medium. Even though the light does not pass the interface, a evanescent wave is 
generated which decays exponentially within a few hundred nanometers. Both in 
plant and animal cells, TIRF has been used to visualise proteins located on the PM 
(Webb et al. 2006; Vizcay-Barrena et al. 2011). In plant cells, however, the utilisa-
tion of TIRF is hampered due to presence of the plant cell wall (Shaw 2006) whose 
thickness is comparable to the effective excitation depth of the evanescent wave. 
In VAEM, the laser light is focussed closer to the centre of the backfocal plane such 
that not all light is reflected at the cover glass to water interface; instead, a thin 
band of illuminating light penetrates the sample. By varying the the focus position 
in the backfocal plane, we can adjust the depth at which the sample is illuminated. 
Due to the curvature of the plant root, however, only a narrow region of the outer 
PM of the epidermal root cells in close proximity to the cover slip can be visualised.
In this chapter we explore the possibilities of VAEM in live A. thaliana epider-
mal root cells and investigate wheter this technique can provide us with insights 
into receptor distribution and behaviour after receptor activation. Our results in-
dicate that VAEM can visualise both the PM of plant roots, and also the endosomal 
compartments just below the PM. The PM receptor molecules tested in these exper-
iments all show an inhomogeneous distribution, clustered across the membrane. 
The cluster density is not altered by activating the signalling complex, by over-ex-
pression of the receptor or by influencing the endocytosis of the receptor, although 
the number of receptors per cluster was variable. This indicates that the formation 
of clusters is not specifically coupled to the signalling activity of the receptor.
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Materials & Methods
Growth conditions and plant lines
Arabidopsis thaliana plants of ecotype Columbia (Col-0) were used as wild type. 
Seeds were surface sterilised and germinated on ½ Murashige and Skoog medium 
(Duchefa) supplemented with 1% sucrose (Sigma) and 1% Daishin agar (Duche-
fa). Plants were grown at 22 ˚C under fluorescent light, with 16 h light/8h dark 
photoperiods. Col-0 plants expressing BRI1 (AT4G39400) fused to GFP under its 
native promoter, here referred to as BRI1-GFP 1, were provided by N. Geldner 
(Geldner et al. 2007). BRI1-GFP 2 was a BRI1-GFP line overexpressing the trans-
gene roughly three-fold, and was provided by J. Chory (Friedrichsen et al. 2000). 
Col-0 plants expressing SERK3-mCherry or SERK3-GFP under control of its native 
promoter were generated as previously described (Bücherl et al. 2013). BRI1-GFP 
line 2 was crossed with the SERK3-mCherry line to create a plant harbouring both 
transgenes .The serk1 serk3 mutant plant harbouring BRI-GFP was produced by 
crossing BRI-GFP line 2 with the double mutant serk1-3 (GABI-KAT line 448E10) 
serk3-2 (SALK_116202) resulting in the serk1serk3 BRI-GFP line. det2 seeds were 
obtained from the Arabidopsis seed stock centre and crossed with BRI-GFP line 
2. Col-0 plants containing the transgenes Wave6-mCherry and Wave18-RFP were 
provided by N. Geldner (Geldner et al. 2009), LT16B-GFP was provided by C. ten 
Hove (Cutler et al. 2000), VHAa1-mRFP (Dettmer et al. 2006), ARA7/Rab F2B-
mRFP and ARA6/ Rab F1-mRFP were provided by K. Schumacher, Heidelberg. 
KNOLLE-GFP was used as a positive control for the FRAP experiments based on the 
data of (Boutte et al. 2010). The pBIR3::BIR3-GFP line was constructed by Walter 
van Dongen (Biochemistry, WU). Protoplast isolation and transfection for the FRAP 
experiments was performed as described previously (Bücherl et al. 2010).
Hormone and inhibitor treatments
For hormone treatment, six day old seedlings were incubated in 1 mL ½ Murashige 
and Skoog medium, supplemented with 1% sucrose and 1 µM 24-epi-brassinolide 
(BL, Sigma). For brassinazole treatment, seeds were first germinated and grown 
for four days on ½ Murashige and Skoog medium, supplemented with 1% sucrose 
and 1% Daishin agar. After four days the seedlings were transferred to plates com-
plemented with 5 µM brassinazole (BRZ, TCI Europe) and grown on these plates 
for an additional two days. For tyrphostin treatment, six day old seedlings were 
incubated in 1 ml ½ Murashige and Skoog, supplemented with 1% sucrose and 50 
µM tyrphostin A23 or tyrphostin A51.
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VAEM set-up
Live root imaging was performed on a home- build microscopy setup. Instead of a 
standard microscope body, we used a RAMM system as a stage holder (ASI) togeth-
er with a motorised x,y-scanning stage with a z-piezo for controlling precise sample 
placement along the optical axis of the microscope. We used a fibre-coupled laser 
engine (Omicron) equipped with four lasers (405 nm, 473 nm, 561 nm, and 642 
nm) for excitation. Laser intensities are independently controlled by a home-writ-
ten LabVIEW program. The single mode fiber generates a Gaussian shaped beam 
profile and a point source like output. The divergent light is collimated (f = 100 
mm, Thorlabs) and then focussed into the backfocal plane of a 100x NA 1.49 TIRF 
objective (Nikon) by a lens (f = 200 mm, Thorlabs) mounted on a translational 
stage perpendicular to the laser beam in order to allow adjusting the TIRF angle. 
A custom-made multicolor polychroic mirror and a multibandpass filter (Chroma, 
USA) are used to avoid leakage of laser light into the emission path. After the 
spatial filtering of the fluorescence with a two-lens system consisting of two tube 
lenses (f = 200 mm) and an adjustable slit (Thorlabs), the light is spectrally split 
using dichroic mirrors (Chroma) into three beams corresponding to a blue, green, 
and red fluorescence detection channel. The three beams are then focused (f = 
250 mm) on an Ixon Ultra 897 emCCD camera with 512 x 512 pixel (Andor). The 
total magnification of the optical system is 125 x and we measured a pixel width 
corresponding to 130 nm. Data was recorded using micromanager (Edelstein et al. 
2010). 
VAEM imaging, processing and analysing
Live root imaging was performed on the set-up described above. GFP was excited 
with a 473 nm laser (laser power in front of the polychroic mirror 0.98 mW) and 
fluorescence emission was detected from 475-550nm. mCherry was excited with a 
561 nm laser (laser power set at 0.35 mW) and fluorescence emission was detected 
from 560-640 nm. Images were recorded every 100 msec, with an exposure time 
of 100 msec. Movies of 250 or 500 frames were recorded. Each image shown here 
corresponds to the first frame taken, to minimise bleaching effects. For the image of 
the ER marker WAVE6-mCherry, the first 40 frames were merged into one picture. 
A background subtraction (rolling ball radius = 50.0 pixels) was performed on all 
images of PM localised proteins with use of IMAGEJ (IMAGEJA, 51.45j, Max Planck 
Society; Scheider et al. 2012).
For particle size analysis a Gaussian blur filter of 2μm (σ) is subtracted from 
the images. A binary image is constructed from this image, taking a lower intensity 
threshold of 80 a.u. The binary image is subsequently analysed with the particle 
analysis plug-in from FIJI software (IMAGEJA, 51.45j, Max Planck Society; Schnei-
der et al. 2012). 
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For the decay curves a region of interest was defined by an area of 5x5 pixels. 
This region is analysed using the plot z-axis profile function from IMAGEJ (IMAGE-
JA, 51.45j, Max Planck Society; Schneider et al. 2012). 
Confocal microscopy and FRAP experiments
Roots of Arabidopsis seedlings expressing BRI1-GFP line 1, SERK3-GFP or KNOLLE-
GFP, and protoplasts transfected with these constructs were imaged with a CONFO-
COR2/LSM510 confocal microscope (Zeiss) equipped with a 40x water objective 
(numerical aperture 1.2) and an argon ion laser. The argon laser was used for 
excitation of GFP at 488 nm with an output of 40% (6.1 A). GFP fluorescence emis-
sion was detected with a band-pass filter at 505 to 550 nm. The image size was set 
to 512x512 pixels and four scans were averaged for each picture. The bleaching 
routine started with two or three pre-bleached scans, followed by a bleach pulse 
and a follow-up dependent on the bleached protein. For the background-correc-
tion, wild type roots underwent the same bleaching procedure. Protoplasts trans-
fected with BRI1-GFP or SERK3-GFP were analysed in an 8-chamber slide, with 
300 µl of protoplast solution in one chamber. Confocal microscope settings were 
adjusted depending on the size of the protoplasts and signal intensity. Zoom was 
adjusted from 3.9 to 6.9, the scanning time was 786 or 983 ms and the pinhole was 
1.82 or 2.64 AU. The bleach pulse was applied in 15 iterations at 50% transmission 
at 488 nm. The size of bleach regions depended on the sample and settings. Images 
were recorded up to 53 s after the bleach pulse.
Roots of five day old seedling roots stably expressing BRI1-GFP or SERK3-GFP 
were immobilised in 1x PBS (8 g NaCl, 0.2 g KCl, 1.44 g Na2HPO4, 0.24 g KH2PO4 
in 1 L distilled H2O) in a 2-chamber slide (pre-incubated with 0.1% poly-L-lysine 
for a minimum of one hour) with a cover glass and a weight on top. The bleached 
area differed from the whole cell plate to just a part of the cell plate. The bleach 
pulse was applied in 20 iterations at 75% transmission at 488 nm. The recovery 
was followed up to 260 s after the bleach pulse. The excitation laser light was 
set at 488nm, at a power of 5% at and 9% for BRI1-GFP and SERK3-GFP respec-
tively. The images were taken with a 6x zoom, a scan time of 15.73 s and a cycle 
delay of 5 s. A fixed rectangular area of 60x15 pixels (4.5x1.1 µm) was bleached 
on the plasma membrane with 50 iterations at 45% transmission at 488 nm for 
both proteins. The recovery of the fluorescent signal was followed up to 499 s and 
436 s for BRI1-GFP and SERK3-GFP respectively. For FRAP measurements in the 
elongation zone, the excitation laser power was set to 1% at 488 nm to reduce the 
scan-bleaching. The images were taken with a 4x zoom and a scan time of 6.29 s. 
A fixed rectangular area of 60x15 pixels (6.8x1.7 µm) was bleached on the plasma 
membrane for SERK3-GFP. For BRI1-GFP two different areas were used, 30x20 
pixels (3.4x2.3 µm) or 20x15 pixels (2.3x 1.7 µm), but this did not change the 
recovery curve. The bleach pulse was given with 15 iterations at 50% transmission 
at 488 nm for both proteins. 
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FRAP data analysis
FRAP data analysis was performed after background-correction of the data (Sup-
plemental File S1). The data were visualised with Excel (Microsoft Office 2003), 
which was also used for curve fitting (Curve fitting in Microsoft Excel by William 
Lee).
Accession numbers
Sequence data from this article can be found in the Arabidopsis Genome Initiative 
or EMBL/GenBank data libraries under accession numbers: BRI1 (AT4G39400), 
SERK3/BAK1 (AT4G22430), WAVE6/NIP1;1 (AT4G19030), WAVE18/Got1p ho-
molog (AT3G03180), ARA6/RABF1 (AT3G54840), ARA7/RABF2B (AT4G19640), 
VHA-A1 (AT2G28520) LTI6B/RCI2B (AT3G05890), DET2 (AT2G38050) KNOLLE 
(AT1G08560) and BIR3 (AT1G27190). 
Results
Utilising VAEM to visualise endosomal compartments in live A. 
thaliana epidermal root cells
To investigate whether the adapted TIRF technique called VAEM can be used to 
visualise endosomal compartments close to the PM, fluorescently tagged marker 
proteins for different endosomal compartments were employed. In Figure 1A a 
VAEM image shows the PM located protein LT16B-GFP (Cutler et al. 2000) in live 
A. thaliana epidermal root cells. This small integral membrane protein is visible 
in the PM, and shows a rather homogenous distribution. The ER is visualised by 
WAVE6-mCherry (Geldner et al. 2009) (see Figure 1B). In plant cells, the ER forms 
a net-like basket occupying the cortical space just below the plasma membrane. The 
structure seen with VAEM shows the network of membrane tubules and sheets, and 
the movies (supplementary on-line files) show the flowing movement typical for 
the ER. WAVE18-mRFP (Geldner et al. 2009) is a marker protein for Golgi stacks. 
The Golgi apparatus is mobile and shows numerous vesicular structures, which can 
easily be visualised with VAEM (see Figure 1C). The trans-Golgi network (TGN) is 
visualised with the VHAa1-mRFP marker protein (Dettmer et al.) (see Figure 1D). 
These mobile vesicular structures are dynamic, and fusions and protrusions from 
vesicles can be observed (Viotti et al. 2010). In plants, the TGN functions both as 
a sorting place for newly synthesised proteins and in the retrograde transport of 
recycled plasma membrane proteins (Dettmer et al. 2006; Lam et al. 2007). The 
plant TGN is thus equivalent to the early endosome compartment as defined in 
animal cells, with early endosomes (EE) budding off, which go on to mature to late 
endosomes or multi-vesicular bodies (LE/MVB). The marker protein ARA7/Rab 
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F2b (Ueda et al. 2004; Ebine et al. 2011) is a marker for EE and LE/MVB and can 
thus be used to visualise the retrograde trafficking vesicles. In Figure 1E a VAEM 
image of ARA7-mRFP fluorescence in epidermal root cells shows the retrograde 
endosomal vesicles. In Figure 1F ARA6/Rab F1-mRFP fluorescence is visualised; 
this homologue of ARA7 is more specific for LE/MVB’s (Ebine et al. 2011). Thus, 
as Figure 1 indicates, VAEM can be exploited to obtain high-resolution images of 
many different intracellular membrane compartments.
All VAEM images as shown in the manuscript are derived from series of movies 
that can be found in the supplementary on-line files only. Comparative images us-
ing full TIRF mode and VAEM are shown in Supplemental Figure S1, indicating the 
problems associated with full TIRF due to the presence of the cell wall.
Figure 1 Visualisation of A. thaliana membrane compartments with VAEM
Live-cell VAEM imaging was performed on 6 day old Arabidopsis seedling roots expressing fluores-
cent markers for different membrane compartments. Fluorescent markers visualised in the different 
images are (A) PM localised LT16B-GFP, (B) ER localised WAVE6-mCherry, 40 sequential images 
of 100 msec exposure each were merged, (C) Golgi localised WAVE18-mRFP, (D) TGN localised 
VHAa1-mRFP, (E) EE/LE localised ARA7-mRFP and (F) LE localised ARA6/Rab F1-mRFP. Expo-
sure time for all images (except (B)) was 100 msec. Scale bars represent 10 μm. 
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Receptor distribution on the membrane
The PM is composed of a lipid bilayer intermingled by proteins. Studies from an-
imal receptors indicate that proteins do not show free lateral movement through 
the membrane, but movement is restricted within areas, resulting in an uneven 
distribution of proteins in the plane of the membrane (Mattila et al. 2013). To in-
vestigate whether plant membrane receptor molecules also show inhomogeneous 
distribution along the membrane, BRI1-GFP and SERK3-mCherry were visualised 
within the plane of the PM using VAEM. 
The results show that both BRI1 and SERK3 are not homogenously distribut-
ed across the plasma membrane, but show a clear spotted pattern (see Figure 2), 
much more so than the PM-marker LT16-B (see Figure 1). In animal literature, such 
a pattern is referred to as a nanocluster distribution, a term that we will employ 
here as well. BRI1 nanoclusters with clearly high fluorescence intensity are visible, 
with a size in the order of 2-5 pixels per cluster, which equates to roughly 300-500 
nm in diameter. These clusters are observed for both the main receptor BRI1 and 
the co-receptor SERK3. The receptors can only be visualised in the epidermal root 
cells of the elongation zone, an area where BR signalling is reported to be active 
(González-García et al. 2011; Hacham et al. 2011). The root meristem zone itself 
cannot be visualised due to curvature of the root, which causes the epidermal cell 
layer to be outside the critical range for VAEM. Clearly visible are the endosomal 
vesicles on the cytoplasmic side of the PM. These vesicles can be observed both for 
SERK3 and BRI1, although a higher number of vesicles are observed for BRI1. Es-
pecially the BRI1-line 2 (which shows an approximate three time over-expression 
of BRI-GFP compared to wild type) shows a high number of fluorescent endoso-
mal compartments, which are reminiscent of LE/EE compartments. This is in line 
with the observations made using confocal microscopy with the same plant lines 
(Bücherl et al. 2013). 
Brassinosteroid signalling is dependent on both the presence of the main li-
gand binding receptor BRI1 and the SERK co-receptors (Gou et al. 2012). In the 
root, the active signalling complex consists of BRI1 with SERK1 and/or SERK3/
BAK1 (Li et al. 2002; Karlova et al. 2006). Confocal images have shown that BRI1 
and SERK3 co-localise on the membrane, and FRET-FLIM data have shown that 
a minor amount of the BRI1 and SERK3 receptors are already in preformed com-
plexes before activation of the signalling pathway (Bücherl et al. 2013). Via these 
interactions, the co-receptors could influence the distribution of the main receptor 
in the PM. To determine whether the co-receptor affects the main receptor dis-
tribution, VAEM was employed of BRI1-GFP in a serk1 serk3 mutant. The results 
show that the absence of these co-receptors did not influence the main receptor 
distribution, and overall fluorescence intensity does not differ from the normal 
BRI1-GFP line 2 roots (see Figure 2D). The roots of a serk1serk3 double mutant are 
almost completely insensitive to the BL ligand, indicating that no active signalling 
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complexes are made in these roots. This is an indication that the SERK co-receptors 
do not have a role in maintaining the PM distribution of BRI1. 
By combining the BRI1 and SERK3 PM receptor density data from van Esse et 
al. (2011) with the number of nanoclusters per µm2 PM, an estimate of the number 
of receptors present in the clusters can be obtained (see Table 1). For BRI1, it ap-
pears that at near endogenous receptor level there are approximately 6 fluorescent 
receptors in each nanocluster. Intriguingly, upon overexpressing the BRI1 receptor 
approximately three times, each nanocluster now accommodates more BRI1 recep-
tors whereas the nanocluster density appears to be somewhat lower. In the SERK3-
GFP line there are about 50 percent more nanoclusters but these contain only two 
receptors each. A similar calculation for the SERK3-mCherry line results in about 1 
± 1 receptors per nanocluster, but these measurements appear less accurate com-
pared to the GFP-tagged versions. The number of receptors per cluster is in line 
with what can be estimated from the fluorescence decay curves of the clusters, that 
show only few typical single molecule step-wise decay events and mostly a mixture 
(see Supplemental File S2).
Table 1 quantification of receptors in nanoclusters
Given are average number of receptors (column one, (van Esse et al. 2011) or nanoclusters (column 
two) per µm2. From these numbers, the average number of receptor per nanocluster is calculated. 
Numbers are given with their respective standard error of the mean (SEM). For each experiment, at 
least three movies were recorded of three different roots (n=9)
Plant line receptor . μm-2 PM nanoclusters . μm-2 PM no. of receptors per 
nanocluster
BRI- GFP line 1 12 ± 1 2 ± 0.4 (n=9) 6 ± 1
BRI-GFP line 2 34 ± 3 1.5 ± 0.4 (n=9) 22 ± 4 
SERK3-GFP 5 ± 1 3 ± 0.4 (n=11) 2 ± 1
n= number of individual measurements
Values are given ±SEM
To rule out that the observed nanocluster distribution pattern was an inherent 
property of only these two receptors, a third plant receptor, BIR3, was investigated 
as well as an unrelated membrane protein, PIN2 (Friml 2010). BIR3 is an abundant 
PM receptor-like kinase for which the related members BIR1 (Gao et al. 2009) and 
BIR2 (Halter et al. 2014) have been implicated as stabilising components of PM 
receptor complexes involved in PTI. Also BIR3 is distributed in an inhomogenous 
fashion, similar to BRI1 and SERK3, suggesting that a distribution into nanoclus-
ters is a common configuration for plant membrane receptors (see Supplemental 
Figure S3).
When viewing recordings of the VAEM images it appeared that different pat-
terns of movement were present ranging from almost static to rapid directional 
and seemingly more random patterns (see Supplemental files online). Comparing 
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Figure 2 PM distribution of BRI1-GFP and SERK3-mCherry 
VAEM images of live root cell in 6 day old A. thaliana seedlings showing PM distribution of (A) BRI-
GFP line1, (B) BRI1-GFP line 2 and (C) SERK3-mCherry. (D) BRI1-GFP in a serk1serk3 mutant 
plant. Images taken are of epidermal root cells in the early elongation zone. Scale bars represent 
10 μm. 
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these patterns of movement with those of the markers employed above, it appeared 
that rapid movements were associated with intracellular membrane compartments 
rather than with the PM. Because VAEM as used here with fluorescent dyes is not 
reliable for comparing fast-moving objects differing in fluorescent intensity, Fluo-
rescence Recovery after Photobleaching (FRAP) was employed. For BRI1-GFP and 
SERK3-GFP diffusion coefficients were noted of approximately 0.1 µm2*s-1 and a 
mobile fraction between 35 and 60 %. These values are far below the value of 
10 µm2*s-1, determined for free lateral diffusion of a PM receptor (Meissner et al. 
2003; Bacia et al. 2006) and of the KNOLLE-GFP control (see Figure 3). In the 
meristem cells the diffusion coefficients are even lower, rendering both receptors 
virtually immobile when compared to protoplasts (see Table 2). Further analysis 
Figure 3 FRAP analysis of BRI-GFP and KNOLLE-GFP in epidermal root meristem
(A) 260 seconds after bleaching, KNOLLE-GFP fluorescence intensity at the PM is restored. No 
such recovery is observed for BRI1-GFP, which was imaged up to 400 seconds after bleaching the 
PM (only the bleached area is analysed,) (B) Recovery-curves of KNOLLE-GFP (blue line) and 
BRI1-GFP (black line) in epidermal cells in the root meristem. For KNOLLE-GFP n=7, for BRI1-
GFP n=15, measured in independent replicas, error bars indicate standard error of means (SEM). 
Error bars ± SEM.
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employing Gaussian fits suggest that most of the observed mobility in the elonga-
tion zones is due to replenishment from internal receptor pools (see Supplemental 
File 3). Taken together, VAEM and FRAP data suggest that both BRI1 and SERK3 
receptors are distributed in PM nanoclusters that are largely immobile and contain 
a small number of individual receptors.
Table 2 Mobile fractions and diffusion coefficients of BRI1 and SERK3
Tissue Mf (%) DC μm2*s-1 N Reference
BRI1-GFP Protoplasts 70 ± 17 2.2 ± 0.7 Kwaaitaal et al. (2011)
Meristem 28 ± 2 0.009 ± 0.002 15 van Esse, 2013
Elongation zone 35 ± 3 0.11 ± 0.04 15 van Esse, 2013
SERK3-GFP Protoplasts 78 ± 5 0.55 ± 0.07 4 van Esse, 2013
Meristem 78 ± 3 0.0009 ± 0.002 5 van Esse, 2013
Elongation zone 58 ± 2 0.08 ± 0.02 5 van Esse, 2013
N= number of individual measurements. 
Mf= mobile fraction
DC-= diffusion coefficients
Values are given ±SEM
BRI1 PM-distribution is not altered upon signal activation or 
absence of endogenous ligand
To investigate whether receptor distribution across the PM is influenced by activa-
tion of the signalling pathway, seedlings were first depleted of endogenous ligand 
by incubation with brassinazole (BRZ), a brassinosteroid synthesis inhibitor (Asa-
mi et al. 2000). Prior to VAEM, seedlings were incubated with 1 µM 24 epi-brass-
inolide (BL), a biologically active brassinosteroid, for 1 h. This treatment is rou-
tinely used to fully activate the brassinosteroid signalling pathway and calculated 
to achieve a near maximal receptor-ligand occupancy (van Esse et al. 2012). In-
terestingly, under these conditions of full activation, only a minor amount of BRI1 
and SERK3 was found to interact (Bücherl et al. 2013). It was therefore of great 
interest to apply this mode of full activation to see whether any change was visible 
in nanocluster distribution or amount using VAEM. Surprisingly, for both BRI1-GFP 
and SERK3-mCherry no significant change in the amount of clusters per µm2 PM 
or cluster size could be detected between the BRZ treated roots and the BRZ +BL 
treated roots (see Table 3 and Supplemental Figure S2). The SERK3-mCherry ex-
pressing roots showed a slight decrease in the total number of clusters, presumably 
due to BRZ treatment. BRI1-GFP distribution was also not affected in the brassi-
nosteroid synthesis mutant det2 (see Supplemental Figure S2), which contains less 
than 10 % of the normal WT levels of brassinosteroid (Fujioka et al. 1997). Taken 
together these data indicate that compared to the normal wild-type situation of 
untreated roots, neither the absence nor the exogenous application of BRs substan-
tially affects the BRI1 and SERK3 PM nanocluster distribution.
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Table 3 Quantification of clusters/ μm2 and cluster size of BRI1 and SERK3 upon ligand 
application
Given are average number of clusters per µm2 and average cluster size in µm2 upon different treat-
ments. 5 µM BRZ was added to the growth media for 3 days prior to ligand stimulation. Ligand 
stimulation was accomplished by incubation of seedlings with 1 µM 24- epi-brassinolide (BL) for 1h. 
All experiments were performed twice, three images were collected for three seedlings per exper-
iment (n=9). Numbers are given with their respective pooled standard error of the mean (SEM).
BRZ BL after BRZ 
pre-treatment
No treatment
BRI1-GFP line 1 clusters/ μm2
cluster size (μm2)
2.4 ± 0.2
0.29 ± 0.04
2.2 ± 0.1
0.31 ± 0.04
2.3 ± 0.1
0.29 ± 0.02
BRI1-GFP line 2 clusters/ μm2
cluster size (μm2)
nd
0.45 ± 0.06
Nd
0.49 ± 0.06
nd
0.41 ± 0.05
SERK3-mCherry clusters/ μm2
cluster size (μm2)
5.1 ± 0.5
0.12 ± 0.02
5.8 ± 0.3
0.08 ± 0.03
8.0 ± 0.5
0.13 ± 0.02
BRI1 and SERK3/BAK1 distribution is influenced by tyrphostin A23
All three integral membrane receptors investigated in this study, BRI1, SERK3 and 
BIR3, showed the same nanocluster distribution, which was not influenced by li-
gand induced activation. This suggests that the observed distribution is not coupled 
to the biological function of these receptors, but might have a more structural 
origin. To further investigate the underlying mechanisms causal to the observed 
nanoclusters, the receptor distribution of SERK3 and BRI1 was visualised after 
treatment with various inhibitors of the endocytic, cytoskeleton or biosynthetic 
pathways. Treatment of BRI1-GFP and SERK3-mCherry seedlings with the pro-
tein synthesis inhibitor cycloheximide, latrunculin B or brefeldin A either alone 
or in combination with BRZ or with BRZ and BL did not result in any consistent 
change in distribution of either receptor (data not shown). In particular, the ab-
sence of clear effects on nanocluster distribution of actin-depolylarizing agent such 
as latrunculin B is puzzling. The only compound that gave a more consistent result 
was tyrphostin A23, a tyrosine kinase inhibitor. Tyrphostin A23 is thought to both 
interfere with endocytosis (Ortiz-Zapater et al. 2006; Dhonukshe et al. 2007) and 
with Golgi-based secretion of proteins (Li et al. 2012). Tyrphostin A23 inhibits 
endocytosis of BRI1-GFP bound to fluorescent ligand, and in this way increases BR 
signalling (Irani et al. 2012). However, tyrphostin A23 also seemed to increase the 
intracellular amount of BRI, perhaps due to inhibition of Golgi-based secretion. To 
see whether interference with the normal endocytic route would alter the receptor 
distribution on the membrane, BRI1-GFP and SERK3-mCherry were visualised on 
the PM in seedlings treated with tyrphostin A23 or the inactive variant tyrphostin 
A51. As can be seen in Figure 4, the overall PM fluorescence diminishes for both 
receptors, causing the clustering to be less pronounced. However, both receptors 
are still present in their nanocluster arrangement. Unfortunately, reliable quan-
tification of the SERK3-mCherry clusters was not possible due to the decreased 
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Figure 4 Receptor distribution upon tyrphostin application
(A) BRI1-GFP 1 PM distribution in untreated seedlings (left), seedlings treated with 50 μM tyr-
phostin A23 for 1 h (B) and seedlings treated with 50 μM tyrphostin A51 (C). (D) SERK3-mCherry 
PM distribution in untreated seedlings, seedlings treated with 50 μM tyrphostin A23 for 1 h (E) 
and seedlings treated with 50 μM tyrphostin A51 (F). Receptor clustering is less pronounced after 
tyrphostin A23 treatment because overall fluorescence intensity appears diminished. Scale bars 
represent 10 μm.
Table 4 Quantification of clusters per μm2 of BRI1 upon tyrphostinA23 application 
Given are average numbers of clusters per µm2 observed in the respective plant lines. Numbers 
are given with their respective standard error of the mean (SEM). The number of clusters does not 
significantly differ between the treatments, as assessed via a Student’s t-test. 
tyrphostin A23 tyrphostin A51
+BL -BL +BL -BL
Bri1-GFP line1 2.2 ±0.1 (n=14) 2.5 ± 0.2 (n=17) 2.7 ±0.2 (n=8) 3.0 ± 0.2 (n=12)
n= number of individual measurements
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fluorescence intensity. Quantification of the clusters in the tyrphostin A23 treated 
BRI1-GFP roots indicated that the number of clusters per µm2 was not significantly 
affected by the treatment, neither in the presence, nor in the absence of the brass-
inosteroid ligand BL (see Table 4). Thus, although the amount of PM located BRI1 
receptors did change upon tyrphostin treatment, it appeared that the nanocluster 
density was not affected.
Discussion 
Our results using Variable Angle Epifluorescence Microscopy (VAEM) to visualise 
SERK3 and BRI1 plasma membrane (PM) distribution clearly demonstrate that 
these receptors are arranged in nanoclusters in the PM of Arabidopsis root cells. 
Cluster formation of receptors has been observed more often; for instance the 
Epidermal Growth Factor Receptor (EGFR) is present in oligmeric clusters in the 
membrane (Clayton 2005). These clusters consist of approximately 2 receptors in 
an unstimulated situation, which is in the same range as our results for the brassi-
nosteroid receptor BRI1 and its coreceptor SERK3. For EGFR, the nanocluster dis-
tribution is thought to be coupled to the biological activity of the receptor (Ariotti 
2010), and a marked increase in the number of receptors per cluster is observed 
upon ligand binding (from 2.2 to 3.7 receptors per nanocluster; Clayton, 2005). 
However, no change in distribution was observed for either SERK3 or BRI1 upon 
ligand application, or depletion of endogenous ligand. In addition, the fact that a 
third PM receptor, BIR3, is also observed in a nanocluster distribution, suggests 
that the formation of nanoclusters is a general feature of plant receptors.
Receptors that are arranged in nanoclusters are considered to be part of larger 
arrangements of signalling proteins (Clayton et al. 2005). In addition, the stoi-
chiometry between the different components can be altered without affecting the 
arrangement (Plowman et al. 2008). Similar observations were made here; when 
comparing the PM of two BRI1-GFP lines, that differed about 3-fold in receptor 
density while retaining the same nanocluster density. Also, a decrease in PM local-
ised BRI1-GFP by tyrphostin A23, did not change the nanocluster density. Changing 
the receptor stoichiometry within the confinements of the nanoclusters could be 
a mechanism of the plant cell to regulate signalling output, especially in the sit-
uation of SERK3, which is part of different signalling complexes in the same cell 
(Robatzek et al. 2006; Savaldi-Goldstein et al. 2007). 
Using FRAP, the BRI1-GFP nanoclusters appeared largely immobile. As in the 
case of EGFR, animal receptor nanoclusters are thought to be confined by the corti-
cal actin filament network and cholesterol rich domains (Orr et al. 2005). However, 
for BRI1 and SERK3, treatment with Latrunculin B (an actin depolymerising agent) 
did not result in consistent changes in nanocluster distribution. Lateral diffusion 
of plant receptors is thought to be restricted directly or indirectly by the presence 
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of the plant cell wall (Martinière et al., 2012). Restricted diffusion of receptor 
proteins due to physical barriers from, for instance, the underlying cytoskeleton, 
or, in the case of plant cells, the cell wall, could induce clustering (Jaqaman and 
Grinstein 2012). The classical model for PM receptor activation assumes ligand-in-
duced endocytosis. This could involve removal of entire nanoclusters from the PM 
or a change in their stoichiometry. In the BRI1-GFP and SERK3-mCherry VAEM re-
cordings both events were observed. Due to the absence of a clear link with ligand 
availability this was not investigated further at this time.
Given the observed restrictions in lateral movement, it is unlikely that BRI1 
nanoclusters are formed after arrival of the proteins at the PM. At present, it is 
unknown where plant PM receptor nanocluster assembly takes place. One way in 
which this could be accomplished is via the preformation of the higher order sig-
nalling complexes, inserted in their respective position in the membrane as a fully 
assembled unit. Preformation of complexes has been observed for BRI1 and SERK3 
(Bücherl, 2013), corroborating this idea. It would be of great interest to investigate 
whether these proteins are indeed inserted in the membrane together, or whether 
minor mobility within the confinements of the clusters is sufficient to form recep-
tor complexes after insertion in the membrane. A combination of VAEM and FRET 
might indicate the location of preformed and ligand induced complexes between 
main receptor and co-receptors in respect to the nanoclusters, and could provide 
interesting answers into the dynamics of BR signal activation within the complex 
confinements of the plant PM and cell wall.
The receptor clusters observed with VAEM in this study were rather big; 300-
500 nm across, which does not seem to correspond to the 2-6 receptor molecules 
which were calculated to be part of these clusters. Most likely this is due to the 
diffraction limit of the technique used. The VAEM technique can greatly increase 
resolution due to selective illumination of a thin surface layer; however, on its own 
it does not allow going below the diffraction limit caused by the Gaussian distri-
bution of fluorescence. Since the expected cluster size of the receptors is probably 
below the diffraction limit, the use of VAEM is not sufficient to investigate the 
clusters size in detail. It can thus be expected that the 300- 500 nm clusters ob-
served in this study is an over-estimate of the actual receptor cluster size. To further 
investigate the clustering of BRI1 and SERK3, optical super-resolution techniques, 
namely photo-activated localisation microscopy (PALM), should be employed in 
combination with VAEM. However, this report clearly shows that VAEM can be 
used in combination with live A. thaliana root cells to visualise both the PM and 
the underlying cellular compartments and clearly demonstrates the nanocluster 
formation of several plant membrane proteins. 
144
Chapter 5
References
Asami, T., Y. K. Min, N. Nagata, K. Yamagishi, S. Takatsuto, S. Fujioka, N. Murofushi, I. Yama-
guchi and S. Yoshida (2000). "Characterization of brassinazole, a triazole-type brassino-
steroid biosynthesis inhibitor." Plant Physiol 123(1): 93-100.
Bacia, K., S. A. Kim and P. Schwille (2006). "Fluorescence cross-correlation spectroscopy in 
living cells." Nat Methods 3(2): 83-89.
Boutte, Y., M. Frescatada-Rosa, S. Men, C. M. Chow, K. Ebine, A. Gustavsson, L. Johansson, 
T. Ueda, I. Moore, G. Jurgens and M. Grebe (2010). "Endocytosis restricts Arabidopsis 
KNOLLE syntaxin to the cell division plane during late cytokinesis." EMBO J 29(3): 546-
558.
Bücherl, C., J. Aker, S. de Vries and J. W. Borst (2010). "Probing protein-protein Interactions 
with FRET-FLIM." Methods Mol Biol 655: 389-399.
Bücherl, C. A., G. W. van Esse, A. Kruis, J. Luchtenberg, A. H. Westphal, J. Aker, A. van Hoek, 
C. Albrecht, J. W. Borst and S. C. de Vries (2013). "Visualization of BRI1 and BAK1(-
SERK3) membrane receptor hetero-oligomers during brassinosteroid signaling." Plant 
Physiol.
Clouse, S. (2001). "Brassinosteroids." Current biology : CB 11(22): R904.
Cutler, S. R., D. W. Ehrhardt, J. S. Griffitts and C. R. Somerville (2000). "Random GFP::cDNA 
fusions enable visualization of subcellular structures in cells of Arabidopsis at a high 
frequency." Proc Natl Acad Sci U S A 97(7): 3718-3723.
Dettmer, J., A. Hong-Hermesdorf, Y. D. Stierhof and K. Schumacher (2006). "Vacuolar 
H+-ATPase activity is required for endocytic and secretory trafficking in Arabidopsis." 
Plant Cell 18(3): 715-730.
Dhonukshe, P., F. Aniento, I. Hwang, D. G. Robinson, J. Mravec, Y. D. Stierhof and J. Friml 
(2007). "Clathrin-mediated constitutive endocytosis of PIN auxin efflux carriers in Arabi-
dopsis." Curr Biol 17(6): 520-527.
Di Fiore, P. P. and P. De Camilli (2001). "Endocytosis and signaling. an inseparable partner-
ship." Cell 106(1): 1-4.
Ebine, K., M. Fujimoto, Y. Okatani, T. Nishiyama, T. Goh, E. Ito, T. Dainobu, A. Nishitani, 
T. Uemura, M. H. Sato, H. Thordal-Christensen, N. Tsutsumi, A. Nakano and T. Ueda 
(2011). "A membrane trafficking pathway regulated by the plant-specific RAB GTPase 
ARA6." Nature cell biology 13(7): 853-859.
Friedrichsen, D. M., C. A. Joazeiro, J. Li, T. Hunter and J. Chory (2000). "Brassinosteroid-in-
sensitive-1 is a ubiquitously expressed leucine-rich repeat receptor serine/threonine ki-
nase." Plant Physiol 123(4): 1247-1256.
Friml, J. (2010). "Subcellular trafficking of PIN auxin efflux carriers in auxin transport." Eu-
ropean Journal of Cell Biology 89(2-3): 231-235
Fujioka, S., J. Li, Y. H. Choi, H. Seto, S. Takatsuto, T. Noguchi, T. Watanabe, H. Kuriyama, T. 
Yokota, J. Chory and A. Sakurai (1997). "The Arabidopsis deetiolated2 mutant is blocked 
early in brassinosteroid biosynthesis." Plant Cell 9(11): 1951-1962.
Gao, M., X. Wang, D, Wang, F. Xu, X. Ding, Z. Zhang, D. Bi, Y.T. Cheng, S. Chen, X. Li, Y. 
Zhang (2009). "Regulation of cell death and innate immunity by two receptor-like kinas-
es in Arabidopsis." Cell host & microbe 6(1): 34-44.
145
Visualisation of SERK3 and BRI1 Plasma Membrane Distribution using VAEM
Geldner, N., V. Denervaud-Tendon, D. L. Hyman, U. Mayer, Y. D. Stierhof and J. Chory (2009). 
"Rapid, combinatorial analysis of membrane compartments in intact plants with a mul-
ticolor marker set." The Plant journal : for cell and molecular biology 59(1): 169-178.
Geldner, N., D. L. Hyman, X. Wang, K. Schumacher and J. Chory (2007). "Endosomal signal-
ing of plant steroid receptor kinase BRI1." Genes & development 21(13): 1598-1602.
González-García, M. P., J. Vilarrasa-Blasi, M. Zhiponova, F. Divol, S. Mora-Garcia, E. Russino-
va and A. I. Cano-Delgado (2011). "Brassinosteroids control meristem size by promoting 
cell cycle progression in Arabidopsis roots." Development 138(5): 849-859.
Gou, X., H. Yin, K. He, J. Du, J. Yi, S. Xu, H. Lin, S. D. Clouse and J. Li (2012). "Genetic 
evidence for an indispensable role of somatic embryogenesis receptor kinases in brassi-
nosteroid signaling." PLoS genetics 8(1): e1002452.
Hacham, Y., N. Holland, C. Butterfield, S. Ubeda-Tomas, M. J. Bennett, J. Chory and S. Saval-
di-Goldstein (2011). "Brassinosteroid perception in the epidermis controls root meristem 
size." Development 138(5): 839-848.
Halter, T., J. Imkampe, S. Mazzotta, M. Wierzba, S. Postel, C. Bücherl, C. Kiefer, M. Stahl, 
D. Chinchilla, X. Wang, T. Nurnberger, C. Zipfel, S. Clouse, J.W. Borst, S. Boeren, S.C. de 
Vries, F. Tax, B. Kemmerling (2014). "The Leucine-Rich Repeat Receptor Kinase BIR2 Is 
a Negative Regulator of BAK1 in Plant Immunity." Current biology : CB 24(2): 134-143.
Irani, N. G., S. Di Rubbo, E. Mylle, J. Van den Begin, J. Schneider-Pizon, J. Hnilikova, M. Sisa, 
D. Buyst, J. Vilarrasa-Blasi, A. M. Szatmari, D. Van Damme, K. Mishev, M. C. Codreanu, 
L. Kohout, M. Strnad, A. I. Cano-Delgado, J. Friml, A. Madder and E. Russinova (2012). 
"Fluorescent castasterone reveals BRI1 signaling from the plasma membrane." Nature 
chemical biology 8(6): 583-589.
Jaillais, Y., M. Hothorn, Y. Belkhadir, T. Dabi, Z. L. Nimchuk, E. M. Meyerowitz and J. Chory 
(2011). "Tyrosine phosphorylation controls brassinosteroid receptor activation by trig-
gering membrane release of its kinase inhibitor." Genes & development 25(3): 232-237.
Jaqaman, K. and S. Grinstein (2012). "Regulation from within: the cytoskeleton in trans-
membrane signaling." Trends in cell biology 22(10): 515-526.
Karlova, R., S. Boeren, E. Russinova, J. Aker, J. Vervoort and S. de Vries (2006). "The Arabi-
dopsis SOMATIC EMBRYOGENESIS RECEPTOR-LIKE KINASE1 protein complex includes 
BRASSINOSTEROID-INSENSITIVE1." Plant Cell 18(3): 626-638.
Kim, T. W., S. Guan, A. L. Burlingame and Z. Y. Wang (2011). "The CDG1 kinase mediates 
brassinosteroid signal transduction from BRI1 receptor kinase to BSU1 phosphatase and 
GSK3-like kinase BIN2." Mol Cell 43(4): 561-571.
Konopka, C. A. and S. Y. Bednarek (2008). "Variable-angle epifluorescence microscopy: a 
new way to look at protein dynamics in the plant cell cortex." The Plant journal : for cell 
and molecular biology 53(1): 186-196.
Lam, S. K., C. L. Siu, S. Hillmer, S. Jang, G. An, D. G. Robinson and L. Jiang (2007). "Rice 
SCAMP1 defines clathrin-coated, trans-golgi-located tubular-vesicular structures as an 
early endosome in tobacco BY-2 cells." Plant Cell 19(1): 296-319.
Li, J., J. Wen, K. A. Lease, J. T. Doke, F. E. Tax and J. C. Walker (2002). "BAK1, an Arabidop-
sis LRR receptor-like protein kinase, interacts with BRI1 and modulates brassinosteroid 
signaling." Cell 110(2): 213-222.
146
Chapter 5
Li, R., N. Raikhel and G. Hicks (2012). Chemical Effectors of Plant Endocytosis and En-
domembrane Trafficking. Endocytosis in Plants. J. Šamaj, Springer Berlin Heidelberg: 
37-61.
Martinière, A., I. Lavagi, G. Nageswaran, D. J. Rolfe, L. Maneta-Peyret, D. T. Luu, S. W. 
Botchway, S. E. Webb, S. Mongrand, C. Maurel, M. L. Martin-Fernandez, J. Kleine-Vehn, 
J. Friml, P. Moreau and J. Runions (2012). "Cell wall constrains lateral diffusion of plant 
plasma-membrane proteins." Proc Natl Acad Sci U S A 109(31): 12805-12810.
Mattila, P. K., C. Feest, D. Depoil, B. Treanor, B. Montaner, K.L. Otipody, R. Carter, L.B. Just-
ement, A. Bruckbauer, F.D. Batista (2013). "The actin and tetraspanin networks organize 
receptor nanoclusters to regulate B cell receptor-mediated signaling." Immunity 38(3): 
461-474
Meissner, O. and H. Haberlein (2003). "Lateral mobility and specific binding to GABA(A) 
receptors on hippocampal neurons monitored by fluorescence correlation spectroscopy." 
Biochemistry 42(6): 1667-1672.
Ortiz-Zapater, E., E. Soriano-Ortega, M. J. Marcote, D. Ortiz-Masia and F. Aniento (2006). 
"Trafficking of the human transferrin receptor in plant cells: effects of tyrphostin A23 and 
brefeldin A." Plant J 48(5): 757-770.
Robatzek, S., D. Chinchilla and T. Boller (2006). "Ligand-induced endocytosis of the pattern 
recognition receptor FLS2 in Arabidopsis." Genes & development 20(5): 537-542.
Santiago, J., C. Henzler and M. Hothorn (2013). "Molecular Mechanism for Plant Steroid 
Receptor Activation by Somatic Embryogenesis Co-Receptor Kinases." Science.
Savaldi-Goldstein, S., C. Peto and J. Chory (2007). "The epidermis both drives and restricts 
plant shoot growth." Nature 446(7132): 199-202.
Shaw, S. L. (2006). "Imaging the live plant cell." The Plant journal : for cell and molecular 
biology 45(4): 573-598.
Tang, W., T. W. Kim, J. A. Oses-Prieto, Y. Sun, Z. Deng, S. Zhu, R. Wang, A. L. Burlingame and 
Z. Y. Wang (2008). "BSKs mediate signal transduction from the receptor kinase BRI1 in 
Arabidopsis." Science 321(5888): 557-560.
Ueda, T., T. Uemura, M. H. Sato and A. Nakano (2004). "Functional differentiation of en-
dosomes in Arabidopsis cells." The Plant journal : for cell and molecular biology 40(5): 
783-789.
van Esse, G. W., S. van Mourik, H. Stigter, C. A. ten Hove, J. Molenaar and S. C. de Vries 
(2012). "A mathematical model for BRASSINOSTEROID INSENSITIVE1-mediated sig-
naling in root growth and hypocotyl elongation." Plant Physiol 160(1): 523-532.
van Esse, G. W., A. H. Westphal, R. P. Surendran, C. Albrecht, B. van Veen, J. W. Borst and S. 
C. de Vries (2011). "Quantification of the brassinosteroid insensitive1 receptor in planta." 
Plant Physiol 156(4): 1691-1700.
Viotti, C., J. Bubeck, Y. D. Stierhof, M. Krebs, M. Langhans, W. van den Berg, W. van Don-
gen, S. Richter, N. Geldner, J. Takano, G. Jurgens, S. C. de Vries, D. G. Robinson and 
K. Schumacher (2010). "Endocytic and secretory traffic in Arabidopsis merge in the 
trans-Golgi network/early endosome, an independent and highly dynamic organelle." 
Plant Cell 22(4): 1344-1357.
147
Visualisation of SERK3 and BRI1 Plasma Membrane Distribution using VAEM
Vizcay-Barrena, G., S. E. Webb, M. L. Martin-Fernandez and Z. A. Wilson (2011). "Subcellular 
and single-molecule imaging of plant fluorescent proteins using total internal reflection 
fluorescence microscopy (TIRFM)." Journal of experimental botany 62(15): 5419-5428.
Wang, X. and J. Chory (2006). "Brassinosteroids regulate dissociation of BKI1, a negative 
regulator of BRI1 signaling, from the plasma membrane." Science 313(5790): 1118-
1122.
Wang, X., U. Kota, K. He, K. Blackburn, J. Li, M. B. Goshe, S. C. Huber and S. D. Clouse 
(2008). "Sequential transphosphorylation of the BRI1/BAK1 receptor kinase complex 
impacts early events in brassinosteroid signaling." Dev Cell 15(2): 220-235.
Webb, S. E., S. R. Needham, S. K. Roberts and M. L. Martin-Fernandez (2006). "Multidimen-
sional single-molecule imaging in live cells using total-internal-reflection fluorescence 
microscopy." Optics letters 31(14): 2157-2159.
Wilson, B. S., J. M. Oliver and D. S. Lidke (2011). "Spatio-temporal signaling in mast cells. 
Advances in experimental medicine and biology 716: 91-1
148
Chapter 5
Supplemental Figures and Files
Supplemental Figure S1  PM distribution of BRI1-GFP using full TIRF and VAEM.
(A) Full TIRF image of BRI1- GFP line 1; (B) VAEM image of the same root at the same place as 
in A. 
149
Visualisation of SERK3 and BRI1 Plasma Membrane Distribution using VAEM
Supplemental Figure S2  BRI1 distribution upon signal activation and ligand depletion.
Live root cells of BRI1-GFP untreated seedlings (A), treated for 3 days with 5 µM brassinazole,(B) 
and BRZ treated seedling roots incubated with 1 µM 24-epi-brassinolide for 1 h . Live root cells of 
BRI1-GFP untreated seedlings (D). BRI1-GFP in live root cells of the det2 mutant (E). 
Supplemental Figure S3  PM distribution of PIN2-GFP, BIR3-GFP compared with BRI1-GFP 
and wild-type controls using VAEM.
Live root cells of PIN2-GFP seedlings (A), BIR-GFP seedlings (B), BRI1-GFP seedlings (C) and 
Col[0] seedlings (D). 
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Analysis of the FRAP data was done essentially as described previously 
(Kwaaitaal et al., 2011). All fluorescence intensities were recorded in arbi-
trary units (a.u.) and corrected for autofluorescence in the wild type control 
according to:
 
 
𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑡𝑡 = 𝐼𝐼𝑡𝑡 − 𝐼𝐼𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑛𝑛𝑛𝑛𝑏𝑏𝑛𝑛𝑏𝑏𝐼𝐼𝑡𝑡,𝑠𝑠𝑏𝑏𝑏𝑏𝑛𝑛𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ − 𝐼𝐼𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑛𝑛𝑛𝑛𝑏𝑏𝑛𝑛𝑏𝑏 𝐼𝐼0,𝑠𝑠𝑏𝑏𝑏𝑏𝑛𝑛𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ − 𝐼𝐼0,𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑛𝑛𝑛𝑛𝑏𝑏𝑛𝑛𝑏𝑏⁄  
 
𝐼𝐼𝑏𝑏𝑏𝑏𝑡𝑡𝑏𝑏,𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 = 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑡𝑡 − 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,0 − 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ 
 
𝐹𝐹𝑛𝑛 = 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑠𝑠𝑛𝑛𝑏𝑏 − 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,0 − 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ  
 
𝐼𝐼(𝑡𝑡) = 𝐹𝐹𝑛𝑛 × �1 − 𝑒𝑒−𝑏𝑏𝑡𝑡�  
 
𝑡𝑡1/2 = ln(2) /𝑘𝑘  
𝐷𝐷𝑏𝑏 = A4×𝑡𝑡1/2 [μm/s2]  
 
 
where Inorm,t is the normalised fluorescence intensity at time t, It is total inten-
sity at time t, Ibackground is the intensity in the wild type control, It,scanbleach is the 
signal level of a spot of the same size as the bleached area for measuring the 
scan-bleaching, I0,scanbleach is the average signal of the scan-bleaching before the 
bleaching procedure, and I0,background is the average signal of the background 
before bleaching. The normalised fluorescence intensities were calculated ac-
cording to:
 
 
𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑡𝑡 = 𝐼𝐼𝑡𝑡 − 𝐼𝐼𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑛𝑛𝑛𝑛𝑏𝑏𝑛𝑛𝑏𝑏𝐼𝐼𝑡𝑡,𝑠𝑠𝑏𝑏𝑏𝑏𝑛𝑛𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ − 𝐼𝐼𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑛𝑛𝑛𝑛𝑏𝑏𝑛𝑛𝑏𝑏 𝐼𝐼0,𝑠𝑠𝑏𝑏𝑏𝑏𝑛𝑛𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ − 𝐼𝐼0,𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑛𝑛𝑛𝑛𝑏𝑏𝑛𝑛𝑏𝑏⁄  
 
𝐼𝐼𝑏𝑏𝑏𝑏𝑡𝑡𝑏𝑏,𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 = 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑡𝑡 − 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,0 − 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ 
 
𝐹𝐹𝑛𝑛 = 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑠𝑠𝑛𝑛𝑏𝑏 − 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,0 − 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ  
 
𝐼𝐼(𝑡𝑡) = 𝐹𝐹𝑛𝑛 × �1 − 𝑒𝑒−𝑏𝑏𝑡𝑡�  
 
𝑡𝑡1/2 = ln(2) /𝑘𝑘  
𝐷𝐷𝑏𝑏 = A4×𝑡𝑡1/2 [μm/s2]  
 
 
where Idata,norm is the calculated normalised intensity, Inorm,bleach is the normal-
ised intensity just after the bleach, and Inorm,0 is the average normalised inten-
sity before bleaching. 
The mobile fraction is defined as:
 
 
𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑡𝑡 = 𝐼𝐼𝑡𝑡 − 𝐼𝐼𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑛𝑛𝑛𝑛𝑏𝑏𝑛𝑛𝑏𝑏𝐼𝐼𝑡𝑡,𝑠𝑠𝑏𝑏𝑏𝑏𝑛𝑛𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ − 𝐼𝐼𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑛𝑛𝑛𝑛𝑏𝑏𝑛𝑛𝑏𝑏 𝐼𝐼0,𝑠𝑠𝑏𝑏𝑏𝑏𝑛𝑛𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ − 𝐼𝐼0,𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑛𝑛𝑛𝑛𝑏𝑏𝑛𝑛𝑏𝑏⁄  
 
𝐼𝐼𝑏𝑏𝑏𝑏𝑡𝑡𝑏𝑏,𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛 = 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑡𝑡 − 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,0 − 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ 
 
𝐹𝐹𝑛𝑛 = 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑠𝑠𝑛𝑛𝑏𝑏 − 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,0 − 𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ  
 
𝐼𝐼(𝑡𝑡) = 𝐹𝐹𝑛𝑛 × �1 − 𝑒𝑒−𝑏𝑏𝑡𝑡�  
 
𝑡𝑡1/2 = ln(2) /𝑘𝑘  
𝐷𝐷𝑏𝑏 = A4×𝑡𝑡1/2 [μm/s2]  
 
 
Where Inorm,end is the normalised intensity after full recovery. The recovery 
curve can be fitted for a molecule undergoing two-dimensional diffusion to 
the next formula:
 
 
𝐼𝐼𝑛𝑛𝑛𝑛𝑛𝑛𝑛𝑛,𝑡𝑡 = 𝐼𝐼𝑡𝑡 − 𝐼𝐼𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑛𝑛𝑛𝑛𝑏𝑏𝑛𝑛𝑏𝑏𝐼𝐼𝑡𝑡,𝑠𝑠𝑏𝑏𝑏𝑏𝑛𝑛𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ − 𝐼𝐼𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑛𝑛𝑛𝑛𝑏𝑏𝑛𝑛𝑏𝑏 𝐼𝐼0,𝑠𝑠𝑏𝑏𝑏𝑏𝑛𝑛𝑏𝑏𝑠𝑠𝑠𝑠𝑏𝑏𝑏𝑏ℎ − 𝐼𝐼0,𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑛𝑛𝑛𝑛𝑏𝑏𝑛𝑛𝑏𝑏⁄  
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where k is the recovery constant, this is related to the half-time of diffusion 
as follows:
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Assuming that there is an unrestricted two-dimensional diffusion the diffu-
sion coefficient, Dc, is related to the half-time of diffusion, as:
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Supplemental File S2
VAEM fluorescence decay 
curves.
(A) Single molecule decay 
curve of SERK3-mCherry. 
(B) Representative decay 
curve of SERK3-mCherry. 
(C) Representative decay 
curve of BRI1-GFP.
For both receptors, discreet 
steps in fluorescence decay 
are observed, indicating that 
the number of receptors in 
the cluster is limited. 
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Supplemental File 3  Gaussian fits of receptor molecules in PM surrounding the anticlinal cell 
wall before and after photobleaching.
The line represents the fit of a Gaussian distribution on the fluorescence intensity data across the 
anticlinal cell wall. Distance 0 is the midpoint of two adjacent plasma membranes in a confocal im-
age. The cytoplasm is situated between 1-05 µm on either side of the midpoint. (A) Fluorescence 
intensity of BRI1-GFP at the bleached area (left) compared to the intensity at a non-bleached area 
of the PM (right). After 400 seconds, the fluorescence intensity at the non-bleached area (right 
panel) was reduced significantly due to scan bleaching. (B) Same as A, except now for SERK3-GFP. 
N=5 different roots; 20 fits per image (n ≥100 data points).
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Chapter 6
The transduction of extracellular signals to intracellular responses is of vital 
importance for all living organisms. The perception of signalling molecules outside 
the cell is often accomplished via ligand binding proteins spanning the plasma 
membrane, i.e. receptor proteins. In plants, the majority of plasma membrane re-
ceptors are part of the family of leucine-rich-repeat receptor-like-kinases (LRR-
RLKs) (Shiu and Bleecker 2001a). These receptors contain an extracellular LRR do-
main, coupled to an intracellular kinase domain via a single pass transmembrane 
helix. The plant RLKs and their animal counterparts, the receptor-tyrosine-kinases 
(RTKs), are thought to form dimers or oligomers to make activation of their cyto-
plasmic kinase domains possible. Sometimes, additional membrane spanning pro-
teins are part of these higher order complexes. If so, we can distinguish between 
the main ligand binding receptor, which contains both the domains to perceive 
signal and to confer this across the membrane to intracellular reactions and co-re-
ceptors (or auxiliary receptors), which on their own cannot perceive the signal or 
transduce the signal into the cell. The somatic embryogenesis receptor kinases ( 
SERKs ) are a family of co-receptors found in plants and show multitasking func-
tions in several, seemingly unrelated, pathways (Albrecht et al. 2005, Albrecht et 
al. 2008, Chinchilla et al. 2009, Roux et al. 2011). Except for SERK5, that has no 
reported function at this time, the SERK genes in Arabidopsis thaliana show partial 
redundancy, with each SERK functioning in its own specific subset of signalling 
pathways. 
In this thesis I have taken a closer look at the SERK family of receptor kinases 
to understand their role as co-receptors in plant signalling cascades and the regu-
lation of their activity. Studies on animal signalling indicate that co-receptors can 
have many different functions in signalling complexes and form an additional layer 
of regulation in signalling cascades, which I have discussed in more detail in the 
introductory Chapter 1. Also in this chapter, I have reviewed the current crystal 
structures available on plant leucine-rich-repeat receptor-like-kinases (Santiago et 
al. 2013, Sun et al. 2013). These structures provide us with the first clues into the 
molecular basis of plant RLK function. Interestingly, the current crystal structures 
of SERK extracellular domains indicate that these co-receptors have interactions 
not only with the main ligand binding receptor, but also with the different ligands. 
The SERK residues that are implicated in ligand interaction are conserved in the 
SERK protein family, so this new evidence does not seem to be able to explain the 
functional divergence observed between the SERK family members. Current struc-
tural, biochemical and genetic evidence define the A. thaliana SERK proteins as 
true co-receptors, part of active signalling complexes via interaction with different 
main ligand binding receptors (Albrecht et al. 2012, Gou et al. 2012, Santiago et 
al. 2013, Sun et al. 2013).
The wide functional diversity seen between different members of the SERK 
protein family must be inherent to differences in protein sequence. In some ways, 
this is rather counter-intuitive, because the SERK proteins are very homologous 
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and show only minor changes. In Chapter 2, I pinpoint which residues/motifs 
or domains are important for the different functions of the SERKs. A sequence 
comparison with SERK sequences from different plant species showed that SERK 
genes are ancient, present already with multiple copies in genomes of non-vascular 
plants (e.g. the moss Physcomitrella patens). The SERKs present in these evolution-
ary older genomes closely resemble the A. thaliana SERK1 and 2 sequences; appar-
ently the SERKs have not changed much throughout 2 M years of evolution. This is 
a strong indication that SERKs are indeed essential for important plant signalling 
pathways. The A. thaliana SERK3 and 4 genes, however, have diverged more in 
protein sequence and belong to a SERK-clade only present in dicotyledons. This 
divergence is probably linked to different functionality of these proteins. Chimeric 
SERK proteins, in which the extracellular domain of one SERK is coupled to the 
cytoplasmic domain of another, show that SERK specificity is rather complex and 
cannot be attributed to any one residue, motif or even domain. 
To further investigate the functional plasticity of SERKs, we aimed to obtain 
additional high-resolution structural data on these co-receptors. In recent years, 
the first crystal structures of plant LRR-RLK domains have been reported. These 
include the kinase domain of SERK3/ BAK1, the extracellular domain of SERK1 
in complex with that of the main receptor BRI1 (Brassinosteroid Insensitive 1) 
and of SERK3 with the main receptor FLS2 (Flagellin Sensing 2). These structures 
have given important clues into the function of SERK co-receptors. High-resolution 
structural data on other SERKs could provide insights into the functional plasticity 
and specificity observed in the SERK protein family. In Chapter 3 I describe our 
attempts to solve the crystal structures of the kinase domains of different A. thalia-
na SERK proteins. This was hampered by low protein production and difficulties 
in purification. We managed to obtain two crystals of the SERK1 kinase domain, 
which diffracted to around 2.5 Å resolution. However, structure elucidation was 
not possible. 
Besides structural information, biochemical investigations into receptor acti-
vation mechanisms are essential and in Chapter 4 I used a combination of spec-
troscopic data and activity assays to understand more of the regulation of activity 
of the SERK kinase domain. Co-receptors can modulate signalling activity, but only 
if their activity is also tightly regulated to avoid aberrant activation of the entire 
receptor complex. In this thesis, and in other reports, it has been shown that ki-
nase domains of receptors and co-receptors are intrinsically active when produced 
in vitro. This means that mechanisms need to be in place in vivo to keep kinase 
domains in their inactive state. In Chapter 4 we investigated one such way of 
keeping proteins inactive, namely intrinsic disorder. In this manner, proteins are 
kept disordered, or unfolded/unstructured, until their activity is needed. Folding, 
or structuring, can subsequently be induced when the protein is at its proper lo-
cation or in the proper complex conformation. Our results show that the SERK1 
kinase domain has the ability to refold itself to an active kinase domain in vitro, 
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thus in the absence of any cellular components. About 80% of the kinase activity 
is regained after only 30 minutes of refolding. We conclude that the SERK1 kinase 
is not only intrinsically active, but folds efficiently to its active state. Therefore it 
seems unlikely that intrinsic disorder is a manner in which the phosphorylation 
activity of the kinase domain is regulated.
Protein function is closely coupled to its location in the cell. SERKs, as RLKs, 
are located at the plasma membrane (PM), which seems to be the major site for 
signalling. The PM is not homogenous and many proteins do not display a free 
diffusion through this lipid bilayer. In Chapter 5 the distribution of the SERK3/ 
BAK1 co-receptor and BRI1 main receptor on the plasma membrane is shown, us-
ing Variable Angle Epifluorecence Microscopy (VAEM), a technique that makes use 
of the difference in refractive index between the sample and cover slide in order 
to create an evanescence wave of excitation light. This evanescence wave only 
penetrates the sample to a certain depth (depending on the angle of the laser) and 
thus excites only those fluorophores in close proximity to the cover slide. The tech-
nique makes it possible to visualise fluorescent proteins with high resolution and 
low background signal in the plane of the plasma membrane or just below. In this 
chapter we show that this technique can be used to visualise the PM of A. thaliana 
live epidermal root cells, and several intracellular membrane compartments in the 
cytoplasm just below the PM. In addition, VAEM was used to show that SERK3/ 
BAK1 and BRI1 are not homogenously distributed across the PM, but in fact are 
present in nanoclusters. These nanoclusters are not influenced by addition or de-
pletion of ligand, and BRI1 is still present in clusters in the absence of SERK1 and 
SERK3/ BAK1. Overexpression of BRI1, or diminishing the number of PM localised 
BRI1 receptors by tyrphostin A23 treatment, influenced the number of receptors 
per cluster, but not the cluster density. We propose that the nanocluster distribution 
in the PM is a general feature of plant PM receptors.
In summary, this thesis provides new insights in the role of SERKs as co-receptors, 
their origin, regulation and localisation. A combination of different techniques, 
biochemical, molecular, bioinformatics and structural, was used to understand how 
SERKs function as co-receptors in plant signalling complexes. 
General discussion
Constant interaction to environmental changes by cellular responses is of utmost 
importance for the survival of any organism. This is illustrated by the fact that as 
many as 10% of the proteins in mammalian cells are involved in signal transduction 
(Good et al. 2011). As the cell is bombarded at any given time by numerous signals 
to which response is needed, efficient signalling is only possible if the proteins and 
substrates of the signalling cascade or tightly regulated in their spatiotemporal 
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organisation (Scott and Pawson 2009). The current view is that cells achieve their 
specific output to extracellular signalling, by organising discreet subsets of signal-
ling components together in space and time (Good et al. 2011) providing the cell 
with the specificity and sensitivity to correctly respond to changes in its environ-
ment. In multicellular organisms, this response must take into account not only the 
signal, but also the response of the neighbouring cells in the tissue. Thus, complex 
mechanisms must be in place to tailor the cellular responses to the same ligand for 
different tissues or developmental stages. 
Response to an extracellular signal starts with the perception of this signal by 
a receptor molecule, which relays this signal via a cascade of second messengers 
to a final cellular response (such as increased transcription, or altered enzyme 
activity). To tailor the response to the signal, a ligand binding receptor can form 
higher order complexes, or signalosomes, of distinct composition (Rub et al. 2009). 
In this manner, the association of ligand binding receptors with different co-recep-
tor molecules (receptors which by themselves cannot perceive ligand or transduce 
the signal) can provide specificity in the signalling output (Kirkbride et al. 2005). 
Co-receptors have been reported to influence affinity to ligands, modulate signal-
ling output, change subcellular localisations and create cross talk between different 
signalling pathways (see Chapter 1). 
The SERK co-receptors in A. thaliana have been shown to be indispensable 
players in several plant signalling pathways (Gou et al. 2012; Albrecht et al. 2005). 
SERK3/ BAK1 transphosphorylation on the Brassinosteroid receptor 1 (BRI1) was 
found to be essential for full downstream signalling activity (Wang et al. 2008), 
both SERK3 and SERK1 extracellular domains have been reported to interact with 
ligand (in vitro) (Santiago et al. 2013, Sun et al. 2013), and SERK3/ BAK1 increas-
es the endocytosis of BRI1, while impairing the endocytosis of Flagellin Sensing 2 
(FLS2) (Chinchilla et al. 2007; Russinova et al. 2004). Although these studies pro-
vide much insight in the roles the SERK co-receptors play within plant signalling 
complexes, not much is known on the mechanisms underlying SERK specific func-
tions. The SERK protein family in Arabidopsis consists of five highly homologous 
members, that each function in a specific subset of signalling pathways (Schmidt 
et al. 1997, Albrecht et al. 2005, Lewis et al. 2010, Li et al. 2002, Nam and Li 
2002, Karlova et al. 2006, Chinchilla et al. 2007, He et al. 2007, Heese et al. 2007, 
Kemmerling et al. 2007, Albrecht et al. 2008, Postel et al. 2010). How these similar 
proteins function in such different pathways is still puzzling. Also the question why 
these proteins have been incorporated in so many, seemingly unrelated, pathways 
has not been addressed. In this thesis, I employed several biochemical and micro-
scopic techniques to investigate the molecular basis of SERK specificity, regulation 
and function in plant signalling pathways. 
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Essential roles of SERKs in signalling complexes
The classic concept of signal transduction mediated by single pass transmembrane 
receptors, such as receptor tyrosine kinases (RTKs), is through ligand induced di-
merization, which allows for transphosphorylation between kinase domains (Hub-
bard and Miller 2007). These transphosphorylation events cause structural changes 
in the kinase domain which stabilises the active state (Hubbard 2004). The forma-
tion of receptor-dimers, or oligomers, is essential for activation of these RTKs; to 
be able to translate ligand binding at the extracellular domain to activation of cyto-
plasmic kinase domains, conformational changes in different parts of the receptor 
is required. An example is the activation of the epidermal growth factor receptor 
(EGFR). In the absence of ligand, preformed dimers of EGFR exist, but are in the 
inactivate state (Moriki et al. 2001); ligand binding induces conformational chang-
es leading to activation via asymmetric kinase dimers (Zhang et al. 2006). 
The plant counterparts of the animal RTKs are the receptor-like-kinases (RLKs), 
belonging to the same superfamily of receptor kinases (Shiu and Bleecker 2001b). 
Examples of RLKs are the brassinosteroid insensitive 1 (BRI1) and flagellin-sensing 
2 (FLS2) receptors and the somatic embryogenesis receptor-like-kinases (SERKs). 
Although knowledge on the dimerization or oligomerization of these receptors is 
not as extensive as for their animal counterparts, the emerging theme is that com-
plexes exist already prior to ligand binding. Both FLS2 and BRI1 were found to 
form homodimers in absence of ligand (Wang et al. 2005, Gendron and Wang 
2007, Hink et al. 2008, Sun et al. 2012) and preformed complexes have also been 
observed between SERK3 and BRI1 (Bücherl et al. 2013). However, for both FLS2 
and BRI1, ligand binding to their extracellular domains did not induce homodimer-
ization, nor did it induce large conformational changes (Hothorn et al. 2011, Sun 
et al. 2013). Thus, these in vitro experiments provide indications that the ‘simple’ 
mode of activation, where ligand binding induces a particular dimer conformation 
that leads to kinase activation, does not hold true for these receptors. As a conse-
quence, additional players, i.e. the SERK co-receptors, are needed within the active 
signalling complex. This idea is corroborated by the fact that signalling is complete-
ly lost in a plant lacking the necessary members of the SERK family (Albrecht et 
al. 2005, Gou et al. 2012). However, a major question that still remains is how the 
SERKs accomplish the activation of the signalling complex. If mere proximity of 
the SERK kinase domain is needed for activation via transphosphorylation events, 
preformed complexes between BRI1 and SERK3 would not be expected (as are 
observed in Bücherl et al. 2013). In addition, this would suggest that the different 
functions of the different SERK members can be attributed to differences in the 
cytoplasmic domain. As was shown in Chapter 2, the mechanisms underlying SERK 
specificity are much more complex, and more than only the cytoplasmic domain 
is essential for proper SERK function. For this reason, it would be of great interest 
to elucidate how the (inactive) preformed complexes of SERK3 and BRI1 are acti-
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vated and whether this involves asymmetric kinase dimers as in EGFR (Zhang et 
al. 2006). For this, more structural information (especially of the kinase domain 
dimers) of these receptor complexes is needed. 
Even though the crystal structures of extracellular domain complexes have 
indicated that the SERKs associate with both the ligand and the extracellular do-
main of the main ligand binding receptor (Santiago et al. 2013, Sun et al. 2013) 
the data presented in Chapter 2 demonstrates that also the extracellular domain 
cannot be the sole determinant for SERK specificity. Moreover, although the crystal 
structures indicate a role for the SERKs in ligand binding, functional data is still 
missing to evaluate the importance of these interactions. The presence of SERKs 
in receptors is essential for signalling (Albrecht et al. 2005, Gou et al. 2012), but 
whether the SERK-ligand interactions contribute to this, or whether the SERK-main 
receptor interactions are sufficient, remains to be investigated. As Kinoshita et al. 
(2005)has calculated the binding affinity of BRI1 for BL in absence and presence 
of the co-receptor SERK3/ BAK1 and found no difference, the affinity of the SERK 
co-receptors for the respective ligands might be too low to be of any significance in 
planta. Determining the binding affinity of SERKs for different ligand in vitro via, 
for instance, fluorescent binding assays with fluorescent casasterone (Irani et al. 
2012), could be of great interest to evaluate the possible contribution of this inter-
action to the ligand affinity of the receptor complexes. In addition, it might provide 
answers to the question why SERK2 can form complexes with BRI1 (although only 
in protoplasts), but cannot transmit BR signalling (Albrecht et al. 2008, and unpub-
lished data); as perhaps the affinity of the BRI1-SERK2 complex for the BR-ligand 
is too low for signalling function in planta. 
Incorporation of SERKs in different signalling complexes
Phylogenetic analysis shows that the SERK co-receptors predate the BRI1 and FLS2 
main receptor molecules. This is remarkable, as co-receptors traditionally have not 
been thought to signal independently of their main signalling receptors. Either an-
other ancestral main receptor (such as an ortholog of EMS1/EXS, the proposed li-
gand-binding receptor of the SERK1-SERK2 pair that is involved in male sporogen-
esis; Albrecht et al. 2005) was present in these earlier genomes, or the SERKs have 
an autonomous function not yet uncovered. An example of a co-receptor that also 
has autonomous signalling activity is the p75ntr receptor, initially identified as a 
co-receptor to the Trk tyrosine receptor kinase. p75ntr can directly, and without 
activity of a main ligand-perceiving receptor, signal in apoptosis, Swann-cell mi-
gration and neuronal myelination (Nykjaer et al. 2005). It is not unimaginable 
that SERKs can transmit signals without the presence of main receptors or can be 
activated independently of the main signalling pathway using ligand-binding pro-
teins such as MSBP1 (Shi et al. 2011). To elucidate the ancient role of the SERKs, it 
will be of interest to further investigate the genes that originate from evolutionary 
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older genomes, such as Physcomitrella patens, to determine how they function in 
modern plants genomes. This may provide insight in how SERKs function, and es-
pecially how they have been recruited in the many, seemingly unrelated, signalling 
pathways and complexes. 
Signalling pathways in which SERKs function take place in the same cell often 
at the same time (Robatzek et al. 2006, Savaldi-Goldstein et al. 2007). This calls 
for tight regulation on the formation of signalling complexes, as the SERKs need 
to be divided amongst the different complexes. One way in which this could be 
accomplished is by the preformation of signalling complexes in the ER or Golgi 
network, after which they are transported to the plasma membrane (PM) as a full 
signalling unit. Preformed complexes shortly after biosynthesis have been observed 
for SERK3 and BRI1 (Bücherl et al. 2013), although only a minor amount. In addi-
tion, clear ligand-induced hetero-oligomer formation has been observed between 
SERK3 and FLS2 (Roux et al. 2011) and SERK3 and BRI (Chapter 2). Whether 
preformation of complexes alone is sufficient to regulate the division of the co-re-
ceptors amongst the different signalling pathways remains to be determined.
In order to have further insight into the organisation of receptors in the PM-lo-
cated complexes, it was of interest to see how BRI1 and SERK3 are present in the 
PM. Previous work using confocal microscopy suggested that most of the recep-
tors co-localised in the PM but few physically interacted. Because the BRI1-SERK3 
heterodimers were not uniformly present, spatial segregation between active and 
non-active complexes in the PM appears to be the case (Bücherl et al. 2103). As is 
seen in Chapter 5, BRI1 and SERK3 are present in nanoclusters in the PM that are 
almost completely immobile. Therefore it seems unlikely that a large exchange of 
receptors can occur between clusters before or after ligand binding. Most likely, the 
clusters already contain all the components needed for the formation of an active 
signalling complex, which is in line with the almost instantaneous association and 
transphosphorylation observed between SERK3 and FLS2 upon ligand application 
(Schulze et al. 2010). However, it is puzzling how this relates to the slow kinetics 
of heterodimer formation between SERK3 and BRI1 observed after only 30 min 
with FRET-FLIM (Bücherl et al. 2013) and co-immunoprecipitation (Albrecht et 
al. 2012). This could suggest that different stoichiometry within the nanoclusters 
greatly influence the kinetics of complex formation and activation and thereby the 
timing of signalling output. Nanoclusters can be formed by physical features, such 
as lipid microdomains or the cytoskeleton (He and Marguet 2011). In plant cells, 
the ordering in the PM is reported to be caused by the presence of the cell wall 
(Martinière and Runions 2013), and some indications exists that cluster formation 
might be coupled to signalling activity (Demir et al. 2013, Wang et al. 2013). How-
ever, for BRI1 and SERK3, this remains to be investigated. 
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Regulation of SERK activity
Being essential components of active signalling complexes, SERK kinase phospho-
rylation activity needs to be tightly regulated. Protein phosphorylation can be con-
trolled in various ways, such as transcriptional regulation, availability of substrates 
via recruitment or control of subcellular localisation (Pawson and Scott 1997, Scott 
and Pawson 2009) or regulation at the protein level, via structural or chemical 
modifications to the kinase domain (Hubbard and Till 2000). BRI1 activity is regu-
lated via several mechanisms; auto-inhibition mediated by the C-terminal domain 
(Wang et al. 2005); binding of the inhibitor protein BKI (Wang and Chory 2006), 
and degradation mediated via dephosphorylation by PP2A (Di Rubbo et al. 2011). 
For the SERK proteins no such regulatory elements are presently known. As was 
shown, the SERK1 kinase domain is intrinsically active in vitro (Chapter 4 and Kar-
lova et al. 2009) suggesting that inhibition mechanisms must be in place in vivo. 
Regulation of kinase activity employing intramolecular regulatory domains that 
cause auto-inhibition, as is reported for BRI1 (Wang et al. 2005) can take place in 
various ways. Intramolecular regulatory domains may keep kinase domains inac-
tive, either by allosteric regulation (binding to sites distinct from the active site, 
usually stabilising an inactive conformation) or intrasteric regulation (binding in 
the catalytic site, hindering kinase activity using the specificity and structure of the 
active site) (Krueger et al. 1995, Kobe and Kemp 1999). These regulatory domains 
are often found in the regions flanking the kinase domain; the juxtamembrane 
domain and the C-terminal tail segment. Examples of such regulation mechanisms 
can be seen for the TIE2 kinase domain, where the C-terminal tail blocks access to 
the substrate binding site (Shewchuk et al. 2000 ), or the EphB2 tyrosine kinase re-
ceptor, in which the juxtamembrane domain adopts a structure which prevents the 
formation of the active conformation of the kinase activation loop (Wybenga-Groot 
et al. 2001). Phosphorylation of specific sites in these auto-regulatory domains is 
often required for activation of the kinase (Huse and Kuriyan 2002, de Castro et al. 
2010). However, several other methods are also reported to release inhibition of in-
tramolecular regulatory domains, such as proteolysis, reduction of disulfide bonds 
or protein activators or ligands (Kobe and Kemp 1999). Phosphorylation events 
play a major role in the activation of the signalling pathways involving SERKs, of-
ten in a sequential fashion. Initial phosphorylation events of BRI1 on SERK3/BAK1 
activate the co-receptor kinase domain, which subsequently transphosphorylates 
the main receptor on specific sites (Wang et al. 2008). The following phospho-
rylation of the inhibitor proteins BRI1 Kinase Inhibitor 1 (BKI1) and the BR-sig-
nalling kinase 1 (BSK1) by the fully activated BRI1 are thought to be the first 
steps downstream of the receptor complex (Tang et al. 2008 , Jaillais et al. 2011,). 
Mathematical modeling indicates that the SERK co-receptors mainly function by 
increasing the maximal output of the BRI1 main receptor (van Esse et al. 2013). 
The phosphorylation events in flagellin signalling also occur in strict sequential 
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fashion; the receptor-like-cytoplasmic kinase BIK1 is likely first phosphorylated by 
SERK3/BAK1 and subsequently transphosphorylates the FLS2-BAK1/SERK3 com-
plex to propagate flagellin signalling (Lu et al. 2010). These reports clearly in-
dicate that plant signalling pathways employ phosphorylation (both regulated in 
sequence of phosphorylation and specific residues) to regulate activation. As the 
sequence analysis in Chapter 2 uncovered that especially the C terminal domain 
of the SERKs is divergent and less constraint, and because several phosphorylation 
sites are present in this domain, this could be a very interesting domain for further 
investigations into regulation of SERK kinase activity. 
SERK specificity and redundancy
The Arabidopsis SERK proteins have very similar protein sequences, function in 
specific subsets of signalling pathways and are partially redundant (Albrecht et al. 
2005, Albrecht et al. 2008, Roux et al. 2011). The mechanisms underlying SERK 
functionality and redundancy are therefore rather complex; while most, but not 
all SERKs are capable of interacting with a main ligand binding receptor, signal-
ling capacity is coupled to the presence of domains specific for a particular SERK 
family member. For example, as discussed in Chapter 2, the SERK1 and SERK2 
cytoplasmic domains are interchangeable in male sporogenesis, while the SERK3 
cytoplasmic domain is essential for SERK3 specific functionality in both the BR 
and PTI pathways. To complete this puzzle, SERK1 and SERK3 are partially redun-
dant in BR signalling. It is presently not clear to which properties of the different 
proteins these properties can be traced back to. The C-terminal tail is the most 
divergent region of the cytoplasmic domain and could have an important role. In 
addition, differences between SERK3 and SERK2 tyrosine phosphorylation sites 
points could also be of importance. In contrast to the animal receptor tyrosine 
kinases, plant RLKs were traditionally classified as serine/threonine kinases (Shiu 
and Bleecker 2001b). However, tyrosine phosphorylation has now been reported 
for BRI1, SERK1, SERK3 and several other plant RLKs (Shah et al. 2001, Oh et al. 
2009; Oh et al. 2011) and is suggested to be as important in plants as in animals 
(Ghelis 2011). Tyrosine phosphorylation of BIN2 and BKI are essential steps in the 
BR signalling pathway (Kim et al. 2009, Jaillais et al. 2011). Because of this, it is 
tempting to suggest that differences in tyrosine phosphorylation sites between the 
various SERK proteins could be linked to distinct functionalities in the BR, and 
perhaps also in other, SERK-mediated pathways. 
However, initial results using the SERK chimeric proteins indicate that tyrosine 
phosphorylation cannot be the sole determinant, as the SERK3 kinase domain was 
not sufficient to confer BR signalling capacity to SERK2. This is markedly different 
from most main ligand binding receptors, where mostly the cytoplasmic domain is 
solely responsible for the specificity of downstream signalling (Riedel et al. 1986, 
Riedel et al. 1989). For instance, a chimer between Nod-factor receptors from Lotus 
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japonicas (involved in rhizobium symbiosis) and chitin receptor from A. thaliana 
(involved in defense signalling) created a receptor that activates the downstream 
signalling components corresponding to the cytoplasmic receptor domain, when 
induced with the ligand corresponding to the extracellular receptor domain (Wang 
et al. 2014). For SERKs, it has been established that their extracellular domain 
can bind to multiple ligands (Santiago et al. 2013, Sun et al. 2013) and their 
intracellular domain can phosphorylate multiple associated receptors of different 
signalling pathways (Schwessinger et al. 2011). This might lead to the assumption 
that SERKs specificity is solely created by affinity for complex formation and phos-
phorylation of the main receptor. 
In conclusion, of the various functions that coreceptors may have in transduc-
ing the signal originating from an activated main ligand-binding receptor, to add 
specificity, modulate or determine the output, mediating cross-talk, stabilising the 
multiprotein membrane complex and translocating the main receptor to an inter-
nal compartment it appears that in the case of the SERK proteins, only a function 
in cross-talk (Albrecht et al. 2012) and in receptor translocation (Bücherl et al. 
2013) have been ruled out so far. For all other aspects, evidence has been found 
and in part presented in this thesis of this small class of intriguing Arabidopsis 
co-receptors.
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Het kunnen vertalen van een extracellulair signaal naar een corresponderende 
intra cellulaire reactie is essentieel voor alle levende organismen. Het waarnemen 
van deze extracellulaire signalen, of extracellulaire signaal moleculen, gebeurt 
over het algemeen via ligand bindende eiwitten die over het plasma membraan 
heen steken, de zogenaamde receptor eiwitten. In planten vallen de meeste plas-
ma membraan receptor eiwitten onder de familie van ‘leucine-rich-repeat recep-
tor-like-kinases’ of LRR-RLKs. Deze eiwitten bevatten een extracellulair domein 
met een leucine rijk motief, gekoppeld aan een intracellulair kinase domein via 
een enkel trans-membraan helix. Zowel de plant LRR-RLKs als hun dierlijke tegen-
hangers, de receptor tyrosine kinases (RTKs)worden gedacht dimeren of oligomer-
en te vormen om op die wijze hun intracellulaire kinase domeinen te activeren. 
Soms maken ook andere transmembraan eiwitten onderdeel uit van deze receptor 
complexen. Wanneer dit het geval is, kunnen we onderscheid maken tussen de 
‘hoofd’ receptor, die zowel het domein bevat dat het extracellulaire signaal molec-
uul kan herkennen, als de mogelijkheid bezit om dit signaal over het membraan 
heen te kunnen vertalen naar een cellulaire reactie. Daarnaast kunnen er ook nog 
co- receptoren onderdeel uitmaken van het receptor complex. Deze receptoren kun-
nen op zichzelf staand óf het signaal niet herkennen, óf dit signaal niet omzetten in 
een cellulaire reactie. De somatische embryogenese receptor kinases (SERKs) zijn 
een familie van co-receptoren in planten, die meerdere functies in zeer verschillen-
de, en ogenschijnlijk niet gekoppelde, signaal transductie routes bewerkstelligen. 
Zo werken de SERKs in het vormen van sporen, de groei en ontwikkeling van de 
plant, en het afweermechanisme. In Arabidopsis thaliana bestaat de SERK familie 
uit vijf leden, waarvan alleen van SERK5 nog geen functie bekend is. De andere 
vier SERK leden in Arabidopsis thaliana hebben deels overlappende functies, maar 
elk functioneert wel in zijn eigen specifieke subset aan signaal transductie routes. 
In deze thesis heb ik gekeken naar de SERK familie van receptor kinases, om hun 
rol als co-receptoren in plant signalering en de regulatie van deze eiwitten beter te 
begrijpen. Door studies naar receptor functie en signalering in dierlijke systemen, 
weten we dat co-receptoren veel verschillende functies kunnen vervullen binnen 
signaal complexen, waardoor zij een additionele vorm van regulatie bewerkstelli-
gen voor de signaal transductie. De kennis die hiervan al aanwezig is, heb ik bedis-
cussieerd in Hoofdstuk 1. In dit hoofdstuk heb ik ook een overzicht gegeven van 
de huidige kristal structuren die al gepubliceerd zijn over plant LRR-RLKs. Deze 
structuren geven de eerste aanwijzingen over de onderliggende  moleculaire mech-
anismen van de functie van plant receptor kinases. Interessant genoeg laten deze 
structuren zien dat de extracellulaire domeinen van de SERK eiwitten interacteren 
met niet alleen de hoofd-receptor, maar ook met de verschillende liganden. De ami-
nozuren van SERK die deze interactie met de hoofd-receptor en het ligand aangaan 
zijn aanwezig in de hele familie en kunnen dus de verschillende functies van de 
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verschillende SERK leden niet verklaren. Op dit interessante punt ga ik verder in 
Hoofdstuk 2. Door genetische studies is het duidelijk geworden dat de functio-
nele verschillen tussen de SERK leden niet verklaard kan worden door verschillen 
in expressie, maar door verschillen op eiwit niveau. Echter, doordat de SERK-leden 
enorm op elkaar lijken op aminozuur niveau, is het ietwat onverwacht dat zij zulke 
verschillende functies vervullen in plant signalering. In Hoofdstuk 2 zoom ik 
verder in om te kijken welke residuen/motieven of domeinen belangrijk zijn voor 
de verschillende functionaliteiten binnen de SERK familie. Een vergelijking van de 
sequentie van SERK eiwitten van verschillende plant soorten (van mos, tot rijst en 
tomaat) laat zien dat de SERK genen oude genen zijn, en al met meerdere kopieën 
te vinden zijn in de genomen van niet-vasculaire planten (zoals Physcomitrella pat-
ens). De SERK genen uit deze evolutionair oudere genomen lijken erg op de SERK1 
en 2 van Arabidopsis thaliana, wat aangeeft dat de eiwitten niet veel veranderd zijn 
in 2 miljoen jaar evolutie. Dit is een sterke aanwijzing dat de SERK genen essen-
tieel zijn in belangrijke plant signaal routes. De A. thaliana SERK3 en 4 genen zijn 
echter wel meer veranderd in hun sequentie, en vormen een aparte groep SERK 
genen die alleen in tweelobbige planten aanwezig is. Hoogstwaarschijnlijk is deze 
verandering van de SERK3/4 genen gekoppeld aan een andere functionaliteit van 
deze eiwitten. Het koppelen van het extracellulair domein van een SERK aan het 
intracellulair domein van een andere SERK (waarmee chimere eiwitten ontstaan) 
laat zien dat de specificiteit tussen de verschillende SERK leden een complex ge-
heel is, welke niet kan worden toegeschreven aan één specifiek aminozuur/motief 
of zelfs domein. 
Het vergelijken van de driedimensionale eiwit structuur van de SERK leden 
kan helpen bij het begrijpen van functionele specificiteit en overlap binnen deze 
familie. In de afgelopen jaren zijn de eerste kristal structuren van plant LRR-RLKs 
gepubliceerd. Dit waren het kinase domein van SERK3/BAK1, het extracellulair 
domein van SERK1 in complex met het extracellulair domein van BRI1 (Brassinos-
teroid Insensitive 1, de receptor voor het plant steroïde hormoon brassinosteroid) 
en het complex van het extracellulair domein van SERK3 met FLS2 (Flagellin Sens-
ing 2, de receptor die bacterieel flagelline herkent). Deze structuren geven be-
langrijke informatie over de structuur-functie relatie van plant LRR-RLKs. Extra 
structuren, van de andere SERKs of van andere complexen, kunnen veel informatie 
opleveren over hoe de verschillende functionaliteiten van de SERKs gekoppeld zijn 
aan hun structuur. In Hoofdstuk 3 beschrijf ik onze werkwijze om de kristalstruc-
turen van de kinase domeinen van de verschillende SERK eiwitten op te helderen. 
Onze aanpak werd gehinderd door lage eiwitopbrengst en moeilijkheden tijdens 
de zuivering. Het is gelukt om twee kristallen te groeien van het SERK1 kinase do-
mein, welke een diffractie vertoonde van ongeveer 2.5 Å resolutie. Echter, hiermee 
was het niet mogelijk om de structuur te bepalen. 
Naast structurele informatie, kan biochemische informatie over de eiwitten 
ook veel duidelijkheid geven. In Hoofdstuk 4 gebruik ik een combinatie van 
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spectroscopische technieken en activiteit assays om te onderzoeken hoe de activi-
teit van het kinase domein gereguleerd is. Co-receptoren hebben vaak een functie 
als extra regulatie van een signaal transductie route, maar kunnen dit natuurlijk al-
leen wanneer hun eigen activiteit ook strikt gereguleerd is. Zowel in deze thesis, als 
in andere studies, is het aangetoond dat veel kinase domeinen van receptoren en 
co-receptoren intrinsiek aan staan wanneer zij in vitro geproduceerd worden. Dit 
betekend dat er in vivo mechanismen moeten bestaan die het eiwit inactief houden 
wanneer hun activiteit niet wenselijk is. In Hoofdstuk 4 heb ik een mechanisme 
onderzocht wat eiwitten inactief kan houden, namelijk het houden van het eiwit 
in een intrinsiek wanordelijke staat. Dit betekend dat het eiwit niet de correcte 
structuur heeft, en ongestructureerd of ontvouwen is tot dat de activiteit nodig is. 
Het vouwen of structureren van het eiwit kan dan geïnduceerd worden wanneer 
het eiwit op de juiste locatie is, of onderdeel is van het juiste eiwitcomplex. Onze 
resultaten laten zien dat het SERK1 kinase domein kan hervouwen tot een actief 
kinase in vitro, dus zonder enige vorm van cellulaire context of interactie partners. 
Na 30 minuten hervouwen, is ongeveer 80% van de kinase activiteit herkregen (in 
vergelijking met de kinase activiteit voor het ontvouwen). Hieruit concluderen wij 
dat het SERK1 kinase domein niet alleen intrinsiek actief is, maar zich ook efficiënt 
vouwt tot een actief eiwit. Hierdoor is het onwaarschijnlijk dat intrinsiek ontvou-
wing een manier is waarop de fosforylatie activiteit van SERK1 geregeld is. 
De functie van een eiwit is nauw gekoppeld aan zijn locatie in een cel. De SERK 
eiwitten, aangezien zij RLKs zijn, zijn gelokaliseerd in het plasma membraan. Dit 
lijkt ook de belangrijkste plaats te zijn waarvandaan veel van de signaal trans-
ductie routes beginnen waarin SERKs een rol spelen. Het plasma membraan is 
niet homogeen en veel eiwitten ondervinden beperkingen in hun diffusie door het 
plasma membraan. In Hoofdstuk 5 van deze thesis is de distributie van de SERK3 
co-receptor en de BRI1 hoofdreceptor op het plasma membraan te zien. Om deze 
distributie te visualiseren is gebruik gemaakt van de techniek VEAM, welke gebruik 
maakt van het verschil in de brekingsindex tussen het monster en het dekglaasje 
om een zogenaamde ‘evanescence wave’ te creëren. Deze evanescence wave kan 
enkel tot een bepaalde diepte het monster ingaan (dit ligt aan de hoek waaronder 
het laserlicht op het monster schijnt), en kan dus die fluoroforen aanslaan die zich 
dicht bij het dekglaasje bevinden. Deze techniek maakt het mogelijk om fluorescen-
te eiwitten in het plasma membraan of net daaronder met hoge resolutie en lage 
achtergrond fluorescentie te laten zien. In Hoofdstuk 5 laten we zien dat met 
VEAM fluorescente eiwit op het plasma membraan van levende A. thaliana epider-
mis wortelcellen gevisualiseerd kunnen worden, maar ook sommige intracellulaire 
compartimenten die dicht bij het plasma membraan liggen. Daarnaast is VEAM 
gebruikt om te laten zien dat SERK3/ BAK1 en BRI1 niet homogeen over het mem-
braan zijn verspreid, maar nanoclusters vormen. Deze nanoclusters kunnen niet 
beïnvloed worden door toevoeging of verwijdering van ligand. Daarbij zit BRI1 ook 
nog steeds in nanoclusters wanneer SERK3 of SERK1 niet aanwezig zijn. Overex-
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pressie van BRI1, of verlaging van het aantal membraan gelokaliseerde receptoren 
door middel van het middel tyrphostin A23, zorgde ervoor dat de  hoeveelheid 
receptoren per cluster veranderde, maar niet de verspreiding van de clusters. We 
stellen dat de nanocluster distributie een algemeen kenmerk is van plant receptor 
kinases. 
Deze thesis geeft nieuwe inzichten in de rol van de SERK eiwitten als co-receptor-
en, hun evolutionaire oorsprong, hun regulatie en lokalisatie. Met een combinatie 
van verschillende technieken uit de biochemie, bio-informatica en structurele biol-
ogie, hebben wij de functie van SERKs onderzocht in plant signaleringscomplexen. 
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